Global Analysis of Protein Phosphorylation Regulation upon Stimulation of Exocytosis in the Nerve Terminal by Kohansal Nodehi, Mahdokht
 
Global Analysis of Protein Phosphorylation Regulation 








for the award of the degree 
“Doctor rerum naturalium” 




within the doctoral program Molecular Biology 
























Thesis committee members: 
 
Supervisor, reviewer:                                             Prof. Dr. Reinhard Jahn 
                                                                                      Department of Neurobiology 
                                                                                      Max-Planck Institute for Biophysical Chemistry 
                                                                                      Göttingen, Germany 
 
 
PhD committee member, reviewer:                  Prof. Dr. Henning Urlaub 
 
                                                                                     Bioanalytical Mass Spectrometry Group  
                                                                                     Max-Planck Institute for Biophysical Chemistry 




PhD committee member:                                  Prof. Dr. Jürgen Wienands 
 
                                                                                  Institute for Cellular and Molecular Immunology 
                                                                                  University of Medical Center Göttingen 
                                                                                  Göttingen, Germany 



















I hereby declare that I prepared this PhD thesis, entitled “Global Analysis of Protein 
Phosphorylation Regulation upon Stimulation of Exocytosis in the Nerve Terminal”, on my 
own and with no other sources and aids than those cited. 
 
 
Mahdokht Kohansal Nodehi 




































Table of Contents  
1 Introduction ................................................................................................................................................... 2 
 Synaptic vesicle recycling ................................................................................................................. 2 
 Exocytosis ....................................................................................................................................... 3 
 Endocytosis .................................................................................................................................... 5 
 Synaptic vesicle pools ................................................................................................................ 8 
 Synaptosomes as a model to study exocytosis/endocytosis............................................... 9 
 Activity-dependent regulation of synaptic vesicle recycling ............................................ 11 
 Phosphorylation ........................................................................................................................ 12 
 Modulation of synaptic vesicle recycling by phosphorylation ................................ 13 
1.3.2.1 Exocytosis related phosphoproteins ......................................................................... 14 
1.3.2.2 Endocytosis related phosphoproteins ...................................................................... 16 
1.3.2.3 Cytoskeleton related phosphoproteins .................................................................... 16 
 Kinases and phosphatases of the nerve terminal ......................................................... 17 
1.3.3.1 Calcium/calmodulin-dependent protein kinase II (CaMKII) ........................... 18 
1.3.3.2 Protein kinase A (PKA) ................................................................................................... 20 
1.3.3.3 Protein kinase C (PKC) ................................................................................................... 20 
1.3.3.4 Casein kinase 2 (CK2) ..................................................................................................... 21 
1.3.3.5 Extracellular-signal Regulated Kinase 1/2 (ERK1/2) ........................................ 22 
1.3.3.6 Cyclin-dependent kinase 5 (CdK5) ............................................................................ 22 
1.3.3.7 Glycogen synthase kinase 3 (GSK-3) ......................................................................... 23 
1.3.3.8 Protein phosphatase 1 (PP1) ....................................................................................... 23 
1.3.3.9 Protein phosphatase 2A (PP2A) ................................................................................. 24 
1.3.3.10 Protein phosphatase 2B (PP2B, Calcineurin) ........................................................ 24 
 Modulation of synaptic vesicle pools via kinases/phosphatases ........................... 24 
 Mass spectrometry (MS)-based phosphoproteomics .......................................................... 25 
 Protein Identification ............................................................................................................... 25 
1.4.1.1 Tandem mass spectrometry ......................................................................................... 28 
1.4.1.2 Sample ionization ............................................................................................................. 28 
1.4.1.3 Peptide sequencing .......................................................................................................... 29 
ii 
 
1.4.1.4 Mass spectrometry instrumentation ........................................................................ 31 
1.4.1.5 Peptide and protein identification ............................................................................. 32 
 Phosphosite identification and localization .................................................................... 33 
 Mass spectrometry-based quantification ........................................................................ 34 
 Neuro-phosphoproteomics ................................................................................................... 36 
 Aim of this study ................................................................................................................................. 38 
2 Material and Methods .............................................................................................................................. 39 
 Materials ................................................................................................................................................ 39 
 Chemicals ...................................................................................................................................... 39 
 Enzymes ........................................................................................................................................ 40 
 Kits .................................................................................................................................................. 40 
 Antibodies .................................................................................................................................... 40 
 Buffers ........................................................................................................................................... 41 
 Methods ................................................................................................................................................. 41 
 Biochemical Methods ............................................................................................................... 41 
2.2.1.1 Synaptosomes preparation ........................................................................................... 41 
2.2.1.2 Protein concentration assay (BCA)............................................................................ 43 
2.2.1.3 Synaptosomes stimulation (Glutamate Release Assay) ..................................... 43 
2.2.1.4 Sample collection for mass spectrometry ............................................................... 44 
2.2.1.5 SDS-PAGE and Western Blotting ................................................................................ 44 
2.2.1.6 In vitro kinase assays for mapping of the kinases responsible for the 
phosphorylation of specific sites ..................................................................................................... 45 
 Mass spectrometry methods ................................................................................................. 46 
2.2.2.1 Protein digestion ............................................................................................................... 46 
2.2.2.2 Stable isotope dimethyl labeling ................................................................................ 47 
2.2.2.3 Strong cationic exchange (SCX) chromatography................................................ 47 
2.2.2.4 Phosphopeptide Enrichment ....................................................................................... 47 
2.2.2.5 LC-MS/MS analysis .......................................................................................................... 48 
2.2.2.6 MS raw file processing .................................................................................................... 50 
2.2.2.7 Data processing and bioinformatics analysis ........................................................ 51 
2.2.2.8 Motif-X analysis ................................................................................................................. 51 
2.2.2.9 Other tools, software and databases ......................................................................... 52 




 Establishment of a protocol for the identification and quantification of 
synaptosomal phosphopeptides ............................................................................................................... 53 
 Protein digestion and phosphopeptides enrichment by TiO2 .................................. 53 
 Impact of fractionation on the number of identified phosphopeptides ............... 54 
 Stable isotopic labeling ........................................................................................................... 59 
 Impact of dimethyl labeling on the number of quantified phosphosites............. 60 
 Phosphoproteomics of isolated nerve terminals under different stimulation 
conditions .......................................................................................................................................................... 62 
 Functional analysis of synaptosomes ................................................................................ 63 
 Activity-dependent phosphorylation changes of presynaptic proteins............... 63 
 Functional/localization grouping of regulated phosphosites .................................. 70 
3.2.3.1 Active zone proteins ........................................................................................................ 70 
3.2.3.2 Endocytosis proteins ....................................................................................................... 74 
3.2.3.3 Synaptic vesicle and exocytosis related proteins ................................................. 76 
3.2.3.4 Cytoskeleton and associated proteins ...................................................................... 78 
3.2.3.5 Ion Channels and transporters .................................................................................... 79 
 Mapping Kinases and phosphatases responsible for the phosphorylation 
changes upon stimulation ....................................................................................................................... 80 
 Identification of the presynaptic substrates of CaMKII and Calcineurin (PP2B) ...... 84 
 Impact of Calcineurin inhibition on the exocytosis and phosphorylation status 
of the presynaptic proteins .................................................................................................................... 86 
 Impact of CaMKII inhibition on the exocytosis and phosphorylation status of 
the presynaptic proteins ......................................................................................................................... 92 
4 Discussion .................................................................................................................................................. 100 
 Activity-dependent phosphorylation changes of nerve terminal proteins .............. 100 
 Ca2+ ions are the main regulator of phosphorylation upon stimulation ........... 100 
 Impact of active zone proteins phosphorylation on synaptic transmission ... 101 
 Phosphorylation of cytoskeleton-associated proteins regulates exo- and 
endocytosis ................................................................................................................................................ 102 
 Multisite phosphorylated proteins .................................................................................. 103 
 Possible role of Calcineurin in RRP pool replenishment and kinase regulation .... 104 
 CaMKII might function as the major regulator of kinases/phosphatases upon 
stimulation ..................................................................................................................................................... 106 
iv 
 
 Activity of kinases and phosphatases is tightly coordinated in the nerve terminal
 108 
 Experimental approach ................................................................................................................ 111 
 Stimulation of synaptosomes ............................................................................................ 111 
 Time-course of stimulation-dependent phosphorylation changes ..................... 113 
 Mass-spectrometry approach ............................................................................................ 114 
 Conclusions and perspectives .................................................................................................... 116 
5 References ................................................................................................................................................. 118 
6 Appendices ................................................................................................................................................ 139 
 List of abbreviations ...................................................................................................................... 139 
 Supplementary Tables .................................................................................................................. 141 



















List of Figures 
Figure 1-1: The key steps of synaptic vesicle recycling. ......................................................................... 3 
Figure 1-2: Protein components clathrin-mediated endocytosis are recruited sequentially. 6 
Figure 1-3: Suggested modes of synaptic vesicle recycling. ................................................................. 7 
Figure 1-4: Synaptosome structure. ............................................................................................................. 10 
Figure 1-5: Phosphorylation of amino acids investigated in this work.......................................... 13 
Figure 1-6: The protein kinase reaction. .................................................................................................... 18 
Figure 1-7: Functional domains in the primary structure of calcium/calmodulin-dependent 
protein kinase II (CaMKII). .............................................................................................................................. 19 
Figure 1-8: Functional domains in the primary structure of protein kinase C (PKC) isoforms
 .................................................................................................................................................................................... 21 
Figure 1-9: The general workflow of a shotgun (phospho)proteomics ......................................... 26 
Figure 1-10: Nomenclature of fragment ions. .......................................................................................... 30 
Figure 1-11: The schematic view of a Q-Exactive HF instrument. ................................................... 31 
Figure 1-12: Labeling scheme of the reactions occurs in stable isotope dimethyl labeling. .. 35 
Figure 2-1: The flow diagram of purification of synaptosome from rat brains. ......................... 42 
Figure 2-2: Conversion of glutamate to α-ketoglutarate is coupled to the reduction of NADP+ 
to NADPH by Glutamate dehydrogenase. ................................................................................................... 43 
Figure 3-1: Optimization of protein digestion and TiO2 phosphopeptides enrichment. ......... 55 
Figure 3-2: Effect of strong cation exchange chromatography on the identification of 
phosphosites. ........................................................................................................................................................ 56 
Figure 3-3: Effect of starting material on the identification of phosphopeptides. ..................... 57 
Figure 3-4: Comparison between TiO2 and IMAC phosphopeptides enrichment methods. .. 58 
Figure 3-5: Dimethyl labeling. ........................................................................................................................ 59 
Figure 3-6: Effect of dimethyl labeling on the number of quantified phosphosites. ................. 61 
Figure 3-7: Glutamate release assay. ........................................................................................................... 62 
Figure 3-8: Functional assessment of synaptosomes ............................................................................ 64 
Figure 3-9: Experimental workflow for quantitative phosphoproteomics of synaptosomes in 
different stimulation conditions. ................................................................................................................... 66 
Figure 3-10: Overview of the quantified phosphosites in the three comparisons. .................... 68 
Figure 3-11: Overlap of quantified phosphosites in different comparisons. ............................... 69 
Figure 3-12: Functional/localization categorization of the regulated phosphosites in the 
three comparisons. ............................................................................................................................................. 71 
Figure 3-13: Quantified phosphosites of active zone in the K+, Ca2+ versus K+, EGTA 
comparison. ........................................................................................................................................................... 73 
Figure 3-14: Phosphosites related to clathrin-mediated endocytosis. ........................................... 75 
Figure 3-15: Regulation of synapsin1 phosphosites upon stimulation. ......................................... 77 
Figure 3-16: Motif analysis of the regulated phosphosites and experimental verification of 
the involved kinases. .......................................................................................................................................... 83 
Figure 3-17: Experimental workflow for quantitative phosphoproteomics of synaptosomes 
treated with Calcineurin and CaMKII inhibitors. .................................................................................... 85 
vi 
 
Figure 3-18: Glutamate release assay and immunoblot analysis of synaptosomes treated 
with Cyclosporine A. ........................................................................................................................................... 88 
Figure 3-19: Overview of the quantified phosphosites of synaptosomes treated with 
Cyclosporine A. ..................................................................................................................................................... 89 
Figure 3-20: Motif analysis of the putative substrates of Calcineurin. ........................................... 90 
Figure 3-21: Motif analysis of the downregulated phosphosites by Calcineurin inhibition. . 92 
Figure 3-22: Glutamate release assay and immunoblot analysis of synaptosomes treated 
with KN-93. ............................................................................................................................................................ 93 
Figure 3-23: Overview of the quantified phosphosites of synaptosomes treated with KN-93.
 .................................................................................................................................................................................... 94 
Figure 3-24: Analysis of the downregulated phosphosites by CaMKII inhibition. ..................... 96 
Figure 4-1: CaMKII inhibition downregulates PKA and PKC activity indirectly through the 
downregulation of PDK-1. ............................................................................................................................. 107 
Figure 4-2: Activity of kinases and phosphatases is tightly coordinated in the nerve terminal 
upon stimulation. .............................................................................................................................................. 110 
Figure 4-3: KCl stimulation versus electrical stimulation. ............................................................... 112 
Figure 4-4: Dynamics of glutamate release and protein phosphorylation by KCl versus 
electrical stimulation. ..................................................................................................................................... 115 
 
List of Tables 
Table 1-1: Categorization of the most commonly used quantitative approaches of 
proteomics. ............................................................................................................................................................ 34 
Table 2-1: List of the chemicals used in this study. ................................................................................ 39 
Table 2-2: Enzymes used in this study. ....................................................................................................... 40 
Table 2-3: Kits used in this study. ................................................................................................................. 40 
Table 2-4: Antibodies used in this study, WB (Western Blot). .......................................................... 40 
Table 2-5: List of buffers and their composition used in this study. ............................................... 41 
Table 2-6: Enzymes, control peptides and chemicals used in in vitro kinase assays. .............. 45 
Table 2-7: Sequence of peptides used in in vitro kinase assay. ......................................................... 46 
Table 6-1: List of regulated phosphosites in comparison K+, EGTA vs K+, Ca2+ ....................... 141 
Table 6-2: List of regulated phosphosites in comparison EGTA vs K+, Ca2+ .............................. 145 
Table 6-3: List of regulated phosphosites in comparison EGTA vs K+, EGTA ........................... 150 
Table 6-4: List of upregulated phosphosites upon Calcineurin inhibition (putative 
Calcineurin substrates). ................................................................................................................................. 152 
Table 6-5: List of downregulated phosphosites upon Calcineurin inhibition. ......................... 154 
Table 6-6: List of downregulated phosphosites upon CaMKII inhibition. .................................. 156 
 
Abstract | 1  
 
Abstract 
In chemical synapses, neurons communicate with each other via two mechanisms known as 
fast and slow synaptic transmission. Fast synaptic transmission happens within milliseconds 
and is triggered by the arrival of an action potential to the nerve terminal, resulting in the 
release of neurotransmitters. In contrast, the slow synaptic transmission occurs over 
hundreds of millisecond to minutes and involves elevation of second messengers such as Ca2+ 
ions and cAMP. Second messengers directly or indirectly modulate activity of kinases and 
protein phosphatases (PP) and consequently regulate properties of their substrates via 
phosphorylation/dephosphorylation.  
Up to date, the regulation of synaptic transmission by phosphorylation of presynaptic 
proteins has been studied by targeted and low-throughput approaches. In the current study, 
we have applied tandem mass spectrometry-based phosphoproteomics workflow to globally 
investigate the molecular mechanism of slow synaptic transmission through dynamic 
changes of the nerve terminal protein phosphorylation. Comparison of the stimulated nerve 
terminals phosphoproteome in the presence and the absence of extracellular Ca2+ ions 
revealed that Ca2+ plays a major role in the regulation of protein phosphorylation, while 
membrane depolarization has a minor role. Moreover, it was demonstrated that components 
of active zone protein group undergo extensive phosphorylation changes during stimulation. 
Noteworthy many phosphosites of large scaffolding proteins bassoon and piccolo were 
dephosphorylated.  
In the next step, considering the role of Ca2+ in the regulation of phosphosites, the 
pharmacological specific inhibitors of a Ca2+-dependent kinase (CaMKII) and a phosphatase 
(Calcineurin) were used to investigate their role in regulation of the phosphosites. 
Calcineurin inhibition revealed that many of regulated active zone phosphosites are 
Calcineurin substrates. In addition, it was shown that, phosphorylation of critical 
phosphosites were downregulated upon CaMKII inhibition. 
Overall, our data suggest that upon the stimulation of nerve terminal activity of CaMKII, PKC, 
PKA, ERK1/2, CK2, PP2A, and Calcineurin is upregulated, whereas activity of CdK5, GSK-3, 
PP1 is downregulated. In conclusion, we propose a model in which Ca2+ has a primary role in 
regulation of tightly interconnected network of kinases and phosphatases upon stimulation.
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1 Introduction 
 Synaptic vesicle recycling 
Neuronal communication at the chemical synapses is mediated by release of chemical signals 
(neurotransmitters) from the presynaptic neurons into a space that separates the pre and 
postsynaptic neurons called the synaptic cleft. Neurotransmitters are stored in the spherical, 
membrane-bounded organelle called synaptic vesicle (SV) that consists of proteins and 
phospholipids (Takamori et al., 2006). Upon arrival of an action potential to the nerve 
terminal, it leads the depolarization of the membrane and opening of the voltage-gated 
calcium channels. This leads to the influx of calcium ions into the nerve terminal. It has been 
estimated that SV release is detectable when the concentration of the calcium ions in the 
nerve terminal reaches 1-2 µM and is saturated by more than 20 µM (Bollmann et al., 2000). 
The increase of calcium ion concentration results in the fusion of the SVs to the presynaptic 
membrane (exocytosis) and release of neurotransmitter into the synaptic cleft. Then 
neurotransmitters diffuse toward the postsynapse and bind to their respective receptors that 
are located on the membrane of the postsynaptic neuron. There are two types of postsynaptic 
receptors. First, ionotropic receptors containing a membrane-spanning domain that function 
as the ion channel and the second, metabotropic receptors that do not have the ion channel 
as a part of their structure. However, upon binding of the neurotransmitter, intermediate 
molecules called G-proteins are activated and interact with the ion channels and regulate 
them. The opening of the postsynaptic ion channels directly by ionotropic receptors or 
indirectly by metabotropic receptors results in changes in ion permeability of the 
postsynapse membrane and, consequently it changes the membrane potential and triggers 
the sequence of the subsequent events in the postsynaptic neurons. Meanwhile, in the 
presynaptic part, the membranes of the fused SVs are retrieved from the plasma membrane 
(endocytosis) and actively refilled by neurotransmitters to be ready for the next round of 
exocytosis. The combination of exo- and endocytosis together with the neurotransmitter 
filling of the SVs is called synaptic vesicle recycling (Figure 1-1). Neurotransmitter release by 
chemical synapses requires SV recycling to refill the SV pool, clear the release site and 
prevent continuous expansion of the plasma membrane. In the following sections, a brief 
overview of the two main events of SV recycling pathway (exo- and endocytosis) as well as 
different pools of the SVs in the nerve terminal will be discussed. 
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Figure 1-1: The key steps of synaptic vesicle recycling. 
In the chemical synapses, neurons communicate with each other via release of neurotransmitters. Filled 
synaptic vesicles (SVs) with neurotransmitters undergo docking and priming steps in a specialized site of 
presynaptic membrane called active zone. The arrival of action potential opens voltage-gated calcium channels, 
resulting in the influx of Ca2+ ions into the nerve terminal. Elevated Ca2+ concentration triggers SVs to fuse to 
the membrane and release the neurotransmitters. SVs can make a transient fusion pore to release the 
neurotransmitters recycled by a mechanism called ‘Kiss and Run’ or completely fuse to the plasma membrane 
and later be retrieved by clathrin-mediated endocytosis. The newly retrieved clathrin-coated vesicles undergo 
an uncoating step, during which they lose the clathrin coat. Later, the vesicles are regenerated probably via 
involvement of early endosomes and refilled with neurotransmitter for the next round of exocytosis. Figure 
adapted from (Jahn and Fasshauer, 2012). 
 
 Exocytosis 
The fusion of synaptic vesicle into the presynaptic plasma membrane is a complex and highly 
regulated process that involves different sets of proteins in each step. SVs fusion occurs in 
the part of the membrane specialized for release called active zone. Primarily, SVs are located 
in close proximity of the active zone. This step is known to be regulated by two of the active 
zone proteins, bassoon, and piccolo (Hallermann et al., 2010, Gundelfinger et al., 2015), as 
well as the actin filaments and motor proteins such as Myosin V (Doussau and Augustine, 
2000). In the next step, SVs dock to the active zone via interaction of Rab3a (SV protein) with 
RIM (the central organizer of the active zone) (Coleman et al., 2007). Followed by docking, 
SVs interact with several proteins in the active zone such as Munc13 that prepares them for 
the fast fusion upon arrival of an action potential (priming step). On the molecular level, the 
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docking and priming steps share a lot of proteins, and it is difficult to experimentally assign 
a group of proteins to each of them.  
The primed vesicles fuse to the plasma membrane with the assistance of several proteins, for 
instance, SNARE proteins (soluble N-ethylmaleimide-sensitive factor (NSF) attachment 
protein receptors) that are crucial for the SV fusion. Synaptobrevin (also known as vesicle-
associated membrane protein or VAMP2) is one of the SNARE proteins that is located on the 
SVs. Two other members of the SNARE protein, Syntaxin and SNAP-25 are localized on the 
plasma membrane. The three proteins form an α-helical trans-SNARE complex that functions 
as the engine for membrane fusion (Jahn and Fasshauer, 2012). SNARE proteins are enough 
for the SV fusion in vitro. However, SV fusion in the physiological context requires other 
proteins such as Munc18 and Munc13. Deletion of Munc18 or Munc13 and their respective 
orthologues completely blocks the release of neurotransmitters (Verhage et al., 2000, 
Varoqueaux et al., 2002). Munc18 is known to bind to syntaxin and inhibits the formation of 
trans-SNARE complex but is also needed for the efficient SNARE nucleation (Jahn and 
Fasshauer, 2012). Munc13 is known as the priming factor that facilitates the conformational 
change of syntaxin from close to open and subsequently the formation of the SNARE complex 
(Ma et al., 2013). As it was mentioned above, fusion is triggered by influx of Ca2+ ions through 
voltage-gated calcium channels mainly by P/Q-type (CaV2.1) or N-type (CaV2.2), and less 
likely by R-type (CaV2.3) and l-type (CaV1 series), resulting in high concentrated Ca2+ 
microdomains close to the plasma membrane that are sensed by two calcium sensor proteins 
involved in the SV fusion, synaptotagmin1 and Complexins. Synaptotagmin has two calcium 
binding domains, C2A and C2B. In the presence of calcium, C2 domains bind to the acidic 
phospholipids of the membrane (Chapman, 2008) and to syntaxin alone or in the SNARE 
complex (Rizo et al., 2006) promoting the SV fusion. Complexins are also known to bind to 
the SNARE complex and play the dual inhibitory and stimulatory role in fusion. It binds to the 
surface of the SNARE complex and promotes its zippering (Xue et al., 2010). It also competes 
with synaptobrevin to interact with C-terminal of the SNARE complex (Kummel et al., 2011). 
Ca2+ is known to be buffered fast and efficiently from the cytoplasm (Meinrenken et al., 2002) 
resulting in the termination of the release. 
After fusion of the SVs to the plasma membrane, the SNARE complex remains assembled in 
the plasma membrane. An AAA+ ATPase called N-ethylmaleimide-sensitive factor (NSF) 
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hydrolyzes ATP to disassociate SNARE complex and recycle SNARE proteins (Ryu et al., 
2016). The SVs components together with the SNARE complex are retrieved from the 
membrane by endocytosis to be used for the next round of exocytosis. 
 
 Endocytosis 
Clathrin-Mediated Endocytosis (CME) is the best-studied pathway for the recycling of SVs 
(Jung and Haucke, 2007). The main proteins involved in the building of the clathrin coats are 
clathrin itself and the clathrin adaptor protein called adaptor protein 2 (AP2). Coat assembly 
is initiated in a region close to the active zone called periactive zone (Haucke et al., 2011) 
with the recruitment of the AP2 to capture the SV proteins and the clathrin. AP2 connects the 
clathrin to the membrane. As more adaptor proteins and clathrin are recruited, the coat 
acquires more curvature (Jung and Haucke, 2007, Dittman and Ryan, 2009). Several other 
adaptor proteins are involved in formation of the coats. For example, AP180 that is known to 
bind to synaptobrevin and sort it into the vesicles. AP180 also binds to AP2 as well as 
phosphoinositides. The latter binding is known to regulate clathrin polymerization (Saheki 
and De Camilli, 2012). The curvature of the coat is initially achieved by the structure of the 
clathrin that makes triskelia shape by the assembly of the three light and three heavy chains 
of clathrin molecules (Jung and Haucke, 2007, Saheki and De Camilli, 2012). The curvature is 
then stabilized by other adaptor proteins such amphiphysin and endophilin (Itoh and De 
Camilli, 2006) that contain a domain called Bin, Amphiphysin, Rvs (BAR) domain (McMahon 
and Gallop, 2005). Epsin and its isoforms (Eps15) are another set of adaptor proteins that 
induce the curvature in coats via interaction ENTH domain and PtdIns(4,5)P2. This domain 
is known to bind to clathrin and other components of the endocytosis machinery (Horvath et 
al., 2007). In the next step, the budded coated vesicles are dissociated via a fission machinery 
and mainly by a GTPase called dynamin (Saheki and De Camilli, 2012). At the C-terminal, 
dynamin has a proline-rich domain that binds to the SH3 domain of other endocytotic 
proteins such as amphiphysin, endophilin, intersectin and syndapin, as well as of 
synaptojanin (Dittman and Ryan, 2009). The newly formed synaptic vesicles are uncoated by 
an ATPase called Hsc70 and its cofactor auxilin. It is known that auxilin binds to AP2 and 
therefore targets the Hsc70 to the coated vesicles (Eisenberg and Greene, 2007). Uncoating 
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also involves synaptojanin, which is known to have a role in destabilization of the coat 
assembly (Dittman and Ryan, 2009) (Figure 1-2).  
 
 
Figure 1-2: Protein components clathrin-mediated endocytosis are recruited sequentially. 
Formation of clathrin-coated endocytotic pits during endocytosis requires the sequential recruitment of a 
variety of proteins in different steps. At the early step PI(4,5)P, AP2 and, intersectin nucleate the pit formation. 
Following, clathrin, AP180, stonin 2 induce the curvature of the pit. The curvature is stabilized by the action of 
N-BAR proteins such as Endophilin and amphiphysin. The latter proteins also recruit dynamin that is involved 
in fission of coated pits from the membrane and synaptojanin, Hsc70 and auxilin that cooperate with each other 
in the SV uncoating. Figure is adapted from (Saheki and De Camilli, 2012). 
 
Beside the clathrin-mediated endocytosis, three alternative endocytosis pathways were 
proposed to occur in the synapse (Figure 1-3): Kiss-and-Run, Ultra-fast clathrin-independent 
endocytosis and Activity-Dependent Bulk Endocytosis (ADBE) (Soykan et al., 2016). In 
contrast to CME, Kiss-and-Run pathway occurs in the active zone. In this model, synaptic 
vesicles do not completely fuse to the plasma membrane, but make a transient, nanometer 
pore between the SV membrane and the plasma membrane to release the neurotransmitter 
(Rizzoli and Jahn, 2007). Therefore the composition of the SVs remain intact and can be 
recycled very fast. In fact the Kiss-and-Run pathway (<1 sec) is much faster than CME (10-20 
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sec) (Soykan et al., 2016). In addition, high-pressure freezing electron microscopy revealed 
another even faster pathway called ultrafast endocytosis. Similar to CME, it happens in the 
periactive zone and is dependent on dynamin (Watanabe et al., 2013, Watanabe et al., 2014). 
Furthermore, after a long and strong stimulation, neurons undergo ADBE that does not 
specifically recycle SVs but is rather an emergency response to prevent the expansion of the 
synaptic plasma membrane (Nguyen et al., 2014, Nicholson-Fish et al., 2015). The parameters 
that determine which of the mentioned endocytosis pathways occur are the frequency of the 
stimulation, temperature, the type of the neurons and possibly the distinct pool of the 




Figure 1-3: Suggested modes of synaptic vesicle recycling. 
SVs are fused completely to the membrane and retrieved by the formation of clathrin-coated pits. (b) Following 
complete fusion of SVs to the membrane, they are retrieved via formation of vacuoles-like structure and later 
clathrin and AP-2 are recruited to generate SVs from the endosomal-like vacuoles. (c) SVs do not fuse completely 
to the membrane, rather they make small pores to release the neurotransmitter and are retrieved directly from 
the active zone. (d) Upon simultaneous fusion of multiple SVs, the membrane is retrieved via formation of the 
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 Synaptic vesicle pools 
One of the main features of the chemical synapses is the ability to store the synaptic vesicles 
in the nerve terminal. It is estimated that 100-200 vesicles are stored in the nerve terminal 
of hippocampal neurons. Under the electron microscope these vesicles are similar and do not 
show significant differences in their properties. However, different studies indicated that 
distinct populations of SVs (SV pools) exist in the nerve terminal that can be categorized 
based on their different release capacities. The well-established model that has been 
proposed and is still valid in the field is the three vesicle pools model containing the readily 
releasable pool, recycling pool and the reverse pool (Rizzoli and Betz, 2005). Below I will 
discuss the SV pools in more detail.   
Readily releasable pool (RRP) -The RRP is a part of the recycling pools that contains vesicles 
ready to fuse to the membrane upon stimulation. These vesicles are known to have the 
highest release probability (Waters and Smith, 2002). RRP in the hippocampal boutons is 
depleted within 2 sec of 20 Hz stimulation. The RRP vesicles are docked to the active zone, 
therefore they are the least mobile pool in the nerve terminal (Ruiz et al., 2011). Interestingly, 
it has been suggested that within the RRP, not all the docked vesicles have the similar release 
parameter and some of them are faster than the others (Hanse and Gustafsson, 2001).  
Recycling pool - The recycling pool is defined as the pool of vesicles that can undergo 
recycling repeatedly upon the mild stimulation. It is estimated that it contains 5-20% of all 
vesicles.  Recycling pool vesicles replenish the fused RRP pool vesicles through the transition 
of RP to RRP vesicles which is a rate-limiting step during persistent activity of neuron (Alabi 
and Tsien, 2012). These vessels are not docked to the active zone and during the resting 
condition have high mobility.  
Reverse pool- Vesicles of the reverse pool are reluctant to be released and only upon an 
intense stimulation (10-100 Hz for many seconds or minutes) and after RRP and recycling 
pool fuse to the membrane. The reverse pool contains 80-90% of all the vesicles. Using the 
temperature-sensitive Drosophila dynamin mutant shibire, it was shown that this pool is 
recruited for the release after the recycling pool even in low-frequency stimulation (Hayashi 
et al., 2008). The reverse pool vesicles are scattered in the nerve terminal and have low 
mobility (Rizzoli and Betz, 2005). 
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It was generally assumed that the difference in the release abilities of the SV pools is due to 
their localization regarding to the active zone. RRP are docked and ready to fuse, recycling 
pool is located behind them and ready to be substituted with RRP and reverse pool vesicles 
are located more distant from the active zone. Although this assumption is correct for the 
RRP vesicles that are docked to the active zone, evidence shows that recycling pool and the 
reserve pool intermix with each other and are not recognized spatially (Harata et al., 2001, 
de Lange et al., 2003). Nevertheless, still the recycling and the reserve pools are 
distinguishable by their different release kinetics and reverse pool vesicles are more 
reluctant to be released and also less mobile. Therefore, it has been suggested that there 
should be a mechanism that specifically keeps the reverse pool vesicles tight to each other 
and inhibits their release. It has been proposed that synapsin protein interlinks the vesicles 
to each other and also links vesicles to the actin filaments in the nerve terminal (Gitler et al., 
2004). Therefore, the vesicles with the higher frequency of recycling have less synapsin and 
remain more mobile.  
 
 Synaptosomes as a model to study exocytosis/endocytosis 
Synaptosomes represent nerve terminals of neurons that were detached from the rest of the 
axon and cell body during preparation. Their membrane reseals and makes a close 
environment containing synaptic vesicles and other subcellular organelles (Figure 1-4).  
Synaptosomes were initially isolated in 1958 by Wittaker (Whittaker, 1993), and later they 
were characterized by electron microscopy and biochemical assays. It is known that 
synaptosomes contain all of the molecular machinery that is necessary for the storage and 
the release of neurotransmitters. Besides vesicles, synaptosomes contain functional 
mitochondria that are able to produce ATP to keep them active. Synaptosomes are known to 
be able to hold the cytoplasmic Ca2+ concentration in the range of 100-200 nM in the presence 
of 2 mM extracellular Ca2+ (Verhage et al., 1988). Furthermore, they are able to maintain the 
membrane potential via their functional ion channels and transporters such as Na+/K+ 
ATPase. Preparation of high-quality synaptosomes that are metabolically stable and 
responsive to the stimulus is highly dependent on their isolation methodology. The high 
quality synaptosomes remain active for 3-4 hours after the preparation (Breukel et al., 1997). 
For any phosphoproteomics study, the desired phosphopeptides have to be enriched (see 
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section 1.4.2. for more details). Since synaptosomes are enriched for nerve terminal proteins, 
they make an ideal model for nerve terminal phosphoproteomics. This increases the 
probability of nerve terminal phosphopeptide identification compared to other subcellular 
fractions. All of the mentioned properties make synaptosome an excellent while simple 
system that has been used extensively to study the regulation of neurotransmission and 
synaptic vesicle recycling events such as exo- and endocytosis. Several methods have been 
used to depolarize the membrane of synaptosomes and evoke the neurotransmission release. 
Below I will discuss the three most common approaches. 
 
 
Figure 1-4: Synaptosome structure. 
Electron microscopy (A) and schematic image (B) of synaptosomes. Synaptosomes are the detached nerve 
terminals of neurons from the axon and cell body that contain sub-cellular organelles such as mitochondria and 
synaptic vesicles as well as functional membrane transporters and ion channels. Synaptosomes have been used 
widely as a model to study exo- and endocytosis. Scale bars shows 0.5 μm, adapted from (Daniel et al., 2012) 
 
 
High concentration of K+ ions - In this method the potassium gradient is clamped by 
increasing the extracellular potassium concentration (10-50 mM) resulting in the 
depolarization of the membrane. This opens the voltage-gated calcium channels and 
increases intracellular calcium ion concentration that initiates the neurotransmitter release 
(Nicholls and Sihra, 1986). Elevated KCl introduces a biphasic release of glutamate from the 
synaptosomes, a rapid phase that is complete within 1-5 sec and a slow phase that is half 
complete within 52 sec. After approximately 2 min the release reaches a plateau for several 
minutes. It is known that applying 30 mM KCl results in a transient spike in the intracellular 
Ca2+ concentration to 600 nM, flowing by a plateau that lasts for several minutes (McMahon 
and Nicholls, 1991).  
A B 
 
Introduction | 11  
 
Block of the potassium channels - 4-aminopyridine (1-10 mM) is commonly used to block 
the potassium channels. In contrast to the clamped depolarization produced by KCl, it 
probably induces repetitive firing of action potentials since the release is sensitive to 
Tetrodotoxin (sodium channels inhibitor) (Tibbs et al., 1989). Similar to KCl stimulation, 4-
aminopyridine initiates biphasic release of glutamate. Upon application of 4-aminopyridine, 
the Ca2+ concentration in the nerve terminal is increased up to 500 nM followed by a plateau (in 
contrast to KCl where no spike is seen). Overall, it has been suggested that 4-aminopyridine 
evoked depolarization is closer to in vivo condition because it generates repetitive firing of 
action potential that is sensitive to Tetrodotoxin (McMahon and Nicholls, 1991). 
Electrical stimulation - Synaptosomes are also responsive to electrical pulses. It has been 
shown that synaptosomes are able to release the amino acids (Bradford, 1970) in a Ca2+-
dependent manner upon electrical stimulation without disturbance of their structures 
(Rodina et al., 1980). However, most of the studies with electrical stimulation of 
synaptosomes have applied long lasting (20-30 min) pulses to investigate the metabolic 
responses of synaptosomes. There is very limited knowledge available regarding the 
neurotransmission release upon electrical stimulation (Kuo and Dodd, 2011).  
 Activity-dependent regulation of synaptic vesicle recycling  
It is well established that elevation of Ca2+ ions in the nerve terminal upon stimulation 
regulates the synchronous and also asynchronous neurotransmitter release. The short burst 
of synchronous release of neurotransmitters is mostly explained by the appearance of 
elevated Ca2+ at nano/microdomains in the vicinity of voltage–dependent calcium channels 
(Neher and Sakaba, 2008). However, the asynchronous release is a result of the extended 
elevation of cytosolic Ca2+ concentration upon repetitive stimulation of the nerve terminals. 
Stimulation of nerve terminals not only opens the voltage-gated calcium channels, it also 
triggers the release of calcium from the intracellular sources (Nizami et al., 2010). Two 
different types of molecular Ca2+ sensors in the nerve terminal are able to sense the elevation 
Ca2+ concentration: low-affinity Ca2+ sensors such as synaptotagmins that are able to sense 
the high concentration of Ca2+ in the micro-domains and are responsible for the synchronous 
neurotransmitter release and the high-affinity Ca2+ sensors such as CaM (Chin and Means, 
2000) that have several effectors, including the Munc13, Myosin V and Rab3a, which are 
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involved in the synchronous and asynchronous release (Igarashi and Watanabe, 2007). 
Elevated Ca2+ also modulates the activity of the kinases and phosphatases present in the 
nerve terminal, resulting in regulation of the phosphorylation status of the proteins. Below I 
will discuss the main characterization of protein phosphorylation as the most abundant post 
translational modification (PTM) and the role of phosphorylation in neurotransmission and 
SV recycling.   
 
 Phosphorylation 
It is known that the reversible phosphorylation of proteins modulates their activity, protein-
protein interactions and their subcellular localization (Hunter, 2007). Phosphorylation 
occurs mostly on the serine (S), threonine (T) and tyrosine (Y) amino acids (Figure 1-5). 
Serine was found to be the most frequent phosphorylated amino acid, followed by threonine 
and tyrosine (based on phosphorylation database, phosphositeplus.org). It is known that 
tyrosine phosphorylation is structurally somewhat different from two other counterparts. 
The phosphate group on tyrosine is located further from the peptide backbone than on serine 
and threonine, providing more binding specificity  (Hunter, 2014). Tyrosine phosphorylation 
can be detected by the specific phosphotyrosine-domain of proteins such as Src homology 2 
(SH2) and phosphotyrosine-binding (PTB) domain (Manning et al., 2002). In addition, the 
phosphoserine and phosphothreonine residues are recognized by the five binding modules, 
including 14-3-3 proteins, WW domains, forkhead-associated (FHA) domains and WD40 
repeats/LRR modules in F-box proteins. These domains are present in the proteins that are 
involved in various cellular processes such as ubiquitination, cell cycle or DNA repair (Yaffe 
and Elia, 2001). In addition to S, T, and Y, phosphorylation is reported to occur on basic amino 
acids such as lysine, arginine, and histidine. The phosphorylation of basic amino acids was 
initially observed in prokaryotes. However, recently they have been reported in the 
eukaryotes and their role in the signaling pathways has has been studied (Ciesla et al., 2011). 
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Figure 1-5: Phosphorylation of amino acids investigated in this work. 
Serine/threonine kinases use ATP to incorporate the phosphoryl group (highlighted in red) to the side chain of 
serine/threonine residues. Another class of kinases (tyrosine kinases) is responsible for phosphorylation of 
bulky side chain of tyrosine, adapted from http://urei.bio.uci.edu/~hudel/bs99a/lecture26/lecture7_3.html 
 
 Modulation of synaptic vesicle recycling by phosphorylation 
Protein phosphorylation is an important mechanism involved in regulation of 
neurotransmission. Advances in experimental tools such as genetic manipulation, expression 
and purification of proteins, viral transduction of primary neuronal cultures, development of 
phospho-specific antibodies, in vitro kinase assays and more recently the high throughput 
methods such as chip arrays and synthetic peptides as substrates for kinases and mass 
spectrometry (MS) based phosphoproteomics allowed us to identify many phosphorylated 
proteins in the nerve terminals and study the functional role of the phosphorylation sites in 
the recycling pathway. Most of the known nerve terminal phosphoproteins are involved in 
either exocytosis or endocytosis or both of the pathways such as cytoskeleton-related 
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1.3.2.1 Exocytosis related phosphoproteins 
SNARE proteins are reported to be phosphorylated and modulate neurotransmission. 
Synaptobrevin is known to be phosphorylated by Ca2+/calmodulin-dependent protein kinase 
II (CaMKII) at S61 (Hirling and Scheller, 1996) and casein kinase 2 (CK2) in vitro. This 
phosphorylation might regulate its interaction with other SNARE proteins (Nielander et al., 
1995). Syntaxin1 is phosphorylated at several sites. Syntaxin-1A phosphorylation at S14 and 
T21 by CK2 is known to enhance the release of glutamate from the nerve terminals via 
modulation of its interaction with Munc18 (Rickman and Duncan, 2010). Syntaxin-1A is also 
known to be the Ca2+-dependent substrate of death-associated protein (DAP) kinase at S188. 
This phosphorylation decreases its interaction with Munc18 (Tian et al., 2003). SNAP-25 is 
known to be phosphorylated by PKC at S187 resulting in the enhancement of its interaction 
with synaptotagmin 1 as well as SNARE complex formation and consequently, the release of 
vesicles (Nagy et al., 2002). In contrast, phosphorylation of SNAP-25 at T138 by protein 
kinase A (PKA) decreases the SNARE complex formation (Gao et al., 2016).  
Besides the proteins of SNARE complex, other presynaptic proteins involved in the fusion of 
SVs are also reported to be phosphorylated. The majority of the phosphorylation sites 
modulate the interaction of the proteins and consequently neurotransmission. For instance, 
Munc18 is reported to be phosphorylated at several sites by different kinases. 
Phosphorylation at Y145 (by an unknown kinase) (Lim et al., 2013), S313 (by PKC) (Barclay 
et al., 2003) and T479 (by Dual-specificity tyrosine(Y)-phosphorylation-regulated kinase 1A 
(Dyrk1A)) (Park et al., 2012) is reported to increase the binding of Munc18 to syntaxin and 
therefore inhibit the SNARE complex formation. Also, it is reported that phosphorylation of 
Munc-18 at S241 (by extracellular signal-regulated protein kinase (ERK)) and at T574 (by 
cyclin-dependent kinase 5 (CdK5)) modulates the release of neurotransmitters via an 
unknown mechanism that is not related to the binding to syntaxin (Barclay et al., 2004, 
Schmitz et al., 2016). Interestingly, it is reported that activity-dependent phosphorylation of 
Munc18-1 by PKC leads to its redistribution. Upon stimulation, it is dispersed from the 
synapse and re-clusters in few minutes (Cijsouw et al., 2014).  
As it was mentioned before, NSF is an ATPase that together with its cofactor α-SNAP 
disassembles the SNARE complex after fusion. It is known that NSF is phosphorylated at S460 
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and T461 by PKCε and at T645 by Leucine-rich repeat kinase 2 (LRRK2), enhancing its 
ATPase activity (Chou et al., 2010, Belluzzi et al., 2016). 
Synaptotagmin1 is involved in SV fusion and is the substrate of CaMKII and PKC at T112 
(Hilfiker et al., 1999) and CK2 at T125 and T128 (Davletov et al., 1993). Phosphorylation of 
T112 is known to enhance the potentiation after frequent stimulation (de Jong et al., 2016). 
Complexins are also known to be phosphorylated at S115 in the C-terminal region by CK2. 
Phosphorylation of this site increases the complexin binding to SNARE complex (Shata et al., 
2007, Malsam et al., 2009). Moreover, it has been shown that activity-dependent 
phosphorylation of complexin in Drosophila enhances the spontaneous release of 
neurotransmitters (Cho et al., 2015). 
The components of the active zone are also reported to be heavily phosphorylated. RIM as 
the central organizer of the active zone, , has been reported to be phosphorylated at several 
sites. It is known that it is phosphorylated by CaMKII at S241 and S287, resulting in binding 
to the adaptor protein 14-3-3 (Sun et al., 2003). The PKA-dependent phosphorylation of RIM 
at S413 was initially suggested to trigger long-term plasticity (LTP) (Lonart et al., 2003). 
However, later it was revealed that it is not a critical factor for the LTP (Kaeser et al., 2008). 
Two other phosphosites of RIM (S447 and S745) are phosphorylated by ERK2 via Brain-
derived neurotrophic factor (BDNF) pathway and are involved in synaptic plasticity (Simsek-
Duran and Lonart, 2008).  
The two giant proteins of the active zone, bassoon and piccolo, are known to be heavily 
phosphorylated. However, the functional relevance of these phosphorylation mostly unclear. 
For instance, phosphorylation of bassoon at S2844 is known to play a role in its binding to 
14-3-3 protein (Schroder et al., 2013).  
Munc13 is known as the priming factor of the active zone and a substrate of PKC. Also, it is 
reported that Munc13 undergoes conformation changes upon binding to DAG (the activator 
of PKC) and triggers potentiation of synaptic transmission in hippocampal neurons (de Jong 
et al., 2016). 
Voltage-gated calcium channels are known to be regulated by phosphorylation. 
Phosphorylation N-type calcium channels by CdK5 at the C-terminal enhances their 
interaction with RIM, so they are clustered more efficiently in the active zone and therefore 
neurotransmitter release is enhanced (Su et al., 2012). P/Q-type channels are also 
 
Introduction | 16 
 
phosphorylated by CaMKII at the C-terminus that modulates their activity (Magupalli et al., 
2013). It is known that both N-type and P/Q-type channels interact with the SNARE protein 
via a region in cytoplasmic linker connecting domains II and III of their α1 subunits called 
synaptic protein interaction (synprint) site. Interestingly, this region is known to be the 
substrate of PKC and CaMKII and phosphorylation inhibits their interaction with the SNARE 
proteins (Yokoyama et al., 1997, Degtiar et al., 2000, Jarvis and Zamponi, 2001).  
1.3.2.2 Endocytosis related phosphoproteins 
Phosphoproteins involved in the clathrin-mediated endocytosis of SVs are categorized in a 
group called ‘dephosphins‘. Members of dephosphins are diverse with regard to their 
structure and function in different steps of SV endocytosis. Nevertheless, they share one 
characteristic: They undergo a cycle of phosphorylation and dephosphorylation during a 
round of endocytosis. Upon action potential and influx of Ca2+, they are dephosphorylated by 
a Ca2+/calmodulin-dependent phosphatase called Calcineurin, and rephosphorylated by 
CdK5 during the resting condition. Members of this group are dynamin, the scaffold proteins 
including amphiphysin1 and amphiphysin2, the PtdIns(4,5)P phosphatase, synaptojanin, the 
adaptor proteins, epsin, eps15, and AP180 (Cousin et al., 2001, Samuels and Tsai, 2003). 
Several studies have reported that phosphorylation of CME related proteins inhibits their 
protein-protein interaction with each other. For instance, interaction of AP-2 with clathrin 
(Wilde and Brodsky, 1996), AP-2 with AP-180 (Hao et al., 1999), eps15-Epsin complex with 
AP-2 (Chen et al., 1999), binding of dynamin and synaptojanin to SH3 domain of 
amphiphysin1, and amphiphysin1-AP-2 binding (Slepnev and De Camilli, 2000) are inhibited 
by phosphorylation. 
 
1.3.2.3 Cytoskeleton related phosphoproteins  
Three main cytoskeleton filaments are present in the nerve terminal: actin filaments, 
microtubules, and neurofilaments. It is known that actin filaments are closer to the active 
zone whereas the microtubules do not reach the active zone (Doussau and Augustine, 2000). 
Since the role of actin filaments and their associated proteins in neurotransmission has been 
studied more comprehensively, I will focus on them in the rest of this section. Actin-
associated phosphoproteins are known to modulate the release of glutamate via different 
mechanisms. For instance, synapsin1 that links synaptic vesicles to actin filaments is known 
 
Introduction | 17  
 
to be phosphorylated by several kinases. It is phosphorylated at S9, S556, and S603 by 
CaMKII, at S62, S67, S549, and S551by CdK5 and MAPK (Cesca et al., 2010), and at T301 by 
tyrosine kinase Src (Onofri et al., 2007). Interestingly, phosphorylation of synapsin at 
different sites has diverse effects on its actin-binding feature. Phosphorylation at S62, S67, 
S549, and S551 decreases, whereas phosphorylation at S9, S556, and S603 increases the 
actin-binding. Overall, it is known that upon elevation of the Ca2+ concentration, synapsin  
phosphorylation increases vesicle mobility and release of  neurotransmitters (Cesca et al., 
2010).  
Myosins are actin-based motor proteins and some of myosin isoforms are present in the 
nerve terminals. It is known that myosin V is a motor protein that binds to SVs and facilitates 
their movement along the actin filaments. Binding of myosin V to synaptic vesicles is  Ca2+-
dependent and occurs through synaptobrevin and synaptophysin (Prekeris and Terrian, 
1997). Another member of the myosin family, non-muscle myosin II, has also been shown to 
modulate synaptic transmission (Seabrooke and Stewart, 2011). The regulatory light chain 
of myosin II is phosphorylated by Myosin Light Chain Kinase (MLCK) at T18 and S19, which 
turns on its ATPase activity (Betapudi et al., 2010, Somlyo and Somlyo, 2003). In contrast, 
phosphorylation at S1, S2, and S3 amino acids by PKC has the opposite effect and turns off 
myosin II ATPase activity (Beach et al., 2011). Myosin II is also known to be phosphorylated 
by CK2 and PKC at heavy chain, regulating its assembly and localization (Betapudi, 2014). 
Reorganization of actin filaments has a role in the regulation of the neurotransmission. For 
instance, depolymerization of actin filaments enhances the vesicle secretion in chromaffin 
cells (Zhang et al., 1996). Therefore, actin-associated phosphoproteins such as cofilin, drebin, 
and spectrin that are involved in actin reorganization, might have an indirect role in 
neurotransmission.  
 
 Kinases and phosphatases of the nerve terminal 
Phosphorylation and dephosphorylation of presynaptic proteins mediated by kinases and 
phosphatases present in the nerve terminal. Ser/Thr and Tyr kinases were initially 
discovered in the 1950s and 1980s, respectively. Kinases are the enzymes that transfer the 
γ-phosphoryl group of the ATP to the residues of amino acids (Figure 1-6). Exploring the 
human genome, researchers identified 478 eukaryotic protein kinases that can be 
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categorized into 7 families (CMGC, AGC, CAMK, CKI, STE, TKL, and TK) and 40 atypical kinases 
(Manning et al., 2002). Investigation of mouse genome revealed 549 kinases, majority of 
which are orthologues for human kinases (Caenepeel et al., 2004). Kinases recognize their 
targets physiologically via two mechanisms. First, via recognition of the consensus 
phosphorylation sequence by their active sites. Second, via interaction with the substrate at 
a site distant from the kinase catalytic site or the substrate phosphorylation site (Cheng et al., 
2011).  
Phosphatases are the enzymes that remove the phosphate group from the amino acids. 199 
phosphatases have been reported in human that are classified into 6 families based on 
catalytic domain sequence similarity (Sacco et al., 2012). Ser/Thr phosphatases are not 
known to recognize a consensus sequence motif in their substrate. However, Tyr 
phosphatases are known to have a weak preference for phosphorylated tyrosine residues in 
the specific sequence of the target (Flint et al., 1997). Following in this section, I will discuss 
the regulatory mechanism of the most studied kinases and phosphatases present in the nerve 
terminals. 
 
Figure 1-6: The protein kinase reaction. 
In the reaction of protein phophorylation, kinases transfer γ-phosphoryl group from ATP to the hydroxyl group 
of the protein substrate (HO-R), producing the phosphoproteins and the ADP, adapted from (Roskoski Jr, 2012)  
 
1.3.3.1 Calcium/calmodulin-dependent protein kinase II (CaMKII) 
CaMKII is known to be activated by Ca2+/calmodulin and was discovered in 1981 (Kennedy 
and Greengard, 1981). It is highly abundant in the brain (1-2% of the total protein) and is 
specifically enriched in the synapse, both in the pre and postsynaptic part (Lisman et al., 
2002). CaMKIIα- and β subunits are the most common isomers in the brain that together or 
alone make a dodecameric holoenzymes. Each subunit has the catalytic domain, an auto-
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inhibitory domain, a variable segment and a self-association domain (Figure 1-7). The 
catalytic domain has an ATP and the substrate binding site that catalyzes the transfer of the 
phosphoryl group from the ATP to the substrate. The auto-inhibitory domain has a region 
that is similar to the CaMKII substrate and act as a pseudosubstrate that binds to the active 
site and inhibits the kinase activity. Ca2+/calmodulin binds to a region that has an overlap 
with the pseudosubstrate region, therefore prevents the inhibitory domain from binding to 
the active site of the enzyme. Furthermore, this binding leads to the exposure of T286 on the 
auto-inhibitory domain. T286 can be autophosphorylated by the neighboring subunit and 
upon phosphorylation makes CaMKII insensitive to the Ca2+ concentration and keeps it active 
even in the low concentration of the Ca2+. The self–association domain links the subunits 
together into holoenzyme (Lisman et al., 2002, Rellos et al., 2010). Two other 
autophosphorylation sites T305 and T306 in the calmodulin binding region inhibit binding 
of calmodulin upon phosphorylation. Therefore, upon dissociation of Ca2+/calmodulin, T305 
and T306 are phosphorylated, inhibiting re-association of calmodulin and subsequently the 






Figure 1-7: Functional domains in the primary structure of calcium/calmodulin-dependent protein kinase II 
(CaMKII).  
Catalytic subunit uses ATP to phosphorylate substrates. However, it is inhibited by binding to the auto-
inhibitory domain. Upon binding Ca2+/calmodulin to the auto-inhibitory domain, the inhibitory domain is 
displaced and the enzyme becomes active. Phosphorylation of three threonine residues (T) in this domain is 
important for regulation of CaMKII. Phosphorylation of T286 keeps CaMKII active even in low Ca2+ 
concentration. Phosphorylation of T305 and T306 inhibits calmodulin binding, therefore, auto-inhibits CaMKII 
activity, , adapted from (Lisman et al., 2002). 
 
Besides CaMKII, other members of the CaMK family, for instance CaMKI and CaMKIV are also 
present in the nerve terminal. Unlike CaMKII, these kinases are present in monomeric form 
and have an activation loop phosphorylation site that upon binding to Ca2+/CaM is exposed 
to the upstream CaMK kinase. Upon phosphorylation of this site by CaMKK, these enzymes 
become active for a long period of time (in case of CaMKI, up to 1 h). Interestingly, 
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CaMKK/CaMKI cascades of phosphorylate the Mek/ERK kinases and activate them and plays 
a curtail role in long-term potentiation (LTP) of synapses (Wayman et al., 2008).  
1.3.3.2 Protein kinase A (PKA) 
PKA was discovered in 1969 in adipose tissue for the first time and was known to be activated 
by cyclic adenosine monophosphate (cAMP) (Corbin and Krebs, 1969). PKA has two catalytic 
subunits and two regulatory subunits. Upon binding of cAMP to the regulatory subunit, it 
undergoes a conformational change that inhibits its binding to the catalytic subunit (Elkins 
and Knapp, 2012), resulting in the activation of PKA. Therefore, the regulation of adenylate 
cyclase (the enzyme that catalyzes production of cAMP) has an important role in controlling 
PKA activity. Nine isoforms of adenylate cyclase have been identified in mammalian cells and 
it is known that they are regulated by Ca2+-signaling pathway components in opposite ways. 
For instance, they are inhibited by high concentration of free Ca2+ and activation of CaMKII, 
but, at the same time, are activated through binding to Ca2+/CaM complex and PKC 
phosphorylation (Halls and Cooper, 2011). Although the regulation of PKA by Ca2+ is very 
complex, overall, it has been reported that PKA gets activated upon influx of Ca2+ into the 
nerve terminal (Millan et al., 2003). Interestingly, PKA binds to a family of scaffold proteins 
called A-kinase anchoring proteins (AKAPs) that spatially restrict PKA close to the plasma 
membrane and SV fusion sites (Park et al., 2014). Additionally, PKA activity is regulated by 
phosphorylation of T197 in the activation loop of the catalytic subunit. Phosphorylation at 
this site facilitates the phosphate group transfer to the substrate by stabilizing the transition 
state through an electrostatic interaction (Cheng et al., 2006). It has been suggested that this 
site is phosphorylated via autophosphorylation or by phosphoinositide-dependent kinase-1 
(PDK-1) (Moore et al., 2002). 
 
1.3.3.3 Protein kinase C (PKC) 
Protein kinase C is represented by a multigene family of kinases that are similar in the 
catalytic domain but are different in the regulatory domains. Based on their structure, PKC 
isoforms are categorized into three major groups: conventional PKCs (cPKC; consisting of α, 
βI, and βII isoforms), novel PKCs (nPKC; consisting of δ/θ and ε/η isoforms) and atypical 
PKCs (aPKC; consists of ζ and ι/λ isoforms) (Figure 1-8). All PKC isoforms have a C1 domain 
that binds to diacylglycerol (DAG) and phorbol esters. However, only cPKC and nPKC have 
 
Introduction | 21  
 
the ability to bind to DAG.  cPKC and nPKC but not aPKC contain a C2 domain that only in case 
of cPKC functions as the Ca2+ sensors. Therefore, the cPKCs are regulated both by the 
presence of DAG or phorbol esters and Ca2+. The nPKCs are regulated only by DAG or phorbol 
esters (Heemskerk et al., 2011) and aPKC do not require Ca2+ or DAG for activation and are 
regulated by phosphatidylinositol 3,4,5-P3 (PI-3,4,5-P3) and ceramides (Nakanishi et al., 
1993). Similar to PKA, all the PKCs are also phosphorylated at the T residue (the exact site is 
different in the isomers) in their activation loops. Phosphorylation of this residue is 
necessary for the enzymatic activity of PKCs is known to be performed by PDK-1. Once PKCs 
become active, they bind to the Receptor for Activated C-Kinase (RACK-1) in order to be 
localized to distinct membrane microdomains (Heemskerk et al., 2011).  
 
 
Figure 1-8: Functional domains in the primary structure of protein kinase C (PKC) isoforms 
All PKC isoforms have a conserved catalytic domain at the C-terminal, whereas regulatory domain is variable 
among them. Conventional PKC (cPKC) and novel PKC (nPKC) can be regulated by phorbol esters and 
diacylglycerol through the C1 domain. cPKCs are also regulated by Ca2+ through C2 domain. nPKCs despite 
having C2 domain are not regulated by calcium. In contrast to other isoforms, atypical PKC (aPKC) are regulated 
only by PIP3, and ceramides but not by phorbol esters or calcium ions, adapted from (Steinberg, 2008). 
 
 
1.3.3.4 Casein kinase 2 (CK2) 
CK2 is a heterotetrameric holoenzyme that consists of two catalytic (α and α′) and a non-
catalytic subunit (β) and is classified as an atypical kinase (Venerando et al., 2014). It is 
known that CK2 phosphorylates proteins at the sites specified by acidic determinants (S/T-
X-X-E/D/pS/pT consensus motif). The other characteristic of CK2 is that it is constitutively 
active in the cell and is ready to cooperate with different signals often triggered by an external 
stimulus (Lolli et al., 2012). Several mechanisms are suggested to regulate CK2 activity. In a 
very rare mechanism, CK2 molecules make an inactive polymer via a β subunits and only the 
molecules that can escape from this supermolecule by an unknown mechanism become 
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active. Phosphorylation is another mechanism that has been suggested as the regulatory 
mechanism for CK2. Phosphorylation by other kinases or possibly autophosphorylation has 
an inhibitory effect on the activity of CK2. It has been shown that treatment of CK2 by variety 
of phosphatases results in the enhancement of its kinase activity (Agostinis et al., 1987). 
Furthermore, it has been reported that inositol 1,3,4,5-tetrakisphosphate (IP4) and inositol 
hexaphosphate (IP6) are able to increase the catalytic activity of CK2 (Solyakov et al., 2004). 
 
1.3.3.5 Extracellular-signal Regulated Kinase 1/2 (ERK1/2) 
Extracellular-signal Regulated Kinase 1/2 (also known asMAPK1/3) represent a class of 
Ser/Thr kinases that are involved in Ras-Raf-MEK-ERK signal transduction cascade. MEK is 
a member of dual-specificity kinases that is able to phosphorylate both Ser/Thr and Tyr. It is 
known that MEK activates ERK1/2 by phosphorylation at T204/187 and then Y202/185. 
ERK1/2 is known as a proline-directed kinase that phosphorylates its substrates at P-XXX-
S/T-P consensus sequence (Roskoski Jr, 2012). It has been shown that the increase in 
cytosolic Ca2+ concentration increases Ras activity and consequently enhances activity of the 
ERK1/2.   
1.3.3.6 Cyclin-dependent kinase 5 (CdK5) 
CdK5 is the most abundant member of cyclin-dependent kinase family in the brain (Shah and 
Lahiri, 2014). Unlike other CdKs family members, CdK5 activity is not dependent on cyclin-
binding but requires interaction partners called p35 and p39 (Tsai et al., 1994). Activated 
CdK5 auto-inhibits itself by phosphorylation of p35 at S8 and T138. Phosphorylation of p35 
in these two sites leads to their rapid degradation (Wei et al., 2005) and allows CdK5 to 
regulate its own activity. It is known that T138 is dephosphorylated by PP1 and PP2A leading 
to more stable p35 (Kamei et al., 2007). Moreover, CdK5 can be phosphorylated by Abl, 
ephrin receptor A (EphA) and Fyn kinases, resulting in its activation (Zukerberg et al., 2000, 
Sasaki et al., 2002). CdK5 has several targets in the presynapse. It phosphorylates synapsin1 
at S549 and decreases its binding to actin filaments while binding to SVs remains intact 
(Jovanovic et al., 2001). As it was mentioned above, it phosphorylates Munc18 and decreases 
its binding to syntaxin (Barclay et al., 2003). However, the most-studied role of CdK5 in 
neurotransmission is the re-phosphorylation of dephosphins in the resting condition. It is 
known that CdK5 phosphorylates dynamin1 at S778 (Clayton et al., 2010), as well as 
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amphiphysin at S261 and T310 (Liang et al., 2007, Tomizawa et al., 2003a) and synaptojanin 
at S1144 (Lee et al., 2004). 
1.3.3.7 Glycogen synthase kinase 3 (GSK-3) 
GSK-3 was initially identified as a kinase that phosphorylates glycogen synthase in liver 
(Rylatt et al., 1980). It exists in two different isoforms: GSK-3α and β. It is known that GSK-3 
is constitutively active and is negatively regulated by phosphorylation at the N-terminal (at 
S21 in GSK-3α and at S9 in GSK-3β) (Eldar-Finkelman, 2002). Upon increase of cytosolic Ca2+ 
concertation, the S9/S21 inhibitory site is phosphorylated by CaMKII (Song et al., 2010). GSK-
3β is also phosphorylated at S34 by ERK1/2, which does not directly inhibit the kinase 
activity. However, it increases the capacity of S9/S21 to be phosphorylated. In contrast, the 
tyrosine phosphorylation at 279 of GSK-3α or 216 of GSK-3β are known to enhance the 
activity of the GSK-3. One interesting feature of GSK-3 is that some of its substrates do not 
need to have a very specific sequence, whereas they are required to be phosphorylated by 
another kinase, known as ‘priming phosphorylation’, so they can become the GSK-3 substrate 
(Medina and Wandosell, 2011). GSK-3 is detected in the nerve terminals and phosphorylates 
P/Q-type calcium channels to decrease their activity (Zhu et al., 2010). The phosphorylation 
of GSK-3 at S9/S21 inhibitory site happens only upon intense stimulation of neurons. It is 
known that GSK-3, together with CdK5, re-phosphorylates dephosphins after stimulation in 
the resting condition. In fact, CdK5 does the priming phosphorylation and GSK-3 continues 
phosphorylation of the CME component (Smillie and Cousin, 2011). It is known that GSK-3α 
and GSK-3β are dephosphorylated by PP2A and PP1, respectively, that leads to their 
activation (Hernández et al., 2010). 
 
1.3.3.8 Protein phosphatase 1 (PP1) 
The activity of PP1 is largely regulated by the protein-protein interactions that affects the 
catalytic characteristics of PP1 (gating mechanism) and localization of the enzyme. Two 
regulatory proteins are known to have a role in the gating mechanism: Inhibitor-1 that was 
found initially in the middle of the 70s (Huang and Glinsmann, 1975) and the Dopamine- and 
cAMP-Regulated Phospho Protein 32 (DARPP-32) (Walaas et al., 1983). Both of the 
regulatory proteins are phosphorylated by PKA, making them potent inhibitors of PP1. 
Protein phosphatase 2B is known to dephosphorylate these sites and decreases their PP1 
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inhibitory function. PP1 is also regulated by its localization via Neurabin. Neurabin is a 
regulatory protein of PP1 and it links PP1 to actin filaments. Phosphorylation of Neurabin at 
S100 by CaMKII (Colbran, 2004) and at S461 by PKA significantly reduces its actin-binding. 
Consequently, PP1 diffuses from the nerve terminal which is actin-rich region (McAvoy et al., 
1999).  
 
1.3.3.9 Protein phosphatase 2A (PP2A) 
PP2A is known to be pharmacologically similar to PP1, and it is downregulated by the same 
inhibitors such as Okadaic acid and Calyculin A (Winder and Sweatt, 2001). It is known that 
phosphorylation of PP2A at B'α regulatory subunit by CaMKII decreases its phosphatase 
activity (Fukunaga et al., 2000). In contrast, phosphorylation of PP2A regulatory subunit 
delta at S567 by PKA enhances its activity (Ahn et al., 2007).  
 
1.3.3.10 Protein phosphatase 2B (PP2B, Calcineurin) 
PP2B (also known as Calcineurin) consists of a catalytic subunit (A) and a regulatory subunit 
(B). It is known that high concentrations of Ca2+ ions are the main regulator of Calcineurin. 
Ca2+ ions bind to the B subunit and displace the auto-inhibitory region of PP2B, resulting in 
activation of Calcineurin. However, the activity is enhanced significantly when the complex 
of Ca2+/Calmodulin binds to the regulatory B subunit (Perrino et al., 1995).  Besides Ca2+ ions, 
PP2B is regulated by a family of proteins called Calcipressins. It is known that Calcipressin-1 
is phosphorylated at S108 and S112 by GSK-3β and MAPK, respectively. Phosphorylation 
turns Calcipressin-1 into an inhibitor of PP2B. Also, it decreases the half-life of Calcipressin-
1 (Ma et al., 2012).  
 
 Modulation of synaptic vesicle pools via kinases/phosphatases 
Synaptic strength is known to be precisely tuned in the nerve terminal. This is achieved by 
regulation of SV pool sizes and the availability of SVs to be released. In this section, I will 
discuss the role of kinases/phosphatases on regulation of SV pools.  
Vesicles are known to be clustered by synapsin in the reserve pool (Hilfiker et al., 1999) and 
upon phosphorylation by CaMKII, the clusters will be released and SVs are more available for 
the release. However, other studies revealed that synapsin does not specifically distinguish 
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vesicles of the reverse pool from the other pools, and lack of synapsin affects both recycling 
and RRP pools (Ryan et al., 1996, Mozhayeva et al., 2002). Recently, it has been shown that 
the phosphorylation of synapsin1 at S549 by CdK5 increases the ratio of reserve pool to the 
recycling pool via enhancing its interaction to the actin filaments (Verstegen et al., 2014).   
The CdK5/Calcineurin system is another mechanism that has been proposed to regulate the 
ratio between recycling and reserve pool of vesicles (Kim and Ryan, 2010, Kim and Ryan, 
2013). Cdk5 is known to facilitate the exocytosis via phosphorylation of Munc18 (Fletcher et 
al., 1999) and septin5 (Taniguchi et al., 2007). Also, the CdK5/Calcineurin balance has been 
shown to regulate the release probability of SVs by controlling the influx of calcium into the 
nerve terminal (Kim and Ryan, 2013). CdK5 and Calcineurin also have an opposite effect 
(phosphorylation and dephosphorylation) on the endocytosis-related proteins, resulting in 
regulation of the SV recycling pathway (Cousin and Robinson, 2001). CdK5/Calcineurin 
activity also determines which fraction of SVs is categorized as recycling or reserve pools 
(Fassio et al., 2016). Moreover, PKC and PKA were also suggested to modulate the size of 
synaptic vesicle pools. PKC increases the size of the readily releasable pool (Stevens and 
Sullivan, 1998, Fioravante et al., 2011) and PKA increases the recruitment of SVs from 
reserve pool to the recycling pool (Kuromi and Kidokoro, 2003, Kuromi and Kidokoro, 2000). 
 
 Mass spectrometry (MS)-based phosphoproteomics 
 Protein Identification 
Traditionally, specific proteins could only be detected in complex mixture of extracted 
proteins using specific affinity ligands such as antibodies. These methods are limited to 
proteins for which specific antibodies are available and thus an overview of the protein 
composition of a complex sample could not be obtained. The only alternative method was to 
obtain sequence information for instance by N-terminal sequencing using Edman method 
(Edman, 1949). However, this method requires (i) the separation (purification) of the protein 
from other constituents (e.g. by 2D-electrophoresis), and (ii) an unblocked N-terminus.  
In the last decade, the field has been revolutionize by the developments in mass 
spectrometry. Presently, it is possible to identify thousands of (phospho)proteins in a single 
experiment (Lemeer and Heck, 2009, Kelstrup et al., 2014, Ludwig et al., 2015) by MS-based 
techniques. A general workflow of a typical shotgun proteomics experiment consists of the 
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flowing (Figure 1-9): (1) protein extraction, (2) protein fractionation/enrichment, (3) 
protein digestion, (4) fractionation/enrichment on the peptide level, (5) MS analysis of the 
peptides, followed by MS/MS sequencing of  the selected peptides  and (6) peptide/protein 
identification (database search). 
 
 
Figure 1-9: The general workflow of a shotgun (phospho)proteomics 
Extracted proteins from the cell or tissue can be subjected to a fractionation method (e.g. SDS-PAGE base on 
molecular size) at the protein level or after digestion with an endoprotease (most commonly used, trypsin) at 
the peptide level (e.g. strong cation exchange (SCX)). Modified peptides (here we focus on phosphorylation) can 
be enriched (e.g. titanium dioxide (TiO2) enrichment, phospho-tyrosine immunoprecipitation). Peptides are 
subjected to reverse phase high-performance liquid chromatography (RP-HPLC) that is connected to mass 
spectrometer to be further fractionated prior to entering the instrument. Eluted peptides are ionized by 
electrospray ionization and are analyzed online by mass spectrometer. In data-dependent acquisition (DDA) 
mode, a survey scan (MS1) will measure the mass to charge ratio (m/z) of all the peptides entering into the 
instrument at a particular moment and then the most abundant precursors are selected for the fragmentation 
and generation of MS2 spectra. The (phospho)peptides are identified by matching the experimentally acquired 
MS2 scans and the theoretical MS2 scans generated by search engines software via in silico digestion of desired 




Introduction | 27  
 
Proteins are commonly extracted from the cell or tissue by physical disruption or application 
of lysis buffers containing detergents to rupture the cell membranes. Extracted proteins are 
often fractionated to decrease the complexity of the sample. One of the most common 
methods is SDS-PAGE to separate proteins based on their molecular weight.  
The next step in bottom-up proteomics is the digestion of proteins into peptides that can be 
done either in-solution, on the filter (Wisniewski et al., 2009) or in-gel (Shevchenko et al., 
1996). The most common protease that is used for this purpose is trypsin. Trypsin cleaves 
exclusively at the C-terminal of arginine(R) and lysine(K) amino acids and is suitable for 
proteomics studies due to two main reasons: First: the frequency of R and K in the proteome 
of organisms is optimal to generate 7-20 amino acid peptides that are suitable for 
fragmentation by tandem MS/MS analysis. Second, it leaves a highly basic residue at the C-
terminal of the peptides resulting in efficient ionization and production of high mass y-ion 
series spectra upon fragmentation which in turn makes spectra more informative and easy 
to interpret (Olsen et al., 2004, Medzihradszky and Chalkley, 2015). Other proteases such as 
Lys-C and chymotrypsin are also used but less frequently to improve the coverage of 
proteome and PTM identification (Giansanti et al., 2016). Fractionation/enrichment can also 
be done at the level of peptides. This is more common in the case of PTM identification since 
modifications are more exposed at the peptide level and can be enriched more efficiently.  
Different approaches have been employed for fractionation and enrichment at the peptide 
level. They include: ion exchange chromatography, metal affinity chromatography, 
immunoprecipitation by antibodies (e.g. to enrich phospho-tyrosines) or affinity-base 
enrichment such as lectins for glycosylated peptides. These methods are reviewed in various 
recent publications (Macek et al., 2009, Nilsson, 2012, Zhang et al., 2013b, Zargar et al., 2015).  
Before analysis by mass spectrometer, the peptides are fractionated by reverse-phase high 
performance–liquid chromatography (HPLC), usually connected on-line to the mass 
spectrometer instrument. The peptides are separated based on their hydrophobicity and 
enter the instrument gradually, being analyzed continuously by consecutive scans in the 
mass spectrometer. Below I will discuss several aspects of MS analysis as well as 
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1.4.1.1 Tandem mass spectrometry 
The identification of proteins by MS relies on the identification of at least one unique peptide 
derived from a particular protein. Peptide analysis by a mass spectrometer determines the 
mass/charge (m/z) ratio and the intensity of the peptide in the gas-phase. Although this 
information is valuable, it is not enough for the identification of peptides. The primary amino 
acid sequence of the peptide provides sufficient and necessary information for the peptide 
identification. The method that is widely used for the peptide sequence identification is 
‘Tandem mass spectrometry’ (also known as MS/MS). In this method, the m/z ratio of all the 
peptides eluting at a particular moment from the chromatography separation is measured in 
the first scan (also known as the survey scan or MS1). Then, depending on the speed of the 
instrument, a limited number of the peptides (commonly between 10-30) with the highest 
intensities are selected for the fragmentation. The peptides selected for the fragmentation 
are called the precursor ions. Precursor ions are fragmented to yield smaller parts (product 
ions). The mass of the product ions is determined in the second scan (MS2). In modern mass 
spectrometers, all the processes of the precursor selection and fragmentation occur in an 
automated fashion, called the ‘Data-Dependent Acquisition (DDA)’ mode. The DDA 
acquisition is biased towards the identification of highly abundant peptides (Steen and Mann, 
2004). This limitation makes the identification of phosphopeptides more challenging since 
often phosphorylation occurs at sub-stoichiometric levels. However, improvement in the MS 
instrumentation and phosphopeptides sample preparation can partially overcome these 
limitations (Olsen and Mann, 2013).  
1.4.1.2 Sample ionization 
Since mass spectrometers are able to measure the mass of charged species, the peptides have 
to be ionized before entering the instrument. However, the ionization of large biological 
molecules in the gas phase is not trivial. Two methods have been developed in order to ionize 
the biomolecules while leaving them intact during ionization (soft ionization): electrospray 
ionization (ESI) (Fenn et al., 1989) and matrix-assisted laser desorption ionization (MALDI) 
(Tanaka, 1988). Since, these methods revolutionized the field of the mass spectrometry and 
proteomics, their inventors (John B. Fenn and Koichi Tanaka) were awarded the chemistry 
Nobel Prize in 2002. In ESI, a high electrostatic voltage is set between the tip of the capillary 
needle and the entrance of the mass spectrometer. In the LC-ESI while the sample is eluting 
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from the chromatography column and passing through the needle, they are sprayed in form 
of small charged droplet. As the liquid is evaporating the charge concentration at the surface 
increases, which leads to dissociation of the droplet and a decrease in the size of the droplet. 
This process goes on until the liquid completely evaporates, resulting in charged species. 
However, the exact mechanism leading to the ionization of the analyte by ESI is debated 
(Konermann et al., 2013). In MALDI, the analyte molecules are co-crystallized together with 
a chemical matrix which is typically a benzoic acid derivative and is able to absorb UV. Then 
a laser pulse is fired to the matrix, resulting in production of ionized matrix molecules, 
protonated and deprotonated matrix molecules, matrix clusters and nanodroplets. These 
species are involved in the transfer of protons to the analyte molecules and creation of 
charged analytes in the gas phase through the mechanism that is still under debate 
(Shevchenko et al., 2000, Lu et al., 2015). 
The advantage of ESI over MALDI is that ESI tends to produce multiple charged species. This 
is why, very large proteins can appear at lower m/z values by ESI fragmentation. Therefore, 
theoretically it is possible to analyze unlimited mass range of proteins with ESI (El-Aneed et 
al., 2009). Also, ESI implies use of solvated samples, whereas solid state samples are utilized 
for MALDI. Therefore, ESI is more suitable to be combined with a reverse-phase liquid 
chromatography to separate peptides based on their hydrophobicity in a complex sample 
with simultaneous analysis upon their elution from the column. Recently the more advanced 
chromatography methods (nano-ESI) utilizing slower flow rates (a few hundred nL/min) 
have led to higher ionization efficiency and better sensitivity (Schmidt et al., 2003). 
1.4.1.3 Peptide sequencing 
As mentioned above, in the tandem mass spectrometry after the survey scan, the selected 
precursors are fragmented yielding the product ions. The product ions generated by 
fragmentation are categorized, based on the location of breakage of the peptide backbone, 
into three groups: 1) a- and x- ions, 2) b- and y- ions and 3) c- and z- ions (see Figure 1-10). 
The most widely used fragmentation method for the identification and quantification of the 
proteome is Collision-Induced Dissociation (CID). In this method, the precursors are collided 
multiple times with a neutral gas molecule such as helium, nitrogen or argon. In Thermo 
Scientific mass spectrometers, which were used in this project, the CID occurs in the ion trap 
mass analyzer. Consequently, the precursors break down along the peptide backbone and at 
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peptide bonds. The ion trap analyzer has a low mass cut-off that cannot detect the ions with 
m/z less than 30% of the precursor (Zhang et al., 2005). More recent fragmentation method 
is High-energy Collisional Dissociation (HCD). In contrast to CID, in Thermo Scientific mass 
spectrometers, HCD occurs in a collision cell rather than the ion trap. Then they are 
accumulated in a C-trap, and transferred to be analyzed by a high resolution mass analyzer, 
such as orbitrap. Combination of HCD fragmentation and utilization of orbitrap has 
advantages. It does not have the low cut-off limitation and the resolution of resulting 
spectrum is higher since it generates more product ions leading to a higher quality MS/MS 
spectra.  
Both CID and HCD fragmentation generate the b- and y- ions. Another type of fragmentation 
that is known to be complementary to CID and HCD is the electron transfer dissociation 
(ETD). In this method, the precursors interact with an electron donor resulting in an electron 
transfer to the peptide and cleavage of the peptide backbone and generation of the c- and z- 
fragments ions. It is known that ETD particularly works better on highly charged states of 
peptides (Guthals and Bandeira, 2012). The advantage of ETD in phosphoproteomics is that 
it does not induce the neutral loss of phosphoric acid as it happens via CID fragmentation and 
leaves the phosphorylation modification intact (Quan L, 2013).  
 
 
Figure 1-10: Nomenclature of fragment ions.  
Fragments ions are grouped based on the location of the fragmentation on the peptide backbone. A- and x-ions 
are the result of breakage of alkyl-carbon bonds. B- and y- ions are generated after the breakage of peptide bond 
and c- and z- ions are formed after breakage of amino-alkyl bond. A-, b-, c- ions contain the N-terminal of the 
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1.4.1.4 Mass spectrometry instrumentation 
In the tandem mass spectrometers, the first and the second mass scan occur in more than 
one mass analyzer. These instruments are often hybrid mass spectrometers which combine 
different mass analyzers to obtain better performance. So far, different mass analyzers have 
been developed with different characteristics in mass accuracy, dynamic range, mass scan 
speed and the resolution (Glish and Burinsky, 2008). The most common mass analyzers are 
quadrupole, ion traps, time-of-flight and orbitrap. Most hybrid analyzers are ion trap-
orbitrap, quadrupole-TOF, and quadrupole-orbitrap. The Q-Exactive instrument that was 
mostly used in this study is a hybrid quadrupole-orbitrap mass spectrometer that combines 
the high-performance precursor selection feature of quadrupole to the high-resolution and 
accurate-mass detection of orbitrap. Figure 1-11 demonstrates the schematic view of a Q-
Exactive HF instrument. 
Figure 1-11: The schematic overview of Q-Exactive HF instrument.  
RF lens increases the efficiency of ion capture, focuses and transmits them. AABG prevents the neutral particles 
from entering the quadrupole and, consequently, decreases the noise. Quadrupole is used to select the 
precursor ions and also to enable the parallel data acquisition. Precursor ions are transferred to HCD cell where 
they are fragmented efficiently to generate product ions. Then the product ions are collected in C-Trap which 
focuses ions efficiently and injects them to the orbitrap mass analyzer. Orbitrap detects the mass of ions 
accurately with a high resolution. Adapted from Planet Orbitrap manual (http://planetorbitrap.com/q-
exactive#.V_YpzXq8Nlw). 
 
In the recent years, the orbitrap mass analyzers have significantly contributed to the 
proteomics field. Therefore, I will devote the rest of this section to the characteristics of the 
orbitrap mass analyzers. The orbitrap analyzer consists of three electrodes. One is located in 
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the center and two outer electrodes that have cup shape facing each other. When the voltage 
is applied between the outer and central electrodes it produces an electrical field that is 
strictly linear along the axis. Simultaneously, the radial component of the electrical field 
attracts the ions to the central electrode. When ions are injected in the volume between outer 
and central electrodes, they are trapped in the electrostatic field between the electrodes and 
rotate and oscillate around the central electrode. Using the image current detection and 
Fourier transformation algorithm, the axial frequency movements of ions are converted to 
the m/z ratio (Zubarev and Makarov, 2013). Orbitraps have high mass resolution, mass 
accuracy, dynamic range, and upper mass limit (Scigelova and Makarov, 2006). Recently, the 
invention of high-field (HF) orbitrap analyzers that have smaller trap size has increased the 
resolution of these series of mass analyzers (Makarov et al., 2009). 
 
1.4.1.5 Peptide and protein identification 
Improvements in the high-throughput proteomics and generation of several thousands of 
spectra in one experiment rendered the annotation of spectra unfeasible. Several search 
engines and software have been developed to identify and reliably quantify the 
peptides/proteins automatically and also to localize the PTM on the peptides. The general 
workflow of the search engines relies on the generation of a library with theoretical MS2 
spectra in silico based on the sequence of desired protein(s) or complete genome of an 
organism as well as the specific endoproteases and probable quantitation labels and/or 
PTM(s). Then they compare the experimental MS2 spectra with the theoretical MS2 spectra. 
For each experimental MS2 spectrum several theoretical spectra can be assigned with a score 
that is calculated based on the quality of the match between the theoretical and the 
experimental spectrum. Peptides with the highest score value are then identified (Paulo, 
2013). Since this workflow is prone to yield false positive identification of peptides, a 
statistical approach called false discovery rate (FDR) is used to filter out false positive results. 
FDR is calculated by matching the experimental spectra with a decoy database that can be 
the reverse or scrambled sequence of the desired proteins. Commonly, the 1% FDR is 
acceptable for the shotgun experiments (Elias and Gygi, 2007). In this project, I have used the 
freely available software called MaxQuant which contains a search engine called Andromeda 
(Cox et al., 2011) developed at the Max Planck Institute for Biochemistry. Besides protein and 
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PTM identifications, MaxQuant is designed for a reliable quantification of stable isotopic 
labeled samples such as SILAC or dimethyl labeled samples based on 3D peak extraction at 
the MS1 level (Cox and Mann, 2008). 
 Phosphosite identification and localization 
Phosphoprotein analysis by MS has similarities and differences compared to the general 
workflow of protein analysis. In this section, I will address the differences in more detail. The 
main challenge of the phosphosites identification by MS in DDA mode is that phosphorylation 
occurs at sub-stoichiometric level. Therefore, enrichment is necessary for the 
phosphopeptides to be selected for fragmentation and subsequent identification. In section 
1.4.1 several methods of phosphopeptides enrichment were introduced. The most common 
method is the complexing of phosphate group with metals, for instance, immobilized metal 
affinity chromatography (IMAC) (Villen and Gygi, 2008) or with metal oxides such as 
titanium/zirconium (TiO2 or ZrO2) (Larsen et al., 2005). Furthermore, a highly specific 
phospho-tyrosine antibody has been developed to specifically enrich the phospho-tyrosine 
residues (Rush et al., 2005). 
In the fragmentation step, depending on the type of fragmentation, the phosphopeptides are 
identified differently. CID fragmentation results in neutral loss of phosphoric acid (H3PO3, 98 
Da) by phosphorylated serines and threonines (Boersema et al., 2009a). Phospho-tyrosines 
produce a reporter immonium ions with the m/z value of 216.043 (Steen et al., 2001). 
However, the low mass cut-off of ion trap makes the detection of immonium ions difficult 
(see section 1.4.1.3). In HCD fragmentation, the multiple cleavage events results in richer 
fragmentation of phosphopeptide (Jedrychowski et al., 2011). In contrast to CID and HCD, 
fragmentation by ETD do not result in the natural loss, leading to a higher quality of MS2 
spectra (Quan L, 2013). Several studies have compared the phosphopeptide identification 
yield under different fragmentation methods. It was reported that HCD fragmentation is 
more efficient in the number of identified phosphosites and identification quality (higher 
Mascot score) than CID (Nagaraj et al., 2010) or ETD (Marx et al., 2013). Moreover, the 
unambiguous phosphosite localization in the phosphopeptides relies on the efficient 
fragmentation and the high-quality MS2 scan. Phosphosite localization is particularly 
challenging if several phosphorylable amino acids (S, T, Y) happen to be present in a peptide 
close to each other. Therefore, each search engine and software calculates the localization 
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score that determines the confidence of phosphorylation localization (for instance, 
localization probability in MaxQuant/Andromeda platform) (Sharma et al., 2014, Olsen et al., 
2006b). 
 Mass spectrometry-based quantification 
Mass spectrometers are able to measure two main parameters of the peptides: 1) the m/z 
value of the precursor as well as the product ions and 2) their intensity. The m/z values are 
used for the identification of the peptide/protein, whereas the intensities provide 
information about the abundance of peptides and can be used to collect the quantitative data. 
MS-based quantification methods can be categorized into two main groups: relative and 
absolute quantification. While in a relative quantification the abundance of the 
peptide/protein in one or more experimental treatments are compared to a control 
treatment, in an absolute quantification the concentration of proteins is determined (Table1-
1). Also, the relative and absolute quantification methods can be subcategorized into two 
groups: label-free and label-based methods (Nikolov et al., 2012). The most common relative 
label-based method in the field is the Stable Isotope Labeling with Amino acids (SILAC) (Ong 
et al., 2002). Due to the incorporation of isotopic labels in the early stage of the experiment 
(at the protein level), this method is less prone to sample-handling errors and provides the 
most robust quantification of peptides/proteins. It has been shown that it is possible to label 
organisms such as mice by a diet containing heavy amino acids (Krüger et al., 2008). Here, 
we used a type of chemical labeling at the peptide level known as dimethyl labeling method.  
 
 
Table 1-1: Categorization of the most commonly used quantitative approaches in proteomics. 
SILAC: Stable isotope labeling by amino acids in cell culture; iTRAQ: isobaric tags for relative and absolute 
quantification; TMT: tandem mass tag; DML: Dimethyl labeling; XIC: extracted ion chromatogram; AQUA: 
absolute quantitation; iBAQ: intensity based absolute quantitation, adapted from (Nikolov et al., 2012). 
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Dimethyl labeling was introduced for the first time in 2003 as a method for a comparative 
quantification of proteome data (Hsu et al., 2003). In this approach, primary amines (N-
termini and lysine residues of side chains) are selectively dimethylated using formaldehyde 
and cyanoborohydride. The reaction involves formation of Schiff bases during the reaction of 
formaldehyde with the amine which then is reduced by cyanoborohydride. Using deuterium 
and 13C, it is possible to label three samples differentially (light, medium and heavy) (Figure 
1-12). Dimethyl labeling has several advantages: The reaction is fast and is completed in a 
few minutes. It does not produce side products and it is compatible with the rest of 
downstream proteomics/phosphoproteomics workflow (Kovanich et al., 2012). Using 
deuterium in the labels leads to a small shift in the retention time of the labeled samples as 
compared to non-labeled samples and can affect quantification. However, if the 
quantification is based on the entire extracted ion peaks such as the algorithm that is 
designed in MaxQaunt, the deuterium effect on the quantification accuracy is decreased 
significantly and can be neglected (Ji and Li, 2005). 
In recent years, the improvement in the instrumentation (high mass resolution, accuracy and 
high peptide identification rate) and computational power has made label-free quantification 
more popular as a quantification method. 
Figure 1-12: Labeling scheme of the reactions occurs in stable isotope dimethyl labeling. 
Using different isotopomers of the formaldehyde (Deuterium instead of hydrogen) and cyanoborohydride (13C 
instead of 12C), different masses with 4 Da difference can be added to the peptides which makes it possible to 
label three samples differently (light, medium, and heavy) and compare them, (Boersema et al., 2008). 
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Two main approaches for label-free quantification have been introduced: 1) spectral 
counting that relies on the number of peptides which are identified from a given protein (Liu 
et al., 2004), and 2) comparing the peptide peak area in the extracted ion chromatogram (XIC) 
of different samples (Bondarenko et al., 2002). Recently, an improvement in quantification 
algorithm of intensity-based label-free quantification has been incorporated into the 
MaxQuant platform (MaxLFQ) which has made this method compatible with the upstream 
fractionation step. Also, it has increased the extraction of ratio information from peptide 
signals (Cox et al., 2014). Recently, label-free quantification has been gaining more popularity 
in the field due to its advantages over label-based methods such as improvement in the 
number of quantified peptides, possibility to compare an unlimited number of the samples 
and lower cost and effort. However, it has several drawbacks: 1) it is more prone to the 
sample handling variability, consequently less accurate quantitation, 2) it increases the MS 
measuring time and 3) it is less reliable for the quantification of modified peptides rather 
than proteins, since the quantitation information relies on quantification of one individual 
peptide (Cox et al., 2014, Mallick and Kuster, 2010). 
 
 Neuro-phosphoproteomics 
In the last decade, phosphoproteomics has been used to answer diverse questions in the 
neuroscience field. In one of the earliest attempts, Ballif et al. tried to profile the 
phosphorylation sites of a developing mouse brain. Interestingly, they found phosphosites 
with the consensus site of the proline-directed kinase, phosphorylation sites upstream of 
acidic (such as CK2) or downstream of basic residues (for instance CaMKII) to be the most 
frequent phosphosites in their database (Ballif et al., 2004). In other studies, the 
phosphoproteome of developing and adult murine brain have been compared (Palmisano et 
al., 2012, Doubleday and Ballif, 2014) showing that neonatal brain contains three times more 
phosphosites than adult brain (Goswami et al., 2012). Moreover, using kinase knockout mice 
in combination with phosphoproteomics has revealed the role of kinases on the signaling 
pathways (e.g. cGMP-dependent protein kinase type I signaling pathway) (Corradini et al., 
2014). Also, the impact of phosphorylation in neurodegenerative diseases such as Alzheimer 
has been addressed by MS-based phosphoproteomics (Tagawa et al., 2015).  
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On the level of the synapse, studies can be divided into those addressing the post and 
presynaptic compartment. The majority of studies has focused on the postsynaptic 
phosphoproteome. Trinidad et al. in their studies mapped the postsynaptic 
phosphoproteome, which resulted in identification of an extensive number of phosphosites 
on the postsynaptic neurotransmitter receptors such as N-methyl-D-aspartate (NMDA) 
receptors and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
receptors. Also, they have shown that kinases and phosphatases are present in hippocampus 
at a higher level in comparison to the other parts of the brain, suggesting a major regulatory 
role for phosphorylation in hippocampus (Trinidad et al., 2006, Trinidad et al., 2008). In 
addition, in a study similar to the work presented here, quantitative analyses of phosphosites 
in resting and stimulated synapses have been performed. However, this study was focused 
on postsynaptic proteins (Munton et al., 2007). At the presynaptic level, Filiou et al. have 
provided a map of the phosphoproteome using isoelectric focusing (IEF) fractionation (Filiou 
et al., 2010). However, so far there is no high-throughput study available regarding the 
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 Aim of this study 
The presence of a high number of phosphoproteins, as well as kinases and phosphatases at 
the nerve terminals, suggests that reversible protein phosphorylation contributes to the 
regulation and fine-tuning of synaptic transmission. Previously, the role of phosphorylation 
in the regulation of neurotransmission in the nerve terminals has been studied by low-
throughput and targeted approaches or on the postsynaptic parts. Nevertheless, there is no 
comprehensive overview available regarding presynaptic regulation of neurotransmission 
via phosphorylation. Therefore, the major aim of this study was to investigate the activity-
dependent changes of presynaptic proteins phosphorylation by a quantitative and high-
throughput approach. Tandem mass spectrometry-based phosphoproteomics is a suitable 
and unbiased approach to identify de novo phosphopeptides without any pre-knowledge. 
Moreover, in combination with labeling method, it is possible to relatively quantify the 
abundance of the phosphosites in the resting and stimulated conditions.  
In this thesis, I have first established an MS-based phosphoproteomics workflow that enabled 
me to identify and reliably quantify the phosphosites in the nerve terminal. Next, I combined 
the established workflow with synaptosome stimulation treatments to distinguish between 
Ca2+-dependent and membrane depolarization-dependent phosphorylation changes. Using a 
bioinformatics approaches and kinase in vitro assays, I aimed to identify the upregulated and 
downregulated kinases/phosphatases responsible for the dynamics of phosphorylation 
changes upon stimulation.  
Since Ca2+ ions are one of the main second messengers in the nerve terminal and their role in 
regulation of a high abundant kinase (CaMKII) and phosphatase (Calcineurin) in the nerve 
terminal is well-established, I used a specific inhibitors of CaMKII and Calcineurin (KN-93 
and Cyclosporine A, respectively) in combination with the phosphoproteomics workflow to 
identify their substrates and also to assess the role of these enzyme in the signaling pathways 
triggered by stimulation of synaptosomes. Taken together, in this project, I aimed to provide 
a global picture of protein phosphorylation dynamics in the nerve terminal upon stimulation 
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2 Material and Methods 
 Materials 
 Chemicals 
The standard chemicals used in this study were purchased from Merck (Darmstadt, 
Germany) and Sigma-Aldrich (Steinheim, Germany). All chemicals had at least analytical 
purity. Other chemicals are listed in Table 2-1 
Chemicals Source 
Albumin standard Thermo Fisher Scientific, Rockford, USA 
Protease and phosphatase inhibitor Thermo Fisher Scientific, Rockford, USA 
Acetonitrile Thermo Fisher Scientific, Rockford, USA 
2-[4-(2-hydroxyethyl)piperazin-1-
yl]ethanesulfonic acid (Hepes) 
Gerbu Biotechnik, Heidelberg, Germany 
Ethylene glycol tetraacetic acid (EGTA) Gerbu Biotechnik, Heidelberg, Germany 
Formaldehyde (D2, 98%, CD2O) Cambridge Isotope Laboratories, Andover, USA 
Phenylmethylsulfonylfluorid(PMSF) AppliChem, Darmstadt, Germany 
2-Amino-2-hydroxymethyl-propane-1,3-diol 
(Tris) 
VWR International, Leuven, Belgium 
Rapigest Waters, Milford, USA 
Titanium dioxide beads (TiO2) GL Sciences Inc., Tokyo, Japan 
Cyclosporine A Sigma – Aldrich, Steinheim, Germany 
KN-93 Sigma – Aldrich, Steinheim, Germany 









Sequencing grade modified trypsin Promega, Madison, USA 
Calmodulin-dependent Protein Kinase II (CaMKII)  New England BioLabs, Frankfurt, Germany    
Protein Kinase C (PKC) Enzyme System Promega, , Meinheim, Germany    
Protein Kinase A (PKA) Enzyme System  Promega, , Meinheim, Germany 
Table 2-2: Enzymes used in this study. 
 Kits 
Kits Source 
Bicinchoninic acid  (BCA) protein 
concentration assay 
Thermo Fisher Scientific, Rockford, USA 
Western LighteningTM Plus-ECL  Perkin Elmer Applied Biosystems, Massachusetts, 
USA 
Table 2-3: Kits used in this study. 
 Antibodies 
Antibody Species Application and 
dilution  
Source 
Synapsin 1 mouse monoclonal, affinity 
purified 
WB (1:1000) Synaptic 
System 
pS603 Synapsin1 rabbit polyclonal WB (1:1000) Rockland  
Dynamin 1/2/3 rabbit polyclonal, antiserum WB (1:1000) Synaptic 
System 
pS774 Dynamin sheep polyclonal WB (1:1000) Rockland  
pS241PDK-1 rabbit polyclonal WB (1:1000) Cell Signaling 
pT197 PKA C rabbit polyclonal WB (1:1000) Cell Signaling 
pT514 PKC (Pan) rabbit polyclonal WB (1:1000) Cell Signaling 
α-Tubulin mouse monoclonal, affinity 
purified 
WB (1:2000) Synaptic 
System 
mouse IgG (HRP labeled ) goat polyclonal WB (1:2000) BioRad 
rabbit IgG (HRP labeled ) goat polyclonal WB (1:2000) BioRad 
sheep IgG (HRP labeled ) rabbit polyclonal WB (1:2000) Jackson 



















PMSF (Stock Solution) 
 






SDS Running buffer 
320 mM sucrose, 5 mM Hepes, pH=7.4 
 
10 mM glucose, 5mM KCl, 140 mM NaCl, 5 mM NaHCO3, 1 mM 
MgCl2, 1.2 mM Na2HPO4, 20 mM Hepes, pH=7.4 
 
50 mM Tris, 150 mM NaCl, 1% Nonidet P40, pH=7.4 contains 
Pierce protease and phosphatase inhibitors 
 
6%, 9% and 13% Ficoll solutions were prepared in sucrose 
buffer, pH=7.4 
 




15 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5 % (v/v) Tween 20 
 
200 mM Glycine, 25 mM Tris, 0.04 % SDS, 20 % Ethanol 
 
25 mM Tris-HCl, 192 mM Glycine, 0.1 % SDS 
Table 2-5: List of buffers and their composition used in this study. 
 Methods 
 Biochemical Methods 
2.2.1.1 Synaptosomes preparation 
Synaptosomes were isolated from 5-6 weeks old Wistar rats as previously reported by 
Fischer and Mollard (Fischer von Mollard et al., 1991). See Figure 2-1 for a schematic 
representation of our synaptosomes preparation procedure. Briefly, two rats were 
decapitated and cortices and cerebellum were dissected. Samples were homogenized using 
a glass-Teflon homogenizer (RW20-DZM, IKA) in 30 ml ice-cold homogenization buffer 
(containing 200 µM PMSF and Pepstatin A 1 µg/ml) at 900 rpm, 9 strokes. The homogenate 
was centrifuged for 2 min at 5000 rpm, 4 oC in a SS34 rotor (SORVALL) to remove cell debris. 
The supernatant was collected in a new tube and re-centrifuged for 12 min, 11000 rpm, 4 oC 
in the SS34 rotor. The supernatant containing the brain cytosol fraction was discarded, and 
the white pellet containing synaptosomes was resuspended in 6 ml of homogenization buffer. 
At this step, the brown pellet, mostly containing mitochondria was cautiously avoided to be 
resuspended. Three ml of the suspension were loaded on a discontinuous Ficoll gradient (one 
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gradient per cortex) consisting of 13% Ficoll (4 ml), 9% Ficoll (1 ml) and 6% Ficoll (4 ml). 
Gradients were centrifuged for 35 min in a SW41 swing-out rotor (Beckman) at 22500 rpm. 
The band at the interface between 9% and 13% Ficoll was collected, transferred into a SS34 
tube, diluted with 30 ml of homogenization buffer, and re-centrifuged for 12 min at 11000 
rpm (4 oC) to pellet synaptosomes. Finally, synaptosomes were resuspended in 5 ml of 
homogenization buffer (2.5 ml per cortex), and the protein concentration was determined 
using the BCA reaction kit. Normally, the yield was between 5-6 mg of synaptosomal proteins 
per cortex (Figure 2-1) 
 
 




5,000 rpm, 2 min 
P1 S1 
11,000 rpm, 12 min 
P2 S2 
Load on the discontinues Ficoll 
gradient 
22,500 rpm, 35 min 
11,000 rpm, 12 min 








Collect semi-purified synaptosomes 
from 9% Ficoll layer 
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2.2.1.2 Protein concentration assay (BCA) 
To determine the protein concentration, the Pierce BCA Proteins Assay Kit (Thermo Fisher) 
was used. Standard solutions were prepared from Albumin (BSA) in the desired buffer and 
protein concentrations were measured in a 96-well plate using a Tecan Genios Pro plate 
reader according to manufacturer’s manual. 
 
2.2.1.3 Synaptosomes stimulation (Glutamate Release Assay) 
KCl stimulation 
For stimulation, 2.5 mg of synaptosomal proteins were centrifuged for 5 min, 5000 g, RT. 
Obtained pellet was resuspended very gently in 2.5 ml of sodium buffer. Synaptosomes were 
then incubated for 5 min at 37 oC ina water bath. In the next step, NADP+ (1 mM) and either 
CaCl2 (1.3 mM) or EGTA (0.5 mM) were added depending on the stimulation condition. 
Samples were immediately transferred to a quartz cuvette with a stirrer bar and fluorescence 
was measured at 340 nm (excitation) and 440 nm (emission). After three min glutamate 
dehydrogenase (200 U) was added and measurements were continued for another 3 min. 
Subsequently, KCl (50 mM) was added to the reaction to stimulate synaptosomes. Glutamate 
dehydrogenase couples the conversion of glutamate to α-ketoglutarate to NADP+ to NADPH 
reduction (Figure 2-2). The release of glutamate was monitored by fluorescence 
measurement of NADPH for 2 min. For the synaptosomes at the resting condition only NADP+, 
EGTA, and glutamate dehydrogenase were added (No KCl addition). For the inhibition of 
CaMKII and Calcineurin, synaptosomes were incubated prior to resuspension in sodium 
buffer for 10 min with 10 µM KN-93 and 10 µM Cyclosporine A, respectively.  
 
Figure 2-2: Conversion of glutamate to α-ketoglutarate is coupled to the reduction of NADP+ to NADPH 
by Glutamate dehydrogenase. 
 
 




For electrical stimulation, all the steps were done similar to KCl stimulation except 
application of KCl. Instead of KCl, synaptosomes were subjected to electrical stimulation 
through the platinum wire with 1 mm diameter. The diameter of the cuvette and the distance 
between the electrodes were 15 mm. Stimulation was done by square pulses for alternating 
polarity with a frequency of 20 Hz, and a voltage of 7 V.  
 
2.2.1.4 Sample collection for mass spectrometry 
Stimulated synaptosomes were collected directly from the cuvette following glutamate 
release assay and were centrifuged for 2 min at 6200 g, 4 oC. The synaptosome pellet was 
resuspended in 100 µl of lysis buffer containing mixture of protease and phosphatase 
inhibitors (Thermo Fisher Scientific) and incubated on ice for 30 min. Then 900 µl of 100 mM 
TEAB buffer were added, and the synaptosomes were homogenized (RW20-DZM, IKA) with 
3 strokes at maximum speed (2000 rpm). The protein concentration was determined by BCA 
protein concentration assay. 1 mg of protein per sample was precipitated by 100% acetone 
overnight at -20 oC. The next day, proteins were spun down for 30 min at 16200 g, 4 oC. The 
pellets were washed once with 80% acetone and centrifuged again for 30 min at 16200 g, 4 
oC. The protein pellet was dried shortly at RT and later stored at -20 oC for the next step of 
the protocol (protein digestion). 
 
2.2.1.5 SDS-PAGE and Western Blotting 
For the analysis of the proteins, 10 µg of samples were mixed with NuPAGE lithium dodecyl 
sulfate (LDS) sample buffer (Thermo Fisher Scientific) and loaded on a RunBlue SDS gradient 
gel (Expedeon), a pre-casted 4-12% polyacrylamide gel. Electrophoresis was performed in 
Tris-MOPS-SDS run buffer (Expedeon) for 60-90 min at 100-120 V. 
 Western blotting was done according to a previously published protocol (Liu et al., 2014). 
Separated proteins were transferred to a nitrocellulose membrane in transfer buffer using a 
tank apparatus and under 100 V constant voltage application for 1 h. After transfer, 
nitrocellulose membrane was blocked by 5% nonfat milk powder in TBST for 30 min, RT. 
Then, the membrane was incubated overnight at 4 oC with primary antibodies diluted in 
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blocking buffer. Membrane was washed 3 times with TBST for 5 min and then incubated with 
HRP-conjugated secondary antibodies in blocking buffer for 1 hour at room temperature. The 
membrane was again washed 3 times with TBST for 5 min and then covered with Western 
Lightning Plus-ECL oxidizing reagent and enhanced luminol reagent (PerkinElmer) mixed in 
1:1 ratio and visualized by using chemiluminescence detection on a LumiImager (Boehringer 
Ingelheim). 
 
2.2.1.6 In vitro kinase assays for mapping of the kinases responsible for the 
phosphorylation of specific sites 
In vitro kinase assays were carried out using the ADP-GloTM kinase assay kit (Promega). This 
assay is a luminescent kinase assay that measures ADP that is generated from a kinase 
reaction. ADP is converted to ATP and ATP is converted into light by luciferase. The generated 
luminescent signal is proportional to the amount of kinase activity. First, standard curves 
were obtained by measuring the luminescence a series of ADP-ATP dilutions, based on the 
manufacturer’s manual. For each enzyme, the concentration of ATP and kinase were 
optimized to achieve 100% conversion of ATP to ADP using the positive control peptides. In 
all assays 0.2 µg/µl of each peptide were used. Then, phosphorylation of desired 
phosphosites by the respective kinase was calculated by measuring the luminescence of the 
reaction, which is proportional to ATP consumption by the kinase. The percentage of 
consumed ATP was used to characterize the % of the kinase activity. CaMKII was activated 
prior to the assay by addition of 5 µM ATP, 1.2 µM calmodulin and 2 mM CaCl2, followed by 
30 min incubation at 37 oC. In Table 2-6 the concentration of the reagents that were used in 
each kinase assay are listed. The peptides are purchased from Thermo Scientific with a purity 
of 98%. Table 2-7 provides the list and the sequences of the peptides that were used in the 
assay.  
 
Kinase (concentration) Positive control peptide (Source) ATP concentration 
CaMKII (12 U/µl) Autocamide (GenScript) 5 µM 
PKA (0.7 U/µl) Kemptide (Promega) 5 µM 
PKC (5 ng/µl)  Neurogranin (Promega) 25 µM 
Table 2-6: Enzymes, control peptides and chemicals used in in vitro kinase assays. 
 







Protein ID Length (aa) 
SLQRQLSIALPQE Liprin-α3_S75 F1LSE6 13 
SLQRQLAIALPQE Liprin-α3_S75 F1LSE6 13 
MMQRSMSDPKPLS Pclo_S3626 Q9JKS6-2 13 
MMQRSMADPKPLS Pclo_A3626 Q9JKS6-2 13 
TLQRSLSDPKPLS Bsn_S2844 G3V984 13 
TLQRSLADPKPLS Bsn_A2844 G3V984 13 
VPVRSGSIEQASL Rim1_S1141 F1LYS1 13 
VPVRSGAIEQASL Rim1_A1141 F1LYS1 13 
RHERRHSDVALPH Rim1_S413 F1LYS1 13 
RHERRHADVALPH Rim1_S413 F1LYS1 13 
GPIRQASQAGPGP Syn1_S603 P09951 13 
Table 2-7: Sequence of peptides used in in vitro kinase assay. 
 Mass spectrometry methods 
2.2.2.1 Protein digestion  
For protein digestion, the dried protein pellets were dissolved in 80 µl of 1% Rapigest by 
vortexing, sonication and incubation in the thermoshaker at 60 oC for 15 min at 1050 rpm. 
Dissolved protein were reduced by addition of 20 µl of 50 mM DTT and incubation at 60 oC 
for 45 min at 1050 rpm. Following, proteins were alkylated by addition of 20 µl of 100 mM 
CAA and incubation at 37 oC for 45 min at 750 rpm. Then the concentration of RapiGest in the 
samples were reduced to 0.1% by addition of 100 mM TEAB (pH=8). Then the proteins were 
digested by adding trypsin in 1:20 ratio (trypsin to protein ratio) and incubation overnight 
in the thermoshaker at 37 oC and 750 rpm. To stop the digestion reaction and degradation of 
RapiGest, 1% FA was added to the samples and incubated at 37 oC, for 2 h, at 750 rpm. 
RapiGest precipitations were cleared by centrifugation at 13000 rpm for 30 min at 4 oC. The 
supernatant containing the peptides were transferred to a new tube and dried in vacuum 
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concentrator and kept in -20 oC for the next step (Dimethyl labeling). All the reagents were 
dissolved in 100 mM TEAB, pH=8. 
2.2.2.2 Stable isotope dimethyl labeling 
Digested samples were differentially labeled by stable isotope dimethyl labeling according to 
Boersema et al. (Boersema et al., 2009b). Briefly, the digested samples were dissolved in 100 
µl of TEAB (100 mM, pH=8) and separately labeled by light and medium isotope tags by 
adding 4 μl of 4% (vol/vol) CH2O and 4 μl of 4% (vol/vol) CD2O to the light and medium 
samples, respectively. Then 4 μl of 0.6 M NaBD3CN was added to both light and medium 
samples, and samples were incubated at RT for 1 h at 750 rpm in the thermoshaker. To stop 
the reaction, 16 μl of 1% (vol/vol) ammonia and 8 μl of 5% FA (vol/vol) were added to the 
samples. Then the light and medium samples were mixed to a volume ratio of 1:1 and kept 
on ice for the fractionation by strong cation exchange. 
2.2.2.3 Strong cationic exchange (SCX) chromatography 
The fractionation of the peptides by SCX chromatography was performed on a FPLC system 
(SMART, Pharmacia). The mixed light/medium peptides were diluted with the solvent A (10 
mM NH4HCO2, 30% ACN (v/v), pH=2.7) to a final volume of 1 ml and then loaded on a Mono 
S column PC 1.6/5 (Pharmacia Biotech). The peptides were eluted with a gradient of 0–90% 
solvent B (500 mM NH4HCO2, 30% ACN (v/v), pH=2.7) over 40 min at a flow rate of 100 
µl/min. The first twelve fractions, 0.2 ml each, including the flow-through were collected and 
dried in the vacuum concentrator and were subjected to the phosphopeptides enrichment 
separately.  
2.2.2.4 Phosphopeptide Enrichment 
TiO2 enrichment 
The spin column phosphopeptide enrichment by TiO2 was performed mainly according to 
Larson et al (Larsen et al., 2005) with some modifications. In-house TiO2 columns were 
packed with the TiO2 beads (GL Sciences Inc., Tokyo, Japan) and equilibrated with loading 
buffer (200 mg/ml DHB in 80% ACN, 5% TFA). Dried peptides were dissolved in 60 μl of 
loading buffer and loaded onto a TiO2 column by centrifugation at 3000 rpm for 5 min at RT 
(all the washing and elution steps were done with the same settings). The columns were 
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washed three times with 60 μl of loading buffer and five times with 60 μl washing buffer 
(80% ACN, 5% TFA). Then, phosphopeptides were eluted by 40 μl of 0.3 N NH4OH, pH ≥ 10.5 
(three times). Eluted phosphopeptides were dried in the vacuum concentrator for further MS 
analysis. 
Immobilized metal affinity chromatography (IMAC) enrichment 
IMAC enrichment was performed based on a previously described protocol (Villén and Gygi, 
2008). Briefly, 100 µl of IMAC beads (PhosSelect iron affinity gel, Sigma) were washed three 
times with 1 ml of binding buffer (40% ACN (vol/vol), 25 mM FA in H2O) and 50% slurry of 
the beads were prepared. Each peptide fraction from SCX chromatography was dissolved in 
120 µl binding buffer, and 10 µl of IMAC beads was added. Peptides were incubated with the 
beads at RT for 1 h with vigorous shaking. Then resins were washed three times with 120 µl 
of IMAC binding buffer. The phosphopeptides were then eluted three times by incubation of 
the resin with elution buffer (50 mM K2HPO4/NH4OH, pH 10.0) for 5 min. In order to 
neutralize the eluted solution, 40 µl of 10% FA was added to the tubes. Eluted 
phosphopeptides were dried in the vacuum concentrator for further MS analysis. 
2.2.2.5 LC-MS/MS analysis  
For the analysis of the phosphopeptides in this study, three mass spectrometers were used. 
For the optimization part the LTQ Orbitrap Velos (section 3.1), for the stimulation of 
synaptosomes in different conditions the Q Exactive (section 3.2) and for the 
kinase/phosphatase inhibition experiment the Q Exactive HF (section 3.3) were used. In the 
following paragraphs, the operating parameters of each instrument are described.  
LTQ Orbitrap Velos 
Peptides were analyzed on hybrid linear ion trap-Orbitrap Velos (Thermo Scientific) mass 
spectrometer coupled to a nanoflow liquid chromatography system (Agilent 1100 series, 
Agilent). The peptides were pre-concentrated on a trap column (100 µm ID × 20 mm self-
packed with Reprosil-Pur 120 C18-AQ, 5 μm, Dr. Maisch GmbH, Ammerbuch-Entringen, 
Germany) at 5 µl/min in loading buffer (2% ACN, 0.1% FA) and then separated by an 
analytical column (75 µm ID × 200 mm self-packed with Reprosil-Pur 120 C18-AQ, 3 μm, Dr. 
Maisch GmbH) using a linear gradient form 5% to 34% buffer B (95% ACN and 0.1% FA) at 
flow rate of 300 nl/min. The mass spectrometer was operated in data-dependent acquisition 
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mode. Full scan MS spectra were acquired in the range of 350-1600 m/z at a resolution of 
30,000 FWHM at m/z 400. The top 10 most intense peaks per cycle from the survey scan 
were selected for fragmentation in the linear ion trap with Collision Induced Dissociation 
(CID) with the normalized collision energy (NCE) of 35% and isolation window 2 m/z. 
Dynamic exclusion time for precursor ions selected for MS/MS fragmentation was 60 s. 
Automatic gain control target value and maximum ion injection time for MS and MS/MS were 
1×106 in 500 ms and 1×104 in 100 ms, respectively. 
Q-Exactive 
Enriched phosphopeptides in each fraction were analyzed on a Q-Exactive hybrid 
Quadrupole-Orbitrap mass spectrometer (Thermo Scientific) coupled to a NanoLC pump 
(EASY-nLC 1000, Thermo Scientific). The peptides were pre-concentrated on a Reversed 
Phase-C18 precolumn (100 µm ID × 20 mm self-packed with Reprosil-Pur 120 C18-AQ 5 μm, 
Dr. Maisch GmbH, Ammerbuch-Entringen, Germany) at flow rate 5 µl/min in the loading 
buffer (2% ACN, 0.1% FA) and then separated by reversed phase-C18 nanoflow 
chromatography (75 µm ID × 200 mm self-packed with Reprosil-Pur 120 C18-AQ, 3 μm, Dr. 
Maisch GmbH). Peptides were injected with solvent A (0.1% FA) at a flow rate 320 nL/min 
and eluted by 0-37% solvent B (95% ACN, 0.1% FA) with an overall run-time of 45 min. 
Separated peptides were ionized by electrospray ionization (ESI) source in a positive ion 
mode. The mass spectrometer was operated in data-dependent acquisition mode. Full scan 
MS spectra were acquired in the range of 350-1600 m/z at a resolution of of 70,000, m/z 200. 
The top 12 most intense peaks per cycle from the survey scan were selected for 
fragmentation in the collision cell with Higher-energy Collisional Dissociation (HCD) with the 
normalized collision energy (NCE) of 28% and isolation window 2 m/z. Dynamic exclusion 
time for precursor ions selected for MS/MS fragmentation was 20 s. Automatic gain control 
target value and maximum ion injection time for MS and MS/MS were 1×106 in 60 ms and 
1×105 in 120 ms, respectively. 
Q-Exactive HF 
Enriched phosphopeptides in each fraction were dissolved in loading buffer (2% ACN, 0.1% 
FA) and analyzed on a Q-Exactive HF hybrid Quadrupole-Orbitrap mass spectrometer 
(Thermo Scientific) coupled to an Ultimate 3000 RSLC UHPLC (Dionex, USA). The peptides 
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were pre-concentrated on a Reversed Phase-C18 precolumn (100 µm ID × 28 mm self-packed 
with Reprosil-Pur 120 C18-AQ 1.9 μm, Dr. Maisch GmbH, Ammerbuch-Entringen, Germany) 
and then separated by reversed phase-C18 nanoflow chromatography (75 µm ID × 200 mm 
self-packed with Reprosil-Pur 120 C18-AQ, 3 μm, Dr. Maisch GmbH). Peptides were injected 
with solvent A (0.1% FA) at a flow rate 300 nL/min and eluted by 5-46% solvent B (80% 
ACN, 0.08% FA) with an overall run-time of 88 min. Separated peptides were ionized by 
electrospray ionization (ESI) source in a positive ion mode. The mass spectrometer was 
operated in data-dependent acquisition mode. Full scan MS spectra were acquired in the 
range of 350-1600 m/z at a resolution of at a resolution of 120,000. The top 15 most intense 
peaks per cycle from the survey scan were selected for fragmentation in the collision cell with 
Higher-energy Collisional Dissociation (HCD) with the normalized collision energy (NCE) of 
28% and isolation window 2 m/z. Dynamic exclusion time for precursor ions selected for 
MS/MS fragmentation was 30 s. Automatic gain control target value and maximum ion 
injection time for MS and MS/MS were 1×106 in 50 ms and 1×105 in 110 ms, respectively. 
2.2.2.6 MS raw file processing 
The output file from LC-MS/MS runs contain the retention time of the peptides, m/z value, 
intensities as well as the precursor ions and product ions of selected peptides. For the 
identification and quantification of phosphopeptides the acquired raw files were processed 
using the MaxQuant software package version 1.5.0.25 (Cox and Mann, 2008). Spectra were 
searched using the Andromeda search engine (Cox et al., 2011) against the proteome 
database of Rattus Norvegicus (Uniprot complete proteome updated at 2015-01-07, with 
29,378 entries). MaxQuant search was configured as follows; For the MS1 first and the main 
search the mass tolerance was set to 20 and 4.5 ppm, respectively. The multiplicity was set 
to two (DimethLys0 and DimethNter0 was for ‘light’ and DimethLys4 and DimethNter4 for 
‘heavy’ samples). Trypsin/P was fixed as protease and 7 amino acids as the minimum peptide 
length, and maximum of two missed cleavages were allowed. Carbamidomethylation of 
cysteine was set as fixed modification and methionine oxidation, acetylation (on N-terminal), 
phosphorylation on serine/threonine/tyrosine were specified as variable modifications. 
False discovery rate of 1% was applied and re-quantification was enabled. For the 
optimization part, to search for the unlabeled peptides, the multiplicity was set to one and 
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the phosphorylation of serine/threonine/tyrosine phosphorylation was not set as variable 
modification. 
2.2.2.7 Data processing and bioinformatics analysis 
For the downstream data analysis, the resulting phospho(STY).txt output file from the 
MaxQuant was processed by Perseus software version 1.5.0.9 (Cox and Mann, 2008). Perseus 
data processing was configured as follows; only the phosphosites quantified in at least 2 
biological replicates were selected for further analysis. Also the reverse hits of phosphosites 
were filtered out from data processing. Moreover, only Class I phosphosites (phosphosites 
with localization probability more than 0.75) (Olsen et al., 2006a) were accepted for further 
analysis. The mean (in synaptosomes stimulation in different conditions experiments) or 
median (in Calcineurin and CaMKII inhibition experiments) of normalized ratios and the 
intensities of phosphosites across the biological replicates were extracted and transformed 
to log2 and log10, respectively. The transformed values were used to plot the distribution of 
quantified phosphosites (Figure 3-10 A, B, C, Figure 3-19 A and Figure 3-23 A).  
The significantly regulated phosphosites were determined for each experiment using 
Perseus software as follows: For experiment including stimulation of synaptosomes in 
different conditions (section 3.2), significant outliers were determined by two-tailed 
‘Significant A’ test with the p-value ≤ 0.05. For the Calcineurin inhibition experiments (section 
3.2.1), significant outliers were determined by two-tailed ‘Significant B’ test with the p-value 
≤ 0.05. ‘Significant B’ test determines the outliers in an intensity-dependent manner, whereas 
the ‘Significant A’ test only take the log2 ratios as the input (Cox and Mann, 2008, Cox et al., 
2009). For the CaMKII inhibition experiments, two layers of regulated phosphosites were 
defined due to the shift towards the downregulated phosphosites upon CaMKII inhibition 
(see Figure 3-23 A): First, the outliers by one-tailed ‘Significant B’ test with the p-value ≤ 0.05. 
Second, all the phosphosites that are downregulated by at least 2 folds upon stimulation (log2 
ratio = 1). 
2.2.2.8 Motif-X analysis 
To determine the enriched motifs in up and downregulated phosphosites, Motif-X tool 
(Schwartz and Gygi, 2005) was used remotely from motif-x.med.harvard.edu/motif-x.html. 
Sequences of upregulated or downregulated phosphorylation sites in the comparisons were 
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independently searched against the IPI Rat Proteome as background. Central character was 
set as “S” and sequence length was specified as 31. For experiment including stimulation of 
synaptosomes in different conditions (section 3.2), the default suggested setting were used 
for the analysis. For the Calcineurin and CaMKII inhibition experiments (section 3.2.1 and 
3.2.2), the occurrences and significance parameters were set to 10 and 0.00001, respectively. 
 
2.2.2.9 Other tools, software and databases 
For the illustration of proteins, domains and phosphosites in Figures 3-13, 3-14 B and 3-15 
the DOG software (Ren et al., 2009) was used. The area-proportional venn diagram plotter of 
BxToolBox system was used to draw the venn diagrams. The PhosphoSitePlus database was 
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3 Results  
 Establishment of a protocol for the identification and quantification of 
synaptosomal phosphopeptides  
As it was mentioned in introduction, several phosphopeptides enrichment protocols have 
been described. Here, I have optimized parameters in the different steps of sample 
preparation workflow such as digestion, enrichment, and peptide labeling to establish a 
protocol for identification and reliable quantification of the synaptosomal phosphosites. The 
most important parameters that I have optimized are the following: 
i.    Protein digestion (amount of starting material and protein acetone precipitation). 
ii.    Titanium dioxide (TiO2) enrichment of phosphopeptides. 
iii.    Peptides fractionation by strong cation exchange chromatography (SCX) 
iv.    Immobilized metal affinity chromatography (IMAC) as the alternative enrichment 
method. 
 Protein digestion and phosphopeptides enrichment by TiO2 
Following isolation of synaptosomes according to the protocol that was described in section 
2.2.1.1, different amounts of synaptosomes (25 µg to 1 mg) were directly solubilized in 10 µl 
of 1% (W/V) RapiGest and were digested by trypsin with a protein to enzyme ratio of 50:1. 
RapiGest is a commercial surfactant that solubilizes proteins and facilitates the enzymatic 
digestion. The advantage of the RapiGest over the commonly used denaturant such as SDS or 
urea is that it does not modify the peptides structures and does not suppress the tryptic 
enzyme activity. It undergoes hydrolysis in acidic conditions, and one of the fragment 
precipitates, so it can be removed from the solution by a centrifugation step, whereas the 
second hydrolytic fragment is water soluble and is unretained on the reverse phase column. 
This makes it compatible with the MS workflow. Here, it was observed that by increasing the 
amount of synaptosomes for the digestion, the number of identified peptides was decreasing 
(Figure 3-1 A). This might be due to the incomplete solubilization of proteins upon increase 
of the protein:RapiGest ratio. However, the number of identified peptides was improved 
significantly by acetone precipitation of the 1 mg of synaptosomal proteins prior to the 
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solubilization with the RapiGest (Figure 3-1 A).  Therefore, I have applied the acetone 
precipitation in all the following experiments.  
The next step was to enrich the phosphosites from the pool of non-phosphorylated peptides 
generated by trypsinization. For this purpose, we have used the TiO2 enrichment method. In 
this method phosphopeptides with the negative charge will bind to the TiO2 resins in the 
acidic environment and will be eluted in the basic conditions. The specificity of the 
phosphopeptides binding was improved by applying the multifunctional acids such as the 
2,5-dihydroxybenzoic acid (DHB) (Larsen et al., 2005). One of the common ways to use the 
TiO2 resins is to pack them in the pipet tips.  Here, we have tested the different amounts of 
TiO2 resins in two different sizes of the pipet tips, to optimize the overall size of the TiO2 
microcolumns. The highest number of the identified phosphopeptides was achieved when 
we packed small pipet tips with 3 mm of the TiO2 resins (Figure 3-1 B). 
 
 Impact of fractionation on the number of identified phosphopeptides 
In order to decrease the complexity of the peptide mixture and increase the yield of 
phosphopeptides identification, a fractionation step is commonly used upstream of LC-MS 
analysis. Strong cation exchange (SCX) has been used before as a complementary step for the 
phosphopeptides enrichment (Villen and Gygi, 2008). In this method, the negatively charged 
phosphopeptides in the acidic condition have a lower affinity for the negatively charged resin 
of the column than the corresponding non-phosphorylated peptides. Therefore, 
phosphopeptides are enriched in the earlier fractions (Grimsrud et al., 2010). Here, I have 
observed that using strong cation exchange following by TiO2 significantly increased the 
number of the identified phosphosites. Note that a substantial amount of unique 




















Figure 3-1: Optimization of protein digestion and TiO2 phosphopeptides enrichment. 
(A) Different amount of purified synaptosomes were used for the tryptic digestion reaction (trypsin: protein of 
1:50). Protein were solubilized in 10 µl of 1% RapiGest. The more starting material resulted in the lower number 
of identified peptides. A large improvement of peptide identification was observed upon protein precipitation 
by 100% acetone overnight. Data are represented as mean ± SEM, n=3. (B) The different sizes of the TiO2 
microcolumns were used to enrich phosphopeptides. The highest number of phosphopeptides was identified 
by using the smallest microcolumn.  
 
 





Figure 3-2: Effect of strong cation exchange chromatography on the identification of phosphosites. 
(A) Peptides resulted from digestion of one mg of synaptosome were subjected to the strong cation exchange 
chromatography. The first 8 fractions were collected. Phosphopeptides in each fraction were enriched by TiO2 
method and analyzed by mass spectrometer separately. Fractionation by SCX resulted in significantly higher 
identification of the phosphopeptides. Data are represented as mean ± SEM, n=3. (B) Distribution of multiple 
phosphorylated peptides. More than 75% of the peptides contain 1 phosphosite. (C) Distribution of 
phosphorylated amino acids. Serine (S) phosphorylation dominated the identified phosphosites followed by 
threonine (T). Only 1% of the identified phosphosites were phospho-tyrosines (Y).  
 
In the next step, I have checked the distribution of the phosphopeptides based on the multiple 
phosphorylated sites and amino acids. It was revealed that most of the peptides are mono-
phosphorylated and only 17% and 7% of them were di and triply phosphorylated, 
respectively. Regarding amino acids, serine phosphorylation was dominant over threonine 
and tyrosine phosphorylation. Indeed, only 1% of the identified phosphosites were 
phosphorylated at tyrosine (Figure 3-2 B and C).  
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In similar phosphoproteomics studies of the brain, higher amount of the starting material 
was used in order to identify more phosphosites (Villen and Gygi, 2008, Trinidad et al., 2012). 
Here, I have decided to test whether increasing the amount of starting material will result in 
an overall higher number of phosphosite identification. Therefore, I used 10 mg of isolated 
synaptosomes and solubilized them in 8 M urea instead of RapiGest due to its high cost. The 
solubilized synaptosomal proteins were digested by trypsin. Urea was removed by C18 
desalting column and digested peptides were subjected to SCX fractionation and TiO2 
enrichment. It was observed that increasing the starting material 10 fold resulted in almost 
2 fold increase in phosphosite identification (Figure 3-3). Taken together the marginal 
improvement and low practicality of 10-fold increase in the starting material, digestion of 1 
mg of synaptosomes in RapiGest was used as a standard protocol for all experiments further 
in this thesis. 
Figure 3-3: Effect of starting material on the identification of phosphopeptides. 
1 and 10 mg of synaptosomes were digested and subjected to SCX+TiO2 enrichment. Increasing the starting 
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In the next step, I have tested Immobilized Metal Affinity Chromatography (IMAC) as an 
alternative phosphopeptides enrichment method to the TiO2 method. In this method, the 
positively charged metal ions (in this case Fe(III)) were chelated on the solid phase 
iminodiacetic acid resin and interacted with the negatively charged phosphoryl group of the 
phosphosites. Similar to the TiO2 method, the binding and washing buffer had low pH to 
reduce binding of the carboxylic acid group of non-phosphorylated peptides to the resin. The 
elution of the phosphopeptides was performed by high pH buffer. Here, I have used 20 mg of 
synaptosomes, solubilized in 8 M urea and digested with trypsin. The digested peptides were 
fractionated by SCX and divided into two fractions. The first fraction was enriched by TiO2 
and the second fraction by IMAC. This procedure was carried out in 3 biological replicates. 
Here, I have observed that on average the number of the identified phosphosites by IMAC 
was higher than TiO2. However, the number of the identified phosphosites by TiO2 
enrichment method was much more robust than IMAC (see the error bars of Figure 3-4). 
Therefore, I have decided to continue the enrichment by TiO2 rather than IMAC. 
 
Figure 3-4: Comparison between TiO2 and IMAC phosphopeptides enrichment methods. 
10 mg of synaptosomes were digested and subjected to SCX+TiO2 and SCX+IMAC enrichment methods. On 
average higher number of phosphosites were identified by SCX+IMAC method. However, SCX+TiO2 method 






















































Results | 59  
 
 Stable isotopic labeling 
In recent years, most of the proteomics experiments are focused on the differential 
quantification of the protein/peptide abundance under different treatment conditions. 
Similarly, in this study, we aimed to relatively quantify the phosphopeptides of differentially 
treated synaptosomes, using the dimethyl labeling as the labeling method. In this method, 
deuterium-formaldehyde and sodium cyanoborohydride label the N-terminus and the ε-
amino group of the Lys amino acid through the reductive amination (Hsu et al., 2003), 
resulting in the mass shift of 4 Da between light and medium and 8 Da between light and 
heavy labeled peptides. Here we tested the efficiency of the dimethyl labeling by dividing an 
identical digested sample to two fractions and labeled them differently by heavy and light 
dimethyl labeling. Then the two fractions were mixed together and were analyzed by MS. The 
results revealed that (Figure 3-5) more than 94% of the peptides and 93% of the 
phosphopeptides were labeled correctly and accurately (-0.5 < log2 ratio H/L < 0.5).  
Therefore, I used the dimethyl labeling as the method of choice for the relative peptides 
quantification. 
 
Figure 3-5: Dimethyl labeling. 
Dimethyl labeling robustly labeled more than 93% of the (phospho) peptides (log2 heavy/light ratio between 
0.5 and -0.5). 
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 Impact of dimethyl labeling on the number of quantified phosphosites 
In the next step, I have investigated how the dimethyl labeling affects the number of the 
quantified phosphopeptides. For this purpose, I have digested 2×1 mg of synaptosomes and 
performed dimethyl labeling on one of the samples, whereas the second sample remained 
unlabeled. Next, I have subjected both the dimethyl labeled sample and the non-labeled 
sample to the SCX and TiO2 enrichment and analyzed them by mass spectrometer (Figure 3-
6 A). As it is shown in the Figure 3-6 B, dimethyl labeling cuts down the number of quantified 
phosphosites by half in comparison to the identified phosphosites in the label-free approach. 
This is due to the fact that the complexity of the sample mixture at the MS1 level will be 
increased by the labeling. Also, for the quantification by dimethyl labeling both heavy and 
light versions of phosphopeptides have to be identified while in the label-free method 
identification of the single unlabeled phosphopeptide is required. Although dimethyl labeling 
decreases the number of the quantified phosphopeptides, I have decided to use it as the 
quantification method due to its more accurate phosphopeptide quantification when 
compared to the label-free approach.  
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Figure 3-6: Effect of dimethyl labeling on the number of quantified phosphosites. 
(A) 2×1 mg digested synaptosomes were subjected to the label free and dimethyl labeling workflow as depicted 
in figure. (B) The number of identified phosphosites in label free approach was two times higher than quantified 
phosphosites by dimethyl labeling. Data are represented as mean ± SEM, n=3. 
1mg digested synaptosomes 1mg digested synaptosomes 
MS 
Run
Split the sample to two 
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 Phosphoproteomics of isolated nerve terminals under different 
stimulation conditions 
As it was mentioned in section 1.5, the main aim of this project was to investigate the changes 
of the phosphorylation status of presynaptic proteins upon stimulation. For this analysis, 
isolated nerve terminals, (synaptosomes) were used. Synaptosomes were prepared from 5-
6 weeks old rats using a standard subcellular fractionation protocol (see Material and 
Method). To stimulate synaptosomes, high concentration of KCl (50 mM) was used. KCl 
stimulation results in the clamped depolarization of the plasma membrane and the release of 
the glutamate. Glutamate release is fast in the first seconds and reaches a plateau almost 2 
min after stimulation (Figure 3-7). In this study the samples were collected for the further 
analysis by MS 2 min after stimulation to capture the activated steady-state status of the exo- 
and endocytotic machinery. 
 
Figure 3-7: Glutamate release assay. 
Representative trace of NADPH-fluorescence in suspended synaptosomes during subsequent addition of 
glutamate dehydrogenase (GluDH) to convert glutamate and NADP to α-ketoglutarate and NADPH. KCl was 
added to stimulate exocytotic release of glutamate. Synaptosomes were pre-incubated in sodium buffer for 5 
min at 37 oC. Then, they were transferred to a cuvette, followed by the addition of CaCl2 (final concentration 1.3 
mM) and NADP (final concentration 1.3 mM) to the reaction. The baseline was measured for 3 min, then GluDH 
(200 U) was added. The measurement was carried on for another 3 min. Synaptosomes were stimulated by 
addition of KCl (50 mM). The functional and responsive synaptosomes released the glutamate at least 2.5 folds 
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 Functional analysis of synaptosomes  
To ensure that each preparation of isolated synaptosomes used for phosphoproteome 
analysis is responsive to stimulation and their phosphorylation machineries (kinases and 
phosphatases) are functional, synaptosomes were examined by two quality checks prior to 
sample collection for the MS analysis. First, we measured glutamate release by KCl 
stimulation (Figure 3-8 A).  As expected, after addition of KCl (K+), synaptosomes that were 
pre-incubated in the presence of Ca2+ (K+, Ca2+) released glutamate more and faster than in 
the absence of Ca2+ (K+, EGTA). The glutamate release in the presence of calcium is a result of 
exocytosis whereas the release in the absence of Ca2+ is due to non-exocytotic release 
resulting from the reversal of glutamate transporters in the plasma membrane that depend 
on the membrane potential (Nicholls and Sihra, 1986). Also, we observed that release of 
glutamate remained at the baseline without KCl stimulation (EGTA).   
Second, the phosphorylation status of two well-characterized presynaptic phosphosites 
(synapsin1 S603, and dynamin1 S774) was monitored upon stimulation using phospho-
specific antibodies. Synapsin1 S603 and dynamin1 S774 are known to be phosphorylated and 
dephosphorylated upon stimulation, respectively (Jovanovic et al., 2001, Graham et al., 
2007). As shown in the Figure 3-8 B, phosphorylation of both sites changed as expected in all 
replicates, confirming that synaptosomes are functional and the workflow preserves the 
phosphorylation status of the proteins. 
 
 Activity-dependent phosphorylation changes of presynaptic proteins 
It is known that arrival of the action potential to the nerve terminals opens the voltage-gated 
calcium channels via depolarization of the membrane and results in the influx of Ca2+ ions to 
the nerve terminal. This triggers synaptic vesicles to fuse with the membrane and release the 
neurotransmitter (Sudhof, 2013). To distinguish between the Ca2+-dependent and 
depolarization-dependent phosphorylation changes of presynaptic proteins, three 
stimulation conditions were designed as follows: 
(i) Depolarization in the presence of calcium ions (K+, Ca2+)  
(ii) Depolarization in the absence of calcium ions (K+, EGTA) 
(iii) No depolarization (EGTA) 
 
 




Figure 3-8: Functional assessment of synaptosomes 
(A) Glutamate release was measured when synaptosomes were stimulated by KCl in the presence of calcium 
(Ca2+, KCl), the absence of calcium (EGTA, KCl) and when synaptosomes were not stimulated (EGTA). The 
release of glutamate was at the highest level when synaptosomes were stimulated in the presence of calcium. It 
was decreased in the absence of calcium and was at the lowest level when synaptosomes were not stimulated. 
Data represented as mean of three replicates, with the bars indicating the range of values.  
 (B) Immunoblot analysis of two representative presynaptic proteins.  Synaptosomes were collected 2 min after 
stimulation in the 3 above-mentioned conditions for immunoblot analysis with phospho-specific antibodies 
against synapsin Ser603 (pS603) and dynamin Ser774 (pS774).  Upon stimulation in the presence of calcium, 
synapsin Ser603 and dynamin Ser774 phosphorylation were up and downregulated, respectively. For the 
loading control antibodies against synapsin and dynamin that were not sensitive to the phosphorylation sites 
were used, adapted from (Kohansal-Nodehi et al., 2016). 
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Treated synaptosomes in the three mentioned stimulation conditions were collected 2 min 
after stimulation and lysed by lysis buffer to stop the reaction. The same amount of 
synaptosomes for each condition was acetone precipitated and digested by trypsin. Tryptic 
peptides were then labeled differentially (Heavy and Light) by stable isotopes using dimethyl 
labeling. To elucidate the phosphorylation changes of the proteins in each stimulation 
condition compared to the other two conditions, the differentially labeled peptides were 
mixed in 1:1 ratio as it is shown in Figure 3-9. Then the mixed peptides were subjected to 
SCX. The first twelve fractions were collected, and the phosphopeptides in each fraction were 
enriched by TiO2 approach and analyzed by mass spectrometer separately. The mentioned 
comparisons between conditions are listed below:  
# of comparison Abbreviation To investigate… 
Comparison 1 K+, Ca2+ vs K+, EGTA Ca2+-dependent phosphorylation changes 
Comparison 2 K+, Ca2+ vs EGTA Ca2+ and depolarization-dependent phosphorylation changes 
Comparison 3 K+, EGTA vs EGTA Depolarisation-dependent phosphorylation changes 
 
All comparisons were performed in three biological replicates. All the phosphosites with the 
following criteria were filtered out for the further data analysis (See the Material and Method 
section 2.2.2.7).  
 Phosphosites that are quantified in only in one replicate 
 Phosphosites with localization probability less than 0.75  
 Phosphosites that are identified in the decoy database search (reverse phosphosites).   
Due to the rigorous selection criteria, the phosphosites that were reliably quantified in the 
comparison 1, 2 and 3 were 67.9%, 62.5%, and 58.85%, respectively, of the total 
phosphosites that were initially quantified. The regulated phosphosites in comparison 1, 2, 3 
are listed in the Appendices section Tables 6-1, 6-2 and 6-3, respectively. For the list all 








Figure 3-9: Experimental workflow for quantitative phosphoproteomics of synaptosomes in different 
stimulation conditions. 
Synaptosomal proteins treated in the mentioned conditions above (K+, Ca2+), (K+, EGTA) and (EGTA) were 
extracted by lysis buffer followed by acetone precipitation. The protein pellets were dissolved in 1% RapiGest 
and digested by trypsin. Next, digested peptides were labeled by stable isotope dimethyl labeling. To obtain the 
pair-wise comparison between the conditions, differentially labeled peptides were mixed at 1:1 ratio and 
subjected to strong cation exchange chromatography. The first 12 fractions were collected and each fraction 
was separately enriched for phosphopeptides by TiO2 and analyzed by LC-MS/MS, adapted from (Kohansal-
Nodehi et al., 2016). 
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Distribution of the phosphosites in each comparison is shown in Figure 3-10 A, B, C. To 
determine the significantly up or downregulated phosphosites, we have used ‘significant A’ 
test, embedded in ‘Perseus’, the software that was designed to analyze the proteomics data. 
This test determines the phosphosites with significant log2 ratio H/L outliers relative to a 
total population of the phosphosites (p-value ≤ 0.05). Remarkably, in the first two 
comparisons (Ca2+ ions are involved in one of the conditions, Figure 3-10 A and B) dynamics 
of the phosphorylation changes is higher than in the third comparison (no Ca2+ ions, Figure 
3-10 C). In fact, in the third comparison even the phosphosites that are determined to be 
significant outliers, are closely clustered around 1:1 ratio (or log2=0). Note that synapsin1 
S603 and dynamin1 S774 were quantified as up and downregulated phosphosites in the first 
two comparisons (Figure 3-10 A, B) which agree with the western blot analysis by phospho-
specific antibodies (Figure 3-8 B), confirming the high quality of the dataset. 
Next, the overlap of the phosphosites in the three comparisons was investigated. A very high 
overlap of the total quantified phosphosites was observed between the three replicates 
(Figure 3-11 A). Also, a substantial overlap of regulated phosphosites between  
depolarization with Ca2+ versus depolarization without Ca2+ and depolarization with Ca2+ 
versus no depolarization was observed (Figure 3-11 B, C and D). Intriguingly, phosphosites 
that are common in the first two comparisons (these phosphosites are shown in the Figure 3-11 
B with the black oval) showed an identical tendency in regulation and similar fold changes 
(Figure 3-11 E). In addition, the phosphosites regulated in the third comparison showed 
almost no overlap with the regulated phosphosites in the other two conditions. These results 











Figure 3-10: Overview of the quantified phosphosites in the three comparisons. 
Distribution of quantified phosphosites from pair-wise comparisons of (A) depolarization with Ca2+ versus 
depolarization without Ca2+ (K+, Ca2+ versus K+, EGTA) (B) depolarization with Ca2+ versus no depolarization 
(K+, Ca2+ versus EGTA) and (C) depolarization without Ca2+ versus no depolarization (K+, EGTA versus EGTA). 
Stable isotope dimethyl labeling was used for the quantification. To determine significantly regulated 
phosphosites in each comparison the two-tailed ‘Significant A’ test (p-value ≤ 0.05) of the Perseus module was 
used (See Material and Method). (D) The number of quantified up- or down-regulated phosphosites and 
phosphoproteins in the three comparisons. In the first two comparisons (A and B) red/green and black dots 
represent the upregulated/downregulated and the not regulated phosphosites, respectively, in the K+, Ca2+ 
conditions compared to K+, EGTA or EGTA conditions. In the third comparison (C) the red/green and the black 
dots represent the upregulated/downregulated and the not regulated phosphosites, respectively, in the K+, 
EGTA conditions compared to EGTA condition. Note that in the comparisons involving the calcium ions (A and 
B) the regulation of the phosphosites upon stimulation is more pronounced (more regulated phosphosites, with 
the log2 ratio distanced further from 0). The position of the synapsin S603 and dynamin S774 are shown as the 
up and downregulated phosphosites, respectively. In the comparisons were calcium ions were excluded (C), the 
number of the regulated phosphosites was low compared to two other comparisons (A and B) and the log2 of 









Figure 3-11: Overlap of quantified phosphosites in different comparisons. 
The proportional Venn diagram between (A) all quantified phosphosites, (B) regulated phosphosites, (C) 
upregulated phosphosites and (D) downregulated phosphosites in all three comparisons. Although the overlap 
between all the quantified phosphosites in all comparisons was substantial (A), the overlap of regulated 
phosphosites (up or down) was close to 50% between K+, Ca2+ versus K+, EGTA and K+, Ca2+ versus EGTA 
comparisons and almost no overlap between K+, EGTA versus EGTA and the other two comparisons was 
observed (C and D).  
(E) The plot depicting the extent of regulation of phosphosites that were identified both in K+, Ca2+ versus K+, 
EGTA and K+, Ca2+ versus EGTA comparisons (phosphosites are shown with the black oval in B). An almost 
identical direction of phosphosites regulation (up or downregulation) was observed. Also, the log2 ratios of 
dimethyl labeling between the phosphosites were very similar between the two comparisons, adapted from 
(Kohansal-Nodehi et al., 2016). 
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 Functional/localization grouping of regulated phosphosites 
Our analysis revealed that a large fraction of the quantified phosphosites was not changed 
upon stimulation. This attracts a special interest to the fraction of regulated phosphosites 
and their involvement in the regulation of synaptic transmission. In order to gain a better 
overview of the functional properties of the regulated phosphosites in the three comparisons, 
we have annotated proteins manually and categorized them based on their function and 
localization into 15 groups (Figure 3-12) according to a previous study (Boyken et al., 2013). 
With few exceptions (e.g translation/transcription or metabolism of neurotransmitters), the 
majority of proteins containing the regulated phosphosites are known to have a role in 
synaptic vesicle trafficking or in neurotransmitter signaling. In the same line, groups such as 
mitochondrial proteins that are known to constitute a large fraction of presynaptic proteins 
(Boyken et al., 2013) have very low number of regulated phosphosites. This proves that our 
experimental approach is specifically targeting the synaptic transmission related proteins 
and phosphorylation of other proteins present in synaptosomes (such as metabolism related 
proteins) remains unregulated.   
In summary, identification of the regulated phosphosites upon stimulation presented in this 
study provides novel insights into the molecular regulation of neurotransmitter release. In 
the following sections, the groups of proteins with the highest number of regulated 
phosphosites in the K+, Ca2+ versus K+, EGTA comparison and the proteins that are known to 
be involved in synaptic vesicle recycling will be discussed in more detail.  
 
3.2.3.1 Active zone proteins 
In our study, component of active zone protein group showed extensive changes in their 
phosphorylation status upon stimulation. In Figure 3-13 amino acid positions of the 
quantified phosphosites of active zone proteins are shown. Opposite changes (up and 
downregulation) were detected among phosphosites of this group upon stimulation. 
Between the 7 proteins of this group, bassoon and piccolo are massively phosphorylated with 
48 and 31 quantified phosphosites, respectively. 
 
Results | 71  
 
 
Figure 3-12: Functional/localization categorization of the regulated phosphosites in the three 
comparisons. 
Regulated phosphosites were manually categorized based on their function and localization into 15 groups 
according to the previous publication (Boyken et al., 2013). Proteins with other functions/localizations than 




Although bassoon and piccolo are homologous proteins, some differences were observed 
between their phosphorylation patterns. For example, phosphosites of bassoon were 
dramatically downregulated upon stimulation (16 phosphosites), whereas only 4 
phosphosites of piccolo were downregulated and many of them remained not regulated. Also, 
5 phosphosites of bassoon and 2 of piccolo were upregulated. While downregulation of 
majority of the phosphosites can serve as a regulator of the global properties of the protein 
such as surface charge, the upregulated phosphosites might have particular physiological 
significance. For example, it is known that interaction of bassoon with the adaptor protein 
14-3-3 is dependent on the phosphorylation of bassoon of S2844 (Schroder et al., 2013). 
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RIM is known as the central organizer of the active zone. It binds to Munc13 via its N-terminal 
zinc finger (Deng et al., 2011) and with the helices surrounding the zinc finger to Rab3a and 
Rab27 (Wang et al., 2000, Fukuda, 2003). These interactions at the N-terminal of RIM links 
synaptic vesicle to the active zone and to the priming factor Munc13. RIM also binds to N- 
and P/Q-type Ca2+ channels (Kaeser et al., 2011a) and ELKS proteins (Ohtsuka et al., 2002) 
via its PDZ domain and the proline-rich domain located between C2A and C2B. Via C2B 
domain, RIM binds to the liprin-α3 and synaptotagmin 1 (Schoch et al., 2002) and via C2A 
domain to SNARE proteins (Coppola et al., 2001). In our study, 16 phosphosites of RIM were 
quantified (4 upregulated and 3 downregulated, Figure 3-13).  One of the upregulated 
phosphosites (S413) was reported to be the substrate of PKA and its role in the long-term 
plasticity has been investigated extensively (Lonart et al., 2003, Kaeser et al., 2008). The 
other upregulated phosphosite S346 is in the proximity of zinc finger (FYVE2) domain which 
suggests its possible role in the binding of RIM to Munc13 or Rab3a. S742 and S745 located 
between the PDZ domain and the C2A are downregulated upon stimulation. 
Dephosphorylation of these sites might have a role in the interaction of RIM with Ca2+ 
channels or SNARE proteins.  
Munc13 is considered as the priming factor of the active zone and is essential for synaptic 
transmission (Chen et al., 2013). In our dataset, we quantified 2 phosphosites at the N-
terminus of the Munc13a (S255 and S259) that were not regulated upon stimulation. The N-
terminus of the Munc13 is known to be important for its interaction with RIM (Betz et al., 
2001). 
The function of liprin-α3 in the active zone is not completely understood but there is some 
evidence that it is needed for the formation of active zones and the recruitment of synaptic 
vesicles and LAR-type receptor phosphotyrosine phosphatases (Dai et al., 2006, Stryker and 
Johnson, 2007). In this study, 4 phosphosites of liprin-α3 were quantified (1 up, 1 down and 
2 not regulated).  
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Figure 3-13: Quantified phosphosites of active zone in the K+, Ca2+ versus K+, EGTA comparison. 
Main protein components of the active zone with the phosphosites quantified in this study are depicted. 
Red/green and black color represent respectively the up/down and not regulated phosphosites in K+, Ca2+ 
versus K+, EGTA comparison. Phosphosites that are reported to be physiologically relevant are underlined. 
Unmarked phosphosites are identified in the previous proteomic discovery-mode mass spectrometry analysis 
(source: publicly available PhosphoSitePlus database). Phosphosites with asterisk represent phosphosites 
reported in this study for the first time. Phosphosites that are surrounded with the black/red box are the 
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ERC proteins, also known as CAST or ELKS, are important for the regulation of the size of the 
ready releasable pool of synaptic vesicles (Kaeser et al., 2009). We quantified two 
phosphosites in N-terminus of ERC2 (S16 and S18) that were 6 and 7 fold downregulated, 
respectively. Interestingly, a recent publication (Held et al., 2016) showed that the decrease 
of  the readily releasable pool via ERC proteins is due to its N-terminal interaction with liprin-
α3 and bassoon. 
 
3.2.3.2 Endocytosis proteins 
After exocytosis, synaptic vesicles are retrieved from the membrane mainly by the clathrin-
mediated endocytosis pathway. Different studies have shown that proteins involved in this 
process undergo rapid and coordinated dephosphorylation upon Ca2+ influx into the nerve 
terminal through voltage-gated calcium channels. These proteins are collectively called 
‘dephosphins’ and consist of dynamin1, amphiphysins1 and 2, epsin, eps15 and AP180. 
Dephosphins are not structurally related and function in different stages of synaptic vesicle 
endocytosis. In our dataset, we have quantified 64 phosphosites belonging to endocytosis-
related proteins, and 20 of them were changed. Consistent with the previous report, the 
majority of the significantly altered phosphosites (18 phosphosites) were downregulated 
(Figure3-14 A).  
Dynamin1 is a GTPase that binds to the neck of budded vesicles and mediates the fission of 
synaptic vesicles from the membrane. It is known that dynamin binds to SH3 domains of 
proteins such as intersectin, amphiphysin and endophilin through its proline-rich domain 
(PRD) at the C-terminus (Sundborger and Hinshaw, 2014). In our dataset, we have quantified 
9 phosphosites of dynamin1, all close to the PRD domain, and 6 of which were 
dephosphorylated upon stimulation (Figure3-14 B). It is known that phosphorylation of 
dynamin1 by PKC and CdK5 modulates its interaction with other endocytotic proteins 
(Tomizawa et al., 2003b) as well as membrane lipids (Liu et al., 1994). 
Amphiphysins are scaffold proteins that link the early stage endocytotic proteins such as AP2 
and clathrin to the late stage proteins like dynamin and synaptojanin (Cousin and Robinson, 
2001). We have quantified 9 phosphosites of amphiphysin1, none of them are significantly 
regulated. However, a slight downregulation of some phosphosites (S245, S249, S239) 
around proline-rich domain (PRD) was detected. It is known that amphiphysin1 binds to 
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dynamin and synaptojanin through PRD domain. Therefore it can be suggested that these 
sites may have some implications in amphiphysin protein-protein interactions (Craft et al., 
2008). We have also quantified 2 phosphosites of amphiphysin2 (Bin1) that are significantly 
downregulated. 
 
Figure 3-14: Phosphosites related to clathrin-mediated endocytosis. 
(A) The graph is depicting the distribution of the phosphosites of proteins involved in clathrin-mediated 
endocytosis quantified in K+, Ca2+ versus K+, EGTA comparison. Except for two phosphosites all the quantified 
phosphosites are either not regulated or down regulated upon stimulation in the presence of calcium.  
(B) Quantified phosphosites of dynamin1 as a representative of the endocytotic proteins. Dominant 
downregulation of the phosphosites upon stimulation in the C-terminus of the protein was observed. 
Phosphosites that are reported to be physiologically relevant are underlined. Phosphosites that are surrounded 
with the black box are the putative substrates of Calcineurin. 
 
Epsin1 is another member of dephosphins that is reported to be dephosphorylated upon 
stimulation. In our study, we have quantified 3 phosphosites of epsin-1. One of them, in 
contrast to previous reports (Chen et al., 1999), was upregulated upon stimulation. It is 
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AP180 is located under the outer clathrin shell of coated vesicles and links the clathrin shell 
to the vesicle membrane (Hao et al., 1999). In our dataset, 9 phosphosites of AP180 were 
quantified and 3 of them were downregulated (S600, S621, and S627). It is known that AP180 
binds to another clathrin coat assembly protein, AP2, via the patch of amino acids between 
positions 623 and 680 (Hao et al., 1999). Interestingly, all the three downregulated 
phosphosites in our study are close to this region of the protein. This suggests that 
dephosphorylation of AP180 may potentially regulate its interaction with AP2.  
Synaptojanin is a phosphatidylinositol polyphosphate (PtdInsP) phosphatase that mediates 
the uncoating of synaptic vesicles from the clathrin shell. Four phosphosites of synaptojanin 
were quantified in this study that were not significantly regulated. However, these 
phosphosites were to some extent (2 fold) downregulated (S1160, T1048, S1053 and S1147). 
It is known that the enzymatic activity of synaptojanin is decreased by phosphorylation. Also, 
the previous report showed that binding of synaptojanin to endophilin1 is dependent on 
dephosphorylation of S1147 (Lee et al., 2004). 
Besides the proteins involved in clathrin-mediated endocytosis, we have quantified 
phosphosites of proteins engaged in other modes of endocytosis. For example, Syndapin1 
(S346) that functions in activity-dependent bulk endocytosis (Nguyen et al., 2014) and 
Endophilin A2 (S288) that play a role in membrane scission during clathrin-independent 
endocytosis (Renard et al., 2015).  
 
3.2.3.3 Synaptic vesicle and exocytosis related proteins 
Among synaptic vesicle proteins, synapsin1 was the only protein with significantly regulated 
phosphosites (8 and 3 up and downregulated phosphosites, respectively) (Figure 3-15). 
Synapsin links synaptic vesicles to actin filaments and the physiological relevance of many 
synapsin phosphosites is already discovered. For example, it is known that phosphorylation 
at S603 and S566 is upregulated upon stimulation (in consistence with our observation in 
this study) and results in the conformational changes that decreases its affinity to actin 
filaments and synaptic vesicles (Benfenati et al., 1990). Consequently, more free vesicles are 
available for the docking and fusion to the membrane (Schiebler et al., 1986). It is also 
reported that S62, S67 and S549 are downregulated upon stimulation. However, in our 
dataset only S62 was significantly downregulated. It is known that phosphorylation of these 
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sites also affects the structure of synapsin and decreases its affinity to actin but not synaptic 
vesicles (Jovanovic et al., 2000). It has been suggested that dephosphorylation at these sites 
creates a pool of the dephosphorylated synapsin that regulates recycling and reserve pool of 
synaptic vesicles (Jovanovic et al., 2001). In addition, it has been shown in a recent study that 
S551 is involved in the recruitment of synaptic vesicles to the readily releasable pool, and 
phosphorylation by CdK5 enhances the actin-binding of synapsin and consequently 
modulates the size of the readily releasable pool (Verstegen et al., 2014).  
 
 
Figure 3-15: Regulation of synapsin1 phosphosites upon stimulation. 
Quantified phosphosites of synapsin1 are demonstrated. Up and downregulated synapsin1 phosphosites upon 
stimulation are represent in red/green, respectively. Phosphosites that are reported to be physiologically 
relevant are underlined. Phosphosites that are surrounded with the black/red box are the putative substrate of 
Calcineurin/CaMKII (see result chapter, part 3-3), adapted from (Kohansal-Nodehi et al., 2016). 
 
Besides synapsin, we have quantified phosphosites in other synaptic vesicle proteins (Rab3a 
S188, S190, Sv2a S127, Sv2b S33, S36, synaptopodin S19, Syt1 T286, Syt12 S97, S99, Syt2 
T128 and Syt3 587) that were not regulated upon stimulation. We have also quantified two 
phosphosites of SNARE proteins, Vamp2 S74 and S79 that were slightly upregulated. Both 
Syt1 and Vamp2 are known to be substrate of a variety of enzymes such as CaMKII and CK2 
(Popoli, 1993, Davletov et al., 1993, Nielander et al., 1995), but the physiological relevance of 
the phosphorylation in vivo has not been studied. 
In addition to synaptic vesicle proteins, phosphosites of some of the proteins involved in 
exocytosis were also regulated and that will be discussed in the following paragraphs. 
Complexins are known to regulate exocytosis via an interaction with the SNARE complex. It 
is known that complexin is phosphorylated at the C-terminus (S115) by casein kinase 2, and 
phosphorylation of this site enhances the binding of complexin to the SNARE complex (Shata 
et al., 2007). In our study, we have quantified another site of complexin1 (S93) that was 
upregulated upon stimulation. Investigation of the physiological relevance of S93 
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phosphorylation can deepen our knowledge regarding the regulation of the neurotransmitter 
release by complexin. 
We have quantified two phosphosites (S206 and S738) of the N-ethylmaleimide-sensitive 
fusion protein (NSF). NSF is an ATPase that disassembles the SNARE complex after fusion. 
We observed an upregulation of NSF at S206 upon stimulation. Phosphorylation of NSF at 
another site S237 was discovered as an inhibitory factor for the NSF activity (Matveeva et al., 
2001). 
Importantly, many phosphosites of proteins that are known to be involved in synaptic vesicle 
fusion were not regulated upon stimulation in our study: syntaxin1A (S14, T10, S59, and 
S64), SNAP-25 (S25) and Munc18 (S593, and S594). Of note, we have quantified 3 
phosphosites of Munc18 that were slightly downregulated (S506, S507, and S509). Munc18 
is known to be phosphorylated by PKC, CdK5, and ERK1/2 (Fletcher et al., 1999, Barclay et 
al., 2003, Schmitz et al., 2016).  
 
3.2.3.4 Cytoskeleton and associated proteins 
Both cytoskeleton filaments, actin, and microtubules are present in the nerve terminal. 
However, their localizationl is different. While actin filaments reach the active zone, the 
microtubules do not and are mostly present in the center of the nerve terminals (Doussau 
and Augustine, 2000). In this study, we have quantified 17 and 7 phosphosites as up and 
downregulated ones, respectively, that are associated with the cytoskeleton filaments and 
directly or indirectly modulate their structure. Some of these phosphosites will be described 
in the next paragraph.  
Drebin is an actin-binding protein that stabilizes actin filaments and prevents them from 
depolymerization.  Drebin (S241) was observed to be upregulated upon stimulation. It has 
been shown that phosphorylation (of another phosphosite, S142) via CdK5 modulate its 
binding to the actin filaments (Worth et al., 2013).  
Another phosphosite that was shown to be downregulated is S17 of septin5. Septin5 is a 
GTPase and is known to regulate the exocytosis via interaction with syntaxin1. 
Phosphorylation of septin at S17 by CdK5 decreases its interaction with the syntaxin1 
(Taniguchi et al., 2007). 
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Mysoin IIB (Myh10) is a motor protein that is known to be involved in the activity-evoked 
endocytosis of synaptic vesicles in the nerve terminal (Peng et al., 2012). We found two 
phosphosites of Mysoin IIB (S1952 and S1956) to be upregulated phosphosites upon 
stimulation. Interestingly, the previous study showed that a stretch of amino acids that 
contains the two mentioned serines is important for the dynamics of myosin (Juanes-Garcia 
et al., 2015).  
MARCKS is an actin cross-linking protein that is known to be phosphorylated by PKC. 
MARCKS is also considered as the cross-bridge between actin filaments and the plasma 
membrane. We have found three phosphosites of MARCKS (S138, T143, and S163) to be 
upregulated upon stimulation. It is known that phosphorylation inhibits actin cross-linking  
by MARCKS (Nairn and Aderem, 1992). 
 
3.2.3.5 Ion Channels and transporters 
Presynaptic nerve terminals are rich in ion channels and transporters, and many of them are 
known to be regulated by phosphorylation. In this study, 103 phosphosites of channels and 
transporters were quantified in the K+, Ca2+ versus K+, EGTA comparison. Surprisingly, only 
10 phosphosites out of 103 were detected as significantly changed. This suggests that 
channels and transporters are less targeted by kinase and phosphates upon stimulation in 
comparison to other groups of proteins, particularly the ones that are involved in SV-
recycling. Below, I will discuss the phosphosites that were regulated.  
We have quantified 5 phosphosites of P/Q-type calcium channel subunit alpha-1A and 
between them, only one (S1589) was observed to be significantly downregulated. The 
physiological relevance of these phosphosites is not known, but it has been reported that 
phosphorylation of the P/Q-type calcium channel by CdK5 decreases the activity of the 
channel (Tomizawa et al., 2002).  
FXYD domain-containing ion transport regulator 7 is another membrane protein that was 
found to be significantly downregulated at three phosphosites (S56, S58, S60). FXYD family 
is known to be associated with the Na/K-ATPase and decreases Na/K-ATPase affinity to K+ 
while does not impact the affinity towards Na+ (Crambert et al., 2003). Na/K-ATPase is 
necessary to establish and maintain the high‐K+ and low‐Na+ concentration in the cytoplasm. 
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It is conceivable that regulation of the phosphosite of FXYD affects the function of Na/K-
ATPase in maintaining the balance between K+ and low‐Na+ ions. 
Two sites of sodium-dependent neutral amino acid transporter SLC6A17, S682 and S686, 
were observed to be downregulated upon stimulation. SLC6A17 is exclusively expressed in 
the central nervous system and transports proline, glycine, leucine and alanine across the 
plasma membrane in a sodium-dependent manner. There is no information available on the 
regulation of these transporter by phosphorylation. 
We have observed three phosphosites of sodium/potassium/calcium exchanger 2 (Slc24a2), 
S41, S42 and S44, being upregulated upon stimulation. Slc24a2 is known to have a calcium 
channel activity, and in the retina it causes a rapid decrease of cytosolic calcium in the 
presence of light (Sharon et al., 2002). However, its role in the brain and precisely in the nerve 
terminal is not known. Since this protein resides in plasma membrane, it can be suggested 
that it functions as the calcium sensor and upon stimulation plays a role in the homeostasis 
of calcium concentration. 
Moreover, we have quantified one phosphosite (S1103) of plasma membrane calcium-
transporting ATPase 4 (Atp2b4) to be upregulated upon stimulation. This pump has a high 
affinity for Ca2+ and is responsible for the maintaining of Ca2+ concentration at low level in 
the resting condition. Interestingly, the S1103 is known to be the substrate of PKC, and it 
increases the activity of the pump when phosphorylated. Therefore, it can be suggested that 
after stimulation of the synaptosomes, Atp2b4 gets phosphorylated at S1103 and 
consequently becomes more active in order to bring back Ca2+ concentration to the low level 
during the resting condition. 
 
 Mapping Kinases and phosphatases responsible for the phosphorylation 
changes upon stimulation 
Next, we asked which kinases and phosphatases are responsible for the observed regulated 
phosphosites and how their activity is regulated upon stimulation.  To answer this question, 
we used Motif-X software (Schwartz and Gygi, 2005) to investigate which sequence motifs 
are enriched among up and downregulated phosphosites. Our analysis revealed that the 
‘RxxS’ sequence motif (where S is the phosphorylation site and x can be any amino acid) was 
overrepresented among significantly upregulated phosphopeptides in both K+, Ca2+ versus 
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K+, EGTA (Fold increase: 7.36, Motif score: 16.00) and K+, Ca2+ versus EGTA (Fold increase: 
5.98, Motif score: 12.93) comparisons (Figure 3-16 A). It is known that RxxS is the consensus 
motif of the CaMKII as well as PKA and conventional PKC isoforms. This result agrees well 
with the previous reports demonstrating an increased activity of these kinases upon 
depolarization of nerve terminals in the presence of calcium (Millan et al., 2003, Yamauchi, 
2005). 
A similar analysis was carried out for the phosphosites that are downregulated using Motif-
X software. Here, another sequence motif, ‘SP’ was enriched among the downregulated 
phosphosites in both K+, Ca2+ versus K+, EGTA (Fold increase: 8.03, Motif score: 16.00) and 
K+, Ca2+ versus EGTA (Fold increase: 8.21, Motif score: 16.00) comparisons (Figure 3-16 A). 
Phosphatases are not known to have the consensus motifs for their substrates. Nevertheless, 
‘SP’ motif is known to be the consensus motif of proline-directed kinases such as Cdk5, GSK-
3, and ERK1/2. This led us to conclude that activity of these kinases is downregulated upon 
stimulation. However, we have quantified two activating phosphosites in the activation loop 
of ERK1/2 (T183, Y185) as the upregulated phosphosites. That is why, ERK1/2 is less likely 
to be downregulated upon stimulation. Dephosphorylation of the phosphosites with ‘SP’ 
motif upon stimulation happens most likely due to one or both of the following reasons. First, 
CdK5 and GSK-3 are less active upon stimulation than during the resting condition. Second, 
phosphatases target ‘SP’ containing phosphosites more upon stimulation in comparison to 
the resting condition. 
In addition to the motif analysis, we could detect further evidence for the modulation of 
phosphatase activity. For example, the phosphorylation of the regulatory subunit delta 
(LOC100909464) of protein phosphatase 2A (PP2A) at S567 was upregulated upon 
stimulation.  This site is known to be phosphorylated by PKA, resulting in the increase of 
PP2A activity (Ahn et al., 2007). This suggests the higher activation of PP2A upon stimulation.  
Furthermore, upregulation in phosphorylation of Neurabin-2 S100, the regulatory protein of 
protein phosphatase 1 (PP1), was observed upon stimulation. It is known that 
phosphorylation of this site decreases the binding affinity of PP1 to the actin filaments and 
subsequently modulates its presynaptic localization, resulting in its diffusion from the nerve 
terminus (Colbran, 2004). 
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Overall, the data suggest that upon the influx of Ca2+ to the nerve terminal subset of kinases 
and phosphatases such as PKA, PKC, CaMKII, PP2A, and PP2B are activated whereas the 
proline-directed kinases such as CdK5 and GSK-3 as well as PP1 are less active. 
Next, in order to confirm whether the uncharacterized phosphosites containing RxxS motif 
are phosphorylated by one of the PKA, PKC, CaMKII kinases, we have checked the 
phosphorylation of five selected phosphosites of the active zone: RIM1 (S413 and S1141), 
bassoon (S2844), piccolo (S3626) and liprin-α3 (S75) in vitro by PKA, PKC and CaMKII 
kinases. For each site, a 13-mer peptide containing the desired phosphosite positioned in the 
middle was synthesized. The corresponding peptide with the alanine residue instead of 
serine (phosphosite) was used as negative control for each site. The result is shown in Figure 
3-16 B. All of the peptides were phosphorylated at least by one of the kinases. For instance, 
bassoon S2844 was phosphorylated only by CaMKII. RIM1 (S413) was phosphorylated by 
PKA, which is consistent with the previous report (Lonart et al., 2003). RIM1 (S1141), 
bassoon (S2844) and piccolo (S3626) were phosphorylated by both CaMKII and PKA. Liprin-
α3 (S75) was the only phosphosite that was phosphorylated by all the three kinases. These 
results suggest that another regulatory mechanism should control the substrate-kinase 
relationship in vivo since each of the kinases showed selective phosphorylation of the 
substrates despite sharing the common core motif. 
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Figure 3-16: Motif analysis of the regulated phosphosites and experimental verification of the involved 
kinases. 
(A) Sequence analysis of the up and down regulated phosphosites by Motif-X tool. The frequency of the residues 
surrounding the phosphosite (position 0) correlates with the size of the letter. For the up and downregulated 
phosphosites, ‘RxxS’ and ‘SP’ motifs were over-represented, respectively.  
(B) Phosphorylation of five quantified phosphosites of the active zone proteins by PKA, PKC and CaMKII were 
tested by in vitro kinase assay.  For each site, 13 amino acid long peptide was synthesized as a substrate in a 
way that the desired site was located in the middle of the peptide. As a negative control for each site the 
corresponding peptide with alanine substituting serine was used. For the positive control, autocamide-2, 
kemptide, and neurogranin were used as known peptide substrates of CaMKII, PKA, and PKC, respectively. The 
data represent mean values of three replicates, with the error bars indicating the range of values, adapted from 
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 Identification of the presynaptic substrates of CaMKII and Calcineurin 
(PP2B) 
From the data presented in the section 3-2, it is conceivable that CaMKII and Calcineurin are 
more active upon stimulation. The Ca2+-dependency of both enzymes has been extensively 
studied before (Miller and Kennedy, 1986, Sun et al., 2010). In addition, we described in the 
section 3.2.4 that phosphosites with the similar core motif can be targeted by more than one 
kinase in vitro. Therefore, in order to identify the substrate of the mentioned kinases in vivo 
upon stimulation, we have applied specific inhibitors of CaMKII (KN-93) and Calcineurin 
(Cyclosporine A) and combined them with the phosphoproteomics workflow as it is depicted 
in the Figure 3-17 A, B.  
To identify the Calcineurin substrates, synaptosomes were pre-incubated for 10 min with 10 
µM of Cyclosporine A (Cyclo A) dissolved in DMSO, followed by stimulation with KCl (for the 
details see Material and Method section). Synaptosomes were incubated only with DMSO 
prior to the stimulation with KCl for the negative control. After 2 min stimulation both 
CycloA-treated synaptosomes and the control samples were dissolved in lysis buffer and 
equal amounts of them were acetone precipitated, digested and labeled by dimethyl labeling 
approach.  
The labeled peptides of treated and control samples were mixed in the 1:1 ratio and 
fractionated by SCX. The first 8 fractions were collected, and phosphopeptides in each 
fraction were enriched by TiO2 method and analyzed by mass spectrometer. The 
phosphopeptides with the significant log2 ratio of control/CycloA less than 0 were 
considered as the putative substrates of Calcineurin, whereas the phosphopeptides with the 
significant log2 ratio control/CycloA more than 0 were the sites phosphorylation status of 
which was downregulated upon Calcineurin inhibition.  
The same procedure was carried out to identify the CaMKII substrates, this time utilizing 
CaMKII inhibitor, KN-93. Here, the phosphosites with the significant log2 ratio of control/KN-
93 more than 0 were considered as the putative substrate of CaMKII, whereas the 
phosphopeptides with the significant log2 ratio control/KN-93 less than 0 were upregulated 
upon CaMKII inhibition (see Figure 3-17).  
 
 





Figure 3-17: Experimental workflow for quantitative phosphoproteomics of synaptosomes treated with 
Calcineurin and CaMKII inhibitors. 
Synaptosomes were treated either with the Calcineurin inhibitor, Cyclosporine A (CycloA) (A) or with the 
CaMKII inhibitor, KN-93 (B). Treated and non-treated synaptosomes (control) were stimulated in the presence 
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 Impact of Calcineurin inhibition on the exocytosis and phosphorylation 
status of the presynaptic proteins 
To access the effect of Calcineurin inhibition on the exocytosis, I have tested glutamate 
release of synaptosomes treated with 10 µM Cyclosporine A (CycloA). As it is shown in Figure 
3-18 A, CycloA-treated synaptosomes release glutamate even before KCl stimulation and the 
extent of this release was much higher than in the control samples. This phenomenon has 
been report in previous studies (Burley and Sihra, 2000, Sihra et al., 1995). In this reports, it 
was suggested that Calcineurin has an inhibitory effect of voltage-dependent calcium 
channels and upon Calcineurin inhibition both the basal and evoked Ca2+ influx into the nerve 
terminal are increased. Therefore, one explanation of the enhanced release of glutamate by 
CycloA-treated synaptosomes can be due to the higher activity of Ca2+ channels.  
To ensure that the treatment with Cyclosporine A was efficient enough to reduce the activity 
of the Calcineurin, the phosphorylation status of dynamin1 S774 which is known to be the 
substrate of Calcineurin was investigated by phospho-specific antibody (Figure 3-18 B). The 
higher phosphorylation of the dynamin1 S774 was clearly observed in all replicates 
compared to control synaptosomes. Next, I have collected samples (four biological replicates) 
for MS analysis as it was mentioned in the previous section.  
Figure 3-19 A demonstrates the distribution of the quantified phosphosites in pair-wise 
comparisons of CycloA-treated samples versus the control. To identify the significantly 
regulated phosphosites, I have used ‘significant B’ test (Perseus software). This test 
determines phosphosites with a significant outlier log2 ratio H/L in the intensity-dependent 
manner relative to a total population of the phosphosites (p-value ≤ 0.05). All the 
phosphosites with a significant log2 ratio H/L lower than 0 (red dots) were considered to be 
the putative substrates of Calcineurin. Note the position of the dynamin S774 as the known 
substrate of the Calcineurin as the upregulated site upon Calcineurin inhibition proves the 
high quality of the dataset. In addition, phosphorylation of more 50% of upregulated 
phosphosites upon stimulation (K+, Ca2+ vs K+, EGTA) did not changed upon Calcineurin 
treatment (for instance synapsin S603, see the arrow in Figure 3-18), this suggests that the 
regulation of phosphosites by CycloA is specific and the basal release of glutamate by CycloA-
treated synaptosomes is not due to deactivation of phosphorylation machinery upon CylcoA 
application. For the list of up and downregulated phosphosites upon Calcineurin inhibition 
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see the Appendices section, Tables 6-4 and 6-5 (See Supplementary Table S4 for all quantified 
phosphosites in this experiment). 
To have an overview of function of the putative substrates of Calcineurin, I have annotated 
them manually and categorized them into 11 groups. Surprisingly, it was revealed that the 
active zone proteins group have the highest number of phosphosites that are putative 
substrates of Calcineurin. This phosphosites are marked in the Figure 3-13 with the black 
boxes. These sites are distributed among the active zone proteins: bassoon (16 
phosphosites), piccolo (11 phosphosites), RIM1 (3 phosphosites) Munc13 and liprin-α3 
(each 1 phosphosite).  
This group of proteins shares similarities with the proteins involved in clathrin-mediated 
endocytosis known as dephosphins. For instance, majority of their phosphosites undergo a 
cycle of phosphorylation/dephosphorylation in resting/stimulation status and both are the 
substrates of Calcineurin. Therefore, I named them “active zone dephosphins”. 
Cytoskeleton associated proteins group was the second group with the highest number of 
phosphosites as the Calcineurin substrate. This group contains mostly the microtubule 
associated proteins (Map1a, Map1b, Map7d1, Mapt), neurofilament polypeptides as well as 
proteins associated with the spectrin-actin network (beta-adductin and Ankyrin 2).  
The other groups that were directly involved in the synaptic vesicle recycling were 
‘Exocytosis/SV proteins’, ‘channels/receptors’ and ‘Endocytosis’. Four phosphosites of 
synapsin1 (S508, S436, S549 and S551) were detected to be the substrates of Calcineurin. 
Dephosphorylation of synapsin at S549 and S551 by Calcineurin has been previously 
reported (Jovanovic et al., 2001). Also, Munc18 (S516) was detected as the substrate of 
Calcineurin. Phosphosites of voltage-dependent calcium channels (R-type subunit alpha-1E 
S15, N-type subunit alpha-1B S745, and P/Q-type subunit alpha-1A S1981) were also 
determined as Calcineurin substrates.  The activity of calcium channels is known to be 
regulated by kinases such as GSK-3 (Zhu et al., 2010) and Cdk5 (Su et al., 2012). While it has 
been shown that Calcineurin enhances the activity of L-type calcium channels (Norris et al., 
2002), no phosphosite has been detected to be a substrate of Calcineurin in our dataset. 
Dephosphorylation of voltage-dependent calcium channels can be the explanation for the 
stimulus independent release of glutamate from CycloA-treated synaptosomes. 
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Figure 3-18: Glutamate release assay and immunoblot analysis of synaptosomes treated with 
Cyclosporine A. 
(A) Glutamate release was measured for the Cyclosporine A treated (Ca2+, KCl, CycloA) and non-treated (Ca2+, 
KCl) synaptosomes by KCl stimulation in the presence of calcium. Treated synaptosome released glutamate 
even before stimulation and with the much higher extent compared to the control. Data are represented as a 
mean value of three replicates, with the error bars indicating the range of values.  
(B) Immunoblot analysis of dynamin S774 phosphorylation as the known substrate of Calcineurin. 
Synaptosomes were collected 2 min after stimulation for immunoblot analysis with phospho-specific antibody 
against dynamin pS774. Using the Calcineurin inhibitor almost abolished dephosphorylation of dynamin pS774 
upon stimulation in the presence of calcium. For the loading control antibody against dynamin that is not 
sensitive to the phosphorylation was used. 
In line with the previous report (Cousin and Robinson, 2001), proteins involved in 
endocytosis of synaptic vesicles were also detected as the Calcineurin substrates. Dynamin1 
(S774 and 778), AP180 (S300), Endophilin-A2 (S288) and tyrosine-protein phosphatase 
auxilin (S568) were detected as putative substrates of Calcineurin. However, phosphosites of 
the amphiphysins1 and 2, epsin, eps15 and other members of the dephosphins were not 
detected as substrates of the Calcineurin. 
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Figure 3-19: Overview of the quantified phosphosites of synaptosomes treated with Cyclosporine A. 
(A) Distribution of quantified phosphosites from pair-wise comparisons of treated synaptosomes with 
Cyclosporine A versus untreated synaptosomes (control). Stable-isotope dimethyl labeling was used for the 
quantification. To determine the significantly regulated phosphosites the two-tailed ‘Significant B’ test (p-value 
≤ 0.05) of the Perseus module was used (See Material and Method).  The red dots correspond to the 
phosphosites that were significantly upregulated in the treated synaptosomes upon stimulation and are 
considered to be the putative substrate of Calcineurin. The green dots are the sites that were downregulated by 
Calcineurin inhibition. Black dots represent the sites that were not significantly affected by Calcineurin 
inhibition. The position of dynamin1 S774 and synapsin1 S603 are marked with the arrow as the known 
substrate of Calcineurin and CaMKII, respectively.  
(B) Proteins containing phosphosites as the putative substrates of Calcineurin were manually categorized based 
on their function and localization into 11 groups according to the previous publication (Boyken et al., 2013). 
Proteins with other function/localization than listed or uncharacterized proteins were grouped into ‘other’ 
category. Active zone and Cytoskeleton categories were observed as groups containing the highest number of 
phosphosites as the putative substrates of Calcineurin. 
 
Phosphosites of CaMKII (CaMKIIa S279, CaMKIIb S397, T400, and T401) were 
dephosphorylated by Calcineurin. Interestingly, the phosphosites of CaMKIIb S397, T400 and 
T401 are not involved in the activity regulation of CaMKII. These phosphosites are located in 
the association domain and actin binding domains of CaMKII and known to regulate the 
localization of CaMKII (Kim et al., 2015). 
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Next, I used Motif-X to test whether there is a specific motif enriched among the putative 
substrates of Calcineurin. As it is shown in the Figure 3-20 A, the motif ‘SP’ (Fold increase: 
31.75, Motif score: 21.29) and ‘SxxxSP’ (Fold increase: 11.37, Motif score: 16.00) were 
overrepresented among the putative substrates of Calcineurin. This result agrees well with 
the previous experiment described in the section 3.2.4 indicating dephosphorylation of 
phosphosites with ‘SP’ motif upon stimulation. The SxxxSP motif is known to be the 
consensus motif of GSK-3β (Roach, 1991). Interestingly, around 40% and 25% of the 
Calcineurin substrates possess ‘SP’ and ‘SxxxSP’ motif, respectively. Furthermore, the 
substantial percentage of Calcineurin substrates in the active zone has the same motifs 
(almost 48% for ‘SP’ and 20% for ‘SxxxSP’, Figure 3-20 B). From this result, it can be 
suggested that GSK-3β and other proline-directed kinases, especially CdK5, have a significant 
role in the phosphorylation of active zone proteins in the resting condition. 
 
 
Figure 3-20: Motif analysis of the putative substrates of Calcineurin. 
(A) The sequence of phosphopeptides containing putative substrates of Calcineurin were analyzed by Motif-X 
tool to identify the overrepresented sequence motifs. The frequency of the residues surrounding the 
phosphosite (position 0) correlates with the size of the letter.  Motif ‘SP’ and ‘SxxxSP’ were observed to be 
overrepresented.  
(B) Distribution of overrepresented motifs among all putative substrates of Calcineurin and active zone 
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Phosphosites downregulated by Calcineurin inhibition 
Upregulation of the phosphosites (putative substrates of Calcineurin) was not the only 
consequence of Calcineurin inhibition. Downregulation of other sets of phosphosites was also 
observed. One explanation for this phenomenon is the indirect effect of Calcineurin on the 
other kinases and phosphatases. In fact, I have observed 6 phosphosites in the regulatory 
subunits of phosphatases and 10 phosphosites of kinases among the downregulated 
phosphosites upon Calcineurin inhibition. Except for ERK kinases and the Calcipressin-1, no 
published data has described the regulation of other phosphosites. Below, I have discussed 
the role ERK kinases and the Calcipressin-1 phosphosites in more detail.  
The two phosphosites of ERK1 (T183, Y185) were downregulated upon Calcineurin 
inhibition. It is known that these sites are located in the activation loop of the ERK kinase and 
their phosphorylation increases the activity of ERK. In contrast, dephosphorylation of these 
sites decreases the enzymatic activity of ERK1, demonstrating that ERK1 and the Calcineurin 
are co-deactivated.  
Calcipressin-1 (RCAN1) is a known regulator protein of Calcineurin.  In our dataset, two 
phosphosites of Calcipressin-1 (S108 and S112) were observed to be downregulated upon 
Calcineurin inhibition. It is known that these phosphosites are phosphorylated by GSK-3β 
and ERK kinases, respectively, and phosphorylation of these two sites has a dual effect on the 
regulation of Calcineurin. While it increases the inhibitory effect of Calcipressin-1 on 
Calcineurin, it decreases its own half-life (Genesca et al., 2003, Ma et al., 2012). Therefore, it 
is conceivable that Calcineurin auto-regulates itself via Calcipressin-1 dephosphorylation. 
 Using Motif-X, I have observed two motifs, ‘SP’ (Fold increase: 3.54, Motif score: 5.16) and 
‘SxxE’ (Fold increase: 4.29, Motif score: 5.62), as the overrepresented motifs (Figure 3-21) 
among the downregulated phosphosites upon Calcineurin inhibition. While the ‘SP’ motif is 
the core target-site of proline-directed kinases, the ‘SxxE’ is the consensus motif of the casein 
kinase2 (CK2). Since downregulation of two activating phosphosites of ERK kinase upon 
Calcineurin inhibition was observed (see above), it is probable that enrichment of ‘SP’ motif 
among the downregulated sites is the consequence of ERK inhibition.  
Regulation of CK2 by phosphorylation has been previously reported. Interestingly, it has 
been observed that incubation of CK2 with a variety of phosphatases increases its activity 
(Agostinis et al., 1987). Therefore, based on this study and overrepresentation of SxxE motif 
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among the downregulated phosphosites upon Calcineurin inhibition, it can be concluded that 
CK2 activity is co-regulated by Calcineurin.  
 
 
Figure 3-21: Motif analysis of the downregulated phosphosites by Calcineurin inhibition. 
The sequences of the downregulated phosphopeptides upon Calcineurin inhibition were analyzed by Motif-X 
tool to identify the overrepresented motifs. The frequency of the residues surrounding of the phosphosite 
(position 0) correlats to the size of the letter. ‘SP’ and ‘SXXE’ motifs were observed to be overrepresented in this 
dataset. 
 
 Impact of CaMKII inhibition on the exocytosis and phosphorylation status 
of the presynaptic proteins 
The postsynaptic role of CaMKII in synaptic plasticity and memory has been well studied 
(Lisman et al., 2002). However, our knowledge regarding the presynaptic role of CaMKII in 
neurotransmission is limited. Here, I have used the CaMKII inhibitor (KN-93) in combination 
with the phosphoproteomics workflow to identify the phosphosites that are affected by 
CaMKII upon stimulation (see Figure 3-17). First, I have tested the release of glutamate in the 
synaptosomes treated with the 10 µM KN-93. As it is shown in the Figure 3-22 A, treatment 
of synaptosomes with KN-93 decreased the release of glutamate compared to control 
synaptosomes. This result is consistent with previous reports (Ninan and Arancio, 2004, 
Llinas et al., 1991, Llinas et al., 1985). In the next step, I have used a phospho-specific 
antibody to check the status of synapsin S603 (the known substrate of CaMKII) in the treated 
and control synaptosomes after stimulation with KCl, to ensure that KN-93 treatment was 
sufficient to decrease the activity of CaMKII (Figure 3-22 B). Treatment with KN-93 
decreased the phosphorylation of synapsin S603 in all the three biological replicates. 
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Figure 3-22: Glutamate release assay and immunoblot analysis of synaptosomes treated with KN-93. 
(A) Glutamate release was measured for the KN-93 treated (Ca2+, KCl, KN-93) and not treated (Ca2+, KCl) 
synaptosomes upon KCl stimulation in the presence of calcium.  The release of glutamate by the treated 
synaptosomes with KN-93 was lower than by the control synaptosomes. Data represent a mean of three 
replicates, with the bars indicating the range of values.  
(B) Immunoblot analysis of phospho-synapsin S603 as the known substrate of CaMKII. Synaptosomes were 
collected 2 min after stimulation for immunoblot analysis with the phospho-specific antibody against synapsin 
pS603. Application of the CaMKII inhibitor decreased the phosphorylation of synapsin pS603 upon stimulation 
in the presence of calcium in all replicates. Antibody against synapsin that is not sensitive to the 
phosphorylation was used as a loading control. 
 
Figure 3-23 A shows the distribution of the quantified phosphosites in the pair-wise 
comparisons of KN-93-treated samples to the control. A shift towards the positive values 
could be observed in the graph. Phosphosites with the dimethyl ratio higher than 1 (log 2 > 
0) represent the phosphosites that are downregulated upon CaMKII inhibition. Due to the 
observed shift toward positive values, I have defined the significantly downregulated sites 
upon CaMKII inhibition based on the two parameters. First, phosphosites with the outlier 
log2 ratio H/L relative to a total population of the phosphosites based on the one-tailed 
‘significant B’ test (p-value ≤ 0.05, Perseus software, red dots). Second, all the phosphosites 
with the log2 ratio higher than 1 (two fold downregulation, moss dots). Note the position of 
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the synapsin1 S566 as known substrate of the CaMKII among the downregulated 
phosphosites.  
 
Figure 3-23: Overview of the quantified phosphosites of synaptosomes treated with KN-93. 
(A) Distribution of quantified phosphosites from the pair-wise comparisons of treated synaptosomes with KN-
93 versus untreated synaptosomes (control). Stable isotope dimethyl labeling was used for the quantification.  
A shift towards the right was observed in the distribution of phosphosites, showing that many phosphosites 
were directly or indirectly downregulated by the CaMKII inhibition. To determine significantly regulated 
phosphosites, two methods were used. First, one-tailed ‘Significant B’ test (p-value ≤ 0.05) of the Perseus 
module (See Material and Method) similar to the previous experiment (red dots). Second, all the sites that are 
downregulated at least by 2 fold upon CaMKII inhibition (Log2=1) were considered as the downregulated 
phosphosites (moss dots).  The position of the synapsin1 S566 is shown as the known substrate of CaMKII.  
(B) Significantly downregulated sites (determined by Significant B test, red dots in A) were categorized based 
on their function and localization into 11 groups according to a previous publication (Boyken et al., 2013). 
Proteins with function/localization other than listed or uncharacterized proteins were grouped into ‘other’ 
category. Here, we observed Cytoskeleton and Kinase/phosphatase categories as the groups containing the 
highest number of CaMKII substrates.  
 
Sequence analysis of the significantly downregulated sites (determined by ‘Significant B’ test, 
red dots in the Figure 3-23 A) revealed ‘SP’ (Fold increase: 5.19, Motif score: 12.07) and ‘SXE’ 
(Fold increase: 5.62, Motif score: 4.62) motifs to be enriched (Figure 3-24 A). Surprisingly, 
the consensus motif of the CaMKII (R/KxxS) was enriched. Next, I repeated motif analysis 
among all the phosphosites that were at least two fold downregulated upon CaMKII 
inhibition (moss and red dots in Figure 3-23 A). Here, besides consensus motif of proline–
directed kinases (SP), casein kinase 2 motifs (SxEE (Fold increase: 17.08, Motif score: 17.04) 
and SxD (Fold increase: 4.75, Motif score: 5.61)), the CaMKII motifs (KxxS, Fold increase: 4.74, 
Motif score: 8.79 and RxxS, Fold increase: 3.9, Motif score: 8.18) were also enriched (Figure 
3-24 B).  
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Interestingly, comparison of downregulated phosphosites by CaMKII inhibition with 
regulated phosphosites upon stimulation (K+, Ca2+ vs K+, EGTA) revealed that most of the 
downregulated phosphosites upon CaMKII inhibition (83%) are not regulated upon 
stimulation (Figure 3-24 C). Almost 16% of sites are upregulated, containing the 
phosphosites that are known to be the CaMKII substrates, for instance synapsin S603 and 
S566, CaMKII T287 and S279 and bassoon S2844. Importantly, only 1% of phosphosites are 
among the downregulated phosphosites upon stimulation. This proves that the consequence 
of CaMKII inhibition on phosphosites is specific and has a minimum effect on phosphosites 
that are downregulated upon stimulation.  
Figure 3-24 D shows the distribution of the enriched motifs among the downregulated sites. 
Surprisingly, the substrates of proline-directed kinases were affected more (30%) than the 
CaMKII substrates (20%). We observed that the CK2 substrates were also affected (12%). 
One potential explanation of this finding is that CaMKII regulates the activity of other kinases 
and phosphatases directly or indirectly via phosphorylation. To answer this question, I have 
manually annotated significantly regulated sites (Figure 3-23 A, red dots) and categorized 
them into 13 groups. Proteins that are associated with the cytoskeleton appeared to be the 
group with the highest number of the regulated phosphosites. As it was expected, ‘Kinase and 
Phosphatases’ group was the second most regulated group. Phosphosites that belong to 
‘Exocytosis’, ‘Channel and Transporters’ and ‘Active zone’ proteins were the following groups 
with the highest number of regulated phosphosites. Below I have discussed some of these 
phosphosites in more detail. For the complete list of the downregulated sites upon CaMKII 
inhibition see Table 6-6 (All the quantified phosphosites in this experiment is listed in 
Supplementary Table S5). 
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Figure 3-24: Analysis of the downregulated phosphosites by CaMKII inhibition. 
(A) Sequence of the phosphopeptides determined to be significantly downregulated by ‘significant B test’ upon 
CaMKII inhibition were analyzed by Motif-X tool to identify the overrepresented sequences. Motif ‘SP’ and ‘SxE’ 
were the most frequent ones. The frequency of the residues surrounding of the phosphosite (position 0) 
correlates with the size of the letter.  
(B) The sequence of the phosphopeptides downregulated at least two fold upon CaMKII inhibition were 
analyzed by Motif-X tool to identify the overrepresented sequences. Here, motif  ‘SP’, ‘SPxE’, ‘SxEE’, ‘SxD’ as well 
as the known consensus motif of CaMKII substrate, ‘K/RxxS’ were observed to be overrepresented. The 
frequency of the residues surrounding the phosphosite (position 0) correlates with the size of the letter.  
(C) Regulation analysis of downregulated phosphosites by CaMKII inhibition upon stimulation (K+, Ca2+ vs K+, 
EGTA). CaMKII inhibition has the most and least effect on not regulated and downregulated phosphosites upon 
stimulation, respectively.  
(D) Distribution of the overrepresented motifs among the downregulated phosphosites. Almost 20% of the 
downregulated phosphosites contain the known consensus motif of CaMKII substrate (K/RxxS). 
 
Cytoskeleton-associated phosphosites 
Alpha-adducin is an actin-binding protein and is known to have a role in the regulation of 
actin rings in the axon (Leite et al., 2016). In our dataset, S355, S600, and S610 of Alpha-
adducin were observed to be downregulated upon CaMKII inhibition. It is known that S355 
is phosphorylated by CdK1 and ERK2 enabling alpha-adducin to bind myosin-X 
(Myo10)(Chan et al., 2014).  
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Stathmin is a tubulin binding protein that inhibits the polymerization of microtubules. In our 
dataset, downregulation of stathmin S16 was observed. In fact, this site is known to be the 
CaMKII substrate (le Gouvello et al., 1998). Its phosphorylation weakens the binding of 
stathmin to the tubulin (Di Paolo et al., 1997).  
Phosphosites of neurofilament polypeptides, medium polypeptide (S774, S872) and heavy 
polypeptide (S712, S721) were also observed as the downregulated site upon CaMKII 
inhibition. It is known that neurofilaments contain a repetitive sequence of KSP that is a 
target of proline-directed kinases such as ERK, GSK-3 and CdK5 (Holmgren et al., 2012). 
Neurofilament phosphorylation plays a critical role in plasticity, stability and the width of 
neurofilaments (Pant and Veeranna, 1995, Kesavapany et al., 2003). Indeed, three 
phosphosites out of the four downregulated sites in our dataset, have the 'SP’ motif.  
Moreover, in our dataset, microtubule-associated protein tau has been also observed to have 
downregulated sites upon CaMKII inhibition (S573, S150, and S33). These sites are known to 
be phosphorylated and dephosphorylated by GSK-3β and PP2A, respectively (Qian et al., 
2010). It is known that tau aggregation is involved in a variety of neurodegenerative diseases 
and it is more susceptible to aggregation in the hyperphosphorylated state (Wang et al., 
2013). However, there is no available information regarding the role of tau phosphorylation 
in the neurotransmitter release.  
In addition, two phosphosites of Septin5 (T13, S234) that are involved in the regulation of 
neurotransmitter release (Amin et al., 2008) were downregulated upon CaMKII inhibition.  
 
Kinases and phosphatases 
As it was mentioned above, it is revealed that component of kinases and phosphatases group 
was downregulated significantly upon CaMKII inhibition. Some of these phosphosites are 
located in the activation loop of these enzymes and their phosphorylation is known to be 
involved in the regulation of enzymatic activity. Overall, regulation of the phosphosites of 
kinases and phosphatases together with the enrichment of consensus motifs of proline-
directed kinases and CK2 among the downregulated sites upon CaMKII inhibition would 
suggest that these kinases and phosphatases are regulated by CaMKII (directly or indirectly). 
Below I have discussed these downregulated sites in more detail.  
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Four phosphosites of CaMKII were detected to be downregulated upon phosphorylation. 
CaMKIIb T287 is known to be the autophosphorylation site, which when phosphorylated 
makes the activity of the CaMKII independent from Ca2+ concentration (Miller and Kennedy, 
1986). Another identified downregulated phosphosite was S279 of CaMKIIa. This site is also 
known as an autophosphorylation site that decreases the enzymatic activity of CaMKII 
(Lengyel et al., 2000). Three other phosphosites of CaMKIIb were also identified as 
downregulated sites (S276, S280, and S395). These sites are not known to be involved in the 
phosphorylation activity of CaMKII but they have a role in actin binding and association of 
CaMKII subunits (Kim et al., 2015).  
Phosphosites of protein kinase A were also identified as the downregulated sites, one site in 
the catalytic subunit (Prkaca, T198) and one site in the regulatory subunit (Prkar2a, S97). 
Phosphorylation of T198 in catalytic subunit is known to be necessary for the maximum 
activity of the PKA (Adams et al., 1995) and it is either autophosphorylated or 
phosphorylated by PDK-1 (Moore et al., 2002). Downregulation of this site upon inhibition of 
CaMKII suggests that CaMKII and PKA are co-deactivated. The phosphosite in regulatory 
subunit S97 is known to be the substrate of CK2 but there is no evidence that phosphorylation 
of this site affects the activity of PKA (Carmichael et al., 1982).  
Several phosphosites of protein kinase C were also identified as downregulated sites upon 
CaMKII inhibition. One of them is PKCα T497 that is located in activation loop of the kinase 
and is known to be phosphorylated by PDK-1 resulting in activation of PKC (Dutil et al., 1998). 
The other phosphosite is PKCβ S642. This site is known to be the autophosphorylation site 
and regulates binding of PKC to phorbol esters that are necessary for its activation (Flint et 
al., 1990). In addition, two phosphosites of PKCε, S346 and S350, were identified as the 
downregulated sites. These sites are known to be phosphorylated by GSK-3 and MAPK, 
respectively and have a role in binding of PKC to 14-3-3 adaptor protein (Saurin et al., 2008). 
MARK1, T215 is another phosphosite that was identified as downregulated site upon CaMKII 
inhibition. Mark is known to phosphorylate microtubules associated proteins such as tau, 
MAP2, and MAP4 resulting in the disassociation of them from microtubules (Manning et al., 
2002). MARK1 is phosphorylated at T215 by LKB that enhances its activity (Lizcano et al., 
2004).   
 
Results | 99  
 
Beside kinases, phosphosites that are associated with the phosphatases were also 
downregulated upon CaMKII inhibition. One example is PP1 regulatory subunit 1B (DARPP-
32) that is known to inhibit the phosphatase activity of PP1 only when it is phosphorylated 
at T34 by PKA. In our dataset, we have quantified another phosphosite of DARPP-32, S102 as 
the downregulated site. This site is known to be phosphorylated by CK2 and upon 
phosphorylation facilitates the phosphorylation of T34 by PKA (Girault et al., 1989). Overall, 
this suggests that when CaMKII is less active the inhibitory effect of DARPP-32 on the PP1 is 
decreased indirectly through the lowered activation of CK2 and PKA. 
Moreover, two more phosphosites related to the phosphatases were identified (Protein 
phosphatase 1H (S220) and Calcineurin catalytic subunit (S479)). To the best of our 
knowledge no information is available regarding the regulation of these phosphatases via 
phosphorylation of the mentioned sites. 
 
 
Exocytosis Related proteins 
Synapsin is the best-studied phosphoprotein in the nerve terminal. Here, besides synapsin1 
S603 that was shown to be downregulated upon CaMKII inhibition by immunoblotting, 
synapsin1 S556 was also identified as the downregulated site. Both of these sites are known 
to be a substrate of CaMKII with their phosphorylation decreasing the binding of synapsin to 
actin filaments (Jovanovic et al., 2001).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
Complexin1 at S93 was identified as a downregulated site upon CaMKII inhibition. 
Interestingly, this site was detected in the previous experiment as the upregulated 
phosphosite upon stimulation (See section 3.2.3.3). 
Among the active zone proteins, two phosphosites of RIM1 (S991 and S1277) and two 
phosphosites of bassoon (S2844 and S2850) were downregulated. RIM1 S991 and bassoon 
S2844 were quantified as the upregulated phosphosites upon stimulation of synaptosomes 
(See section 3.2.3.1) and S2844 was determined as the substrate of CaMKII in the previous 
experiments by in vitro kinase assay (See Figure 3.16 B). Overall, these observations are 
consistent with the former studies as well as our previous experiments in which 
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4 Discussion  
In this thesis, a combination of MS-based phosphoproteomics and subcellular fractionation 
methods has been employed to investigate the regulation of phosphorylation changes of 
presynaptic proteins upon stimulation. These data provided detailed and valuable 
information regarding the phosphoproteome of presynapse and its regulation. Furthermore, 
through data analysis, in vitro kinase assays and application of pharmacological inhibitors of 
kinases and phosphatases, I was able to show that kinases and phosphatases in the 
presynapse coordinate tightly to facilitate and regulate the exo- and endocytosis upon 
stimulation. In this section, significance of my results in the context of synaptic vesicle 
recycling as well as the advantages and limitations of the presented approach are discussed.  
 Activity-dependent phosphorylation changes of nerve terminal 
proteins 
 Ca2+ ions are the main regulator of phosphorylation upon stimulation 
As outlined in the introduction, at chemical synapse, neurons communicate with each other 
via two mechanisms known as fast and slow synaptic transmission. Fast synaptic 
transmission happens within milliseconds and is triggered by the arrival of action potential 
to the nerve terminal, resulting in the release of neurotransmitters. In contrast, slow synaptic 
transmission occurs over the course of hundreds of milliseconds to several minutes. 
Detection of many phosphoproteins, kinases, and phosphatases in the nerve terminal 
supported the idea that phosphorylation might be involved in the regulation of synaptic 
transmission. Relatively slow enzymatic reactions catalyzed by kinases/phosphatases makes 
it less likely to regulate the fast synaptic transmission. On the other hand, several studies 
have established that these enzymes regulate the slow synaptic transmission that is mostly 
involved in the elevation of second messengers (such as Ca2+, cAMP, or diacylglycerol). 
Second messengers directly or indirectly modulate the activity of kinases and phosphatases 
(Greengard, 2001). At the nerve terminal, elevation of Ca2+ concentration occurs upon arrival 
of an action potential and subsequent depolarization of the membrane. In order to 
discriminate between the effect of Ca2+ elevation and membrane depolarization on protein 
phosphorylation, we have designed three stimulation protocols of synaptosomes as 
described in the section 3.2.2. Our results clearly demonstrate that more phosphosites 
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undergo phosphorylation/dephosphorylation upon depolarization of the membrane in the 
presence of Ca2+ ions (compare Figure 3-10 A, B with panel C). Moreover, phosphorylation 
changes of proteins are more pronounced compared to Ca2+-depleted samples. This led us to 
the conclusion that Ca2+ plays a greater role than membrane depolarization in the regulation 
of protein phosphorylation at the presynaptic terminal. This observation is in line with the 
known fact that Ca2+ directly or indirectly modulates the activity of kinases and 
phosphatases. For instance, it binds (solely or in complex with calmodulin) to the calcium 
sensor domains of CaMKII and conventional PKC isoforms as well as protein phosphatase 2B 
(Calcineurin) and increases their enzymatic activity. Moreover, it is known that Ca2+ activates 
Ca2+-dependent phospholipases and adenylate cyclases, which consequently elevates the 
concentration of other second messengers such as DAG (Kadamur and Ross, 2013) and cAMP 
(Halls and Cooper, 2011) and increases the activity of PKC isoforms (conventional and novel 
isoformes) and PKA, respectively. Each of the mentioned enzymes that are activated by Ca2+ 
in turn also modulate the activity of other kinases and phosphatases. For example, it is known 
that CaMKII increases the activity of ERK1/2, while it inhibits GSK-3 (see section 4.4 for more 
details).  
 
 Impact of active zone proteins phosphorylation on synaptic transmission 
One of the major findings of this study is the extensive phosphorylation changes of active 
zone proteins upon stimulation (see section 3.2.3.1). A growing body of evidence have 
suggested that active zone proteins are involved in SV docking and the recruitment of calcium 
channels to the active zone (Han et al., 2011, Davydova et al., 2014, Nishimune et al., 2012). 
The number and the pattern of phosphosites changes are diverse among the component of 
active zone proteins. In case of bassoon, dephosphorylation was more pronounced upon 
stimulation as compared to other active zone proteins. This is particularly interesting 
considering that bassoon is known to speed up the rate of vesicle reloading at the active zones 
(Hallermann et al., 2010). Therefore, it can be speculated that vast dephosphorylation of 
bassoon upon stimulation modulates neurotransmission via regulation of SV docking. 
Although bassoon and piccolo share structural homology, they have unique segments that 
imply different functions. Piccolo binds to actin-related proteins and regulates F-actin 
assembly in presynapse and consequently synaptic transmission (Waites et al., 2011). 
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Interestingly, in our dataset piccolo was not dephosphorylated as extensively as bassoon. 
This led us to conclude that phosphorylation status of bassoon plays a greater role in the 
regulation of vesicle docking as compared to piccolo. 
Phosphorylation of active zone proteins may also regulate the SV pools size. Recently it was 
reported that ELKS proteins are involved in the increase of RRP pool size via its N-terminus 
(Held et al., 2016) and interestingly in this study, we have quantified two phosphosites at the 
N-terminus of ELKS proteins that are extensively dephosphorylated upon stimulation. RIM is 
the central organizer of the active zone and is also known to increase the RRP pool size and 
tether the N- and P/Q-type Ca2+-channels to the active zone via direct interaction through 
PDZ domain (Kaeser et al., 2011b). In our dataset, we quantified several sites distributed 
through all RIM domains. It is predictable that phosphorylation alters the protein-protein 
interaction of RIM and consequently modulates neurotransmission. 
 
 Phosphorylation of cytoskeleton-associated proteins regulates exo- and 
endocytosis 
In our dataset phosphorylation of cytoskeleton-associated proteins has been observed to be 
largely modulated by stimulation and inhibition of Ca2+-dependent kinases and phosphatases 
(see Figures 3-12, 3-19 B, 3-23 B). Between the cytoskeleton filaments, the role of actin 
filaments in neurotransmitters release has been more extensively investigated. The 
organization of actin filaments has been reported to have a significant role in both exo- and 
endocytosis.  
Upon prolonged synaptic activity, the RRP pool has to be replenished by recycling SVs pool. 
It has been suggested that actin filaments act as a trap for SVs and their disassembly upon 
stimulation facilitate the RRP pool replenishment. In our dataset, we have quantified 
phosphosites of actin-related proteins that are involved in the reorganization of actin 
filaments such as Drebin and Adductin. The phosphorylation of these proteins has been 
reported to modulate their binding to actin filaments which in turn results in reorganization 
of the filaments (Worth et al., 2013). The actin-binding motor proteins (myosins) have been 
also reported to be involved in the movement of SVs at the nerve terminals (Seabrooke and 
Stewart, 2011). Our observation regarding the regulation of myosin phosphorylation upon 
stimulation shows that it might have a role in the modulation of SV movement. 
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Actin filaments are reported to have a controversial effect on endocytosis. On one hand, it is 
suggested that they function as a trap for the components of endocytic machinery and 
prevent their spatial movements (Gaidarov et al., 1999), facilitate the invagination of the 
coated pit (Schmidt and Huttner, 1998) and enhance the fission of coated pits via 
polymerization around the neck of the SV pits (Lamaze et al., 1997). On the other hand, the 
rigid actin filaments may play a role as the barrier for the invagination of coated pits 
(Fujimoto et al., 2000). All the mentioned functions rely on the organization of actin filaments 
and, therefore, it is feasible that phosphorylation of actin-binding proteins indirectly 
regulates endocytosis. 
 
 Multisite phosphorylated proteins 
As it was mentioned before, we have identified proteins, which contain multiple 
phosphorylation sites that simultaneously undergo opposing changes in their 
phosphorylation status such as bassoon, piccolo, and RIM. Two fundamental mechanisms for 
multiple phosphorylations have been reported (Roach, 1991): 1) The substrate has multiple 
recognition sites for one or more kinases. For instance, neurofilaments have multiple KSP 
motifs that are targeted by various proline-directed kinases (Holmgren et al., 2012). 2) 
Phosphorylation of one phosphosite influences the probability of phosphorylation on the 
other sites. The classical example is glycogen synthase which is not a substrate of GSK-3 when 
it is completely dephosphorylated. However, upon phosphorylation by CK2 at a specific site, 
four other sites become available for phosphorylation by GSK-3 (Fiol et al., 1990). The latter 
mechanism might explain our observation of highly coordinated phosphorylation and 
dephosphorylation of active zone proteins in the resting and stimulated conditions, 
especially considering that almost 20% and 50% of active zone phosphosites was contain the 
GSK-3 (SxxxSP) and proline-directed kinases (SP) consensus motifs, respectively (see Figure 
3-20). Another example that is more related to this project is the phosphorylation of 
dynamin-1 at S774 and S778. It is known that S774 is phosphorylated by GSK-3 only if S778 
was previously phosphorylated by CdK5 (Clayton et al., 2010).  
Also, it has been reported that phosphorylation at one site might induce the conformational 
changes in the structure of the substrate that makes it recognizable for another kinase. In this 
mechanism, phosphate group does not participate in the kinase-substrate recognition. 
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DARPP-32, the potential inhibitor of PP1, is a well-known example of this mechanism. 
Phosphorylation of DARPP-32 at T34 is enhanced when it is phosphorylated beforehand at 
S102 by CK2 (Greengard et al., 1999). We have observed this phenomenon in our dataset as 
well (see 3.3.2, Kinases and phosphatases section).  
Beside the mechanism of multisite phosphorylation, another question that is commonly 
raised is why proteins are multiply phosphorylated? One explanation is that several 
phosphorylation events generate a variety of protein forms that have a variety of functions. 
Theoretically, a protein with ‘n’ number of phosphosites can have 2n forms that can have 
several functions or grades of a single function (Salazar and Höfer, 2009). For instance, 
different phosphorylation states of bassoon might be involved in the gradual release of SVs 
upon strong stimulation over time. In case of enzymes, some of the phosphorylation sites 
alter the enzymatic activity, while others regulate the enzyme localization (Kim et al., 2015). 
Furthermore, it can be speculated that multiple phosphorylations are needed for major 
conformation changes of proteins which cannot happen by a single phosphorylation event. 
For example, it is known that phosphorylation of MARCKS by PKC increases its surface 
negative charge and abrogates its interaction with the membrane (Arbuzova et al., 2002).  
 
 Possible role of Calcineurin in RRP pool replenishment and kinase 
regulation 
The role of Calcineurin in endocytosis has been studied extensively. It is known that 
Calcineurin dephosphorylates proteins involved in clathrin-mediated endocytosis 
(collectively called dephosphins) in an activity-dependent manner and also enhances 
endocytosis in the nerve terminal (Marks and McMahon, 1998, Cousin et al., 2001). Our 
results are consistent with both previous observations: major endocytotic proteins are 
dephosphorylated upon stimulation (see section 3.2.3.2) and Calcineurin inhibition, 
abolishes their dephosphorylation (see section 3.3.1). Interestingly, we have observed that 
active zone phosphosites were affected more than endocytosis related sites upon Calcineurin 
inhibition and, interestingly, many of them were the sites that were dephosphorylated upon 
stimulation (see Figure 3-13). Therefore, it seems that the cycle of 
phosphorylation/dephosphorylation of active zone phosphosites is very similar to the 
dephosphins and both are the substrates of Calcineurin during stimulation. Among active 
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zone proteins, bassoon contains the highest number of downregulated sites upon 
stimulation. It is also the putative substrate of Calcineurin. It is known that many of 
Calcineurin substrates have the Calcineurin binding motifs (PxIxIT and LxVP) (Rodriguez et 
al., 2009). In line with our data, we found these motifs in bassoon, piccolo, RIM and Munc13 
(active zone proteins containing phosphosites affected by Calcineurin inhibition), whereas 
the same motifs were absent in ERC1/2, which have no phosphosites affected by Calcineurin. 
Since bassoon is involved in the replenishment of RRP pool during and after stimulation 
(Hallermann et al., 2010, Mendoza Schulz et al., 2014), it is tempting to speculate that 
Calcineurin contributes to SV docking and the replenishment of RRP pool via 
dephosphorylation of bassoon upon stimulation. However, no evidence support a direct 
interaction between bassoon and SVs. Thus, this effect is likely mediated by an adapter 
protein. In fact, it has been reported that Mover protein links bassoon to SVs. It interacts with 
bassoon (Kremer et al., 2007) and also in a phosphorylation-dependent manner with SVs 
(Ahmed et al., 2013). Also, it has been proposed that Mover regulates the release probability 
via the Ca2+-dependent interaction with CaM (Korber et al., 2015). However, in our dataset, 
we quantified one phosphosite of Mover (T34) that was not regulated upon stimulation and 
no function has been reported for it.  
Using the Calcineurin inhibitor and analysis of the up and downregulated phosphosites 
motifs, I have observed that Calcineurin inhibition has a dual effect on the phosphorylation 
of ‘SP’ motif, due to the enrichment of this motif in both up and downregulated sites. This can 
be because Calcineurin has diverse effects on the proline-directed kinases. Three main 
proline-directed kinases (ERK1/2, GSK-3 and CdK5) are known to be present in the nerve 
terminal. In fact, downregulation of two activating phosphosites of ERK1/2 (T183, Y185) 
upon Calcineurin inhibition clearly indicates that ERK1/2 and Calcineurin are co-deactivated. 
This observation has been also reported for pancreatic β cells (Duan and Cobb, 2010). In 
contrast to ERK1/2, consensus motif (SxxxSP) of another proline-directed enzyme, GSK-3, 
was enriched in upregulated phosphosites. It is known that GSK-3 is constantly active unless 
it is phosphorylated at S21 (GSK-3α) or at S9 (GSK-3β) and this site is reported to be the 
substrate of a variety of phosphatases (PP1, PP2A, and PP2B) (Hernandez et al., 2010, Kim et 
al., 2009). Here, we cannot relate the dephosphorylation of S21/S9 of GSK-3 to the activity of 
Calcineurin (otherwise the phosphosites with SxxxSP motif should be enriched in the 
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downregulated sites). Another explanation for this observation is that since GSK-3 needs a 
priming kinase for phosphorylation of its substrate (see introduction section 1.3.3.7), 
downregulation of other kinases results in the inhibition of GSK-3 activity. Two enzymes have 
been reported to function as the primary kinase for GSK-3, the CK2 and CdK5 (Fiol et al., 1990, 
Clayton et al., 2010). Between these two enzymes, CK2 is less likely to be the primary kinase 
for GSK-3, since it is upregulated upon Calcineurin inhibition (see section 3.3.1). Therefore, 
it can be suggested that CdK5 is the primary kinase for GSK-3 and the downregulation of its 
activity results in the decrease of GSK-3 substrate phosphorylation.  
 
 CaMKII might function as the major regulator of kinases/phosphatases 
upon stimulation 
The best-studied function of CaMKII in the presynapse is the activity-dependent 
phosphorylation of synapsin which results in the disassociation of SVs from the actin 
filaments. However, our observation suggests that CaMKII might have another important 
function in the nerve terminal as the regulator of other kinases and phosphatases upon 
stimulation. Application of pharmacological inhibitor of CaMKII resulted in immense 
downregulation of phosphosites in the nerve terminal. More interestingly, many of these 
sites do not have the consensus motif of CaMKII (R/KxxS). Many of these sites contained the 
‘SP’ or ‘SxE/DE motifs (see section 3.3.2). In the same line, it was observed that phosphosites 
belong to ‘Kinases and Phosphatases’ group are highly affected by CaMKII inhibition. These 
sites are mentioned in the section 3.3.2. Here I will discuss their phosphorylation regulation 
in more detail.  
Upon CaMKII inhibition, we have observed the downregulation of autophosphorylation sites 
of CaMKII that decreases its activity (S279) or makes it independent from the Ca2+ 
concentration (T286). Moreover, we have detected the downregulation of activating 
threonine residues in the activation loop of PKA (T198) and PKCα (T497) upon CaMKII 
inhibition. Both of these sites are reported to be the substrates of phosphoinositide-
dependent kinase 1 (PDK-1). PDK-1 activity is upregulated upon phosphorylation at S241. 
Therefore, it is conceivable that CaMKII increases the activity of PKA and PKC via 
phosphorylation of PDK-1 at S241. To test this hypothesis, I have checked the 
phosphorylation status of PDK-1 at S241 as well as PKA (T198) and PKCα (T497) by 
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phospho-specific antibodies against these sites (Figure 4-1). The results confirmed our 
hypothesis, showing the downregulation of PDK-1 at S241, PKA at T198 and PKCα at T497 
upon treatment with KN-93.  
 
Figure 4-1: CaMKII inhibition downregulates PKA and PKC activity indirectly through the 
downregulation of PDK-1. 
The inhibition of CaMKII by KN-93 decreases the phosphorylation of PDK-1 at S102, resulting in the 
downregulation of its activity. Consequently the phosphorylation of PKA at T198 and PKCα at T497 (both 
known to be substrates of PDK-1) is decreased, which in return decreases the activity of PKA and PKC. For the 
loading control antibody against VAMP2 was used. 
 
In our dataset, we were not able to find any direct evidence regarding the downregulation of 
proline-directed kinases upon CaMKII inhibition. However, it has been reported that ERK1/2 
is activated via PKA (Sindreu et al., 2007) and CaMKII (Salzano et al., 2012) via 
phosphorylation of Raf1. That is why, it can be suggested that inhibition of CaMKII directly 
or indirectly via inhibition of PKA downregulates Raf-1 activity and consequently 
downregulates ERK1/2.  
Another kinase that was observed to be downregulated upon CaMKII inhibition is CK2, due 
to the enrichment of ‘SxEE’ and ‘SxD’ motifs among the downregulated phosphosites. 
However, the mechanism of CK2 regulation by CaMKII is not known. Moreover, as was 
described in the previous section, CK2 may function as the priming kinase for GSK-3 and its 
inhibition may downregulate the phosphorylation of GSK-3 substrates. 
Also, the CK2 downregulation indirectly increases the activity of PP1 via DARPP-32. In our 
dataset, we have observed the decrease in DARPP-32 (S102) phosphorylation. This site is 
known to be the substrate of CK2 and in phosphorylated status it increases the availability of 
DARPP-32 to be phosphorylated by PKA at T34 (Greengard, 2001). Phosphorylation at T34 
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makes DARPP-32 a potent inhibitor of PP1. Altogether, it can be concluded that 
downregulation of CaMKII-CK2-DARPP-32 (S102 and T34) pathway increases the activity of 
PP1. 
The CaMKII inhibition also diminished the activity of MARK kinase via downregulation of 
phosphorylation at T215. MARK is known to target microtubule-associated proteins and its 
downregulation can partially explain the extensive downregulation of cytoskeleton-
associated phosphosites upon CaMKII inhibition (see Figure 3-23 B). 
Overall, inhibition of several kinases (CaMKII, PKA, PKC, GSK-3, ERK1/2, CK2 and MARK) and 
upregulation of PP1, explains the mechanism of extensive downregulation of phosphosites 
upon CaMKII inhibition. Also, the fact that upon membrane depolarization the concertation 
of Ca2+ increases and among the kinases, only CaMKII and conventional isoforms of PKC are 
able to directly sense the Ca2+ elevation supports the idea that CaMKII might function as the 
major regulator of other kinases and phosphatases in the nerve terminal upon stimulation.  
 
 Activity of kinases and phosphatases is tightly coordinated in the nerve 
terminal 
As it was discussed in the previous sections, the activity of the kinases and phosphatases is 
highly interconnected with each other and their inhibition (e.g. Calcineurin and CaMKII) 
affects the activity of other kinases and phosphatases.  An important question is how these 
enzymes (kinases/phosphatases), second messengers (Ca2+, cAMP, DAG) and the substrates 
are organized in the nerve terminal and are able to coordinate in a fast, localized and specific 
manner upon stimulation.  
As it was described before, it is highly likely that Ca2+ ions are the main second messengers 
that is upregulated upon stimulation. This elevation occurs via the voltage-gated calcium 
channels that are enriched in the active zone through proteins such as RIM, RIM-binding 
protein, and ELKS.  Therefore, it would be conceivable Ca2+ sensor proteins are also localized 
in the vicinity of the active zones. One of the mechanisms that has been described to localize 
the Ca2+-dependent kinases/phosphatases close to the plasma membrane is the network of 
scaffolding proteins. This mechanism, has been investigated in the postsynapse where the A-
kinase anchoring protein (AKAP79/150) binds to PKA, PKC, Calcineurin (Sanderson and 
Dell'Acqua, 2011) and enzymes that produce the second messengers such as adenylate 
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cyclase (Zhang et al., 2013a) to keep them close to postsynaptic density. In our dataset, we 
could detect phosphosites of AKAP12 and AKAP5 in the nerve terminal. Overall, it can be 
predicted that a similar mechanism (through AKAPs or other scaffolding proteins) localizes 
the components of Ca2+ signaling molecules close to the active zone in presynapse.  
The other possible mechanism for compartmentalization of kinases/phosphatases is binding 
to actin filaments.  It is known that actin filaments are localized close to the active zone 
(Doussau and Augustine, 2000). For instance, PP1 binds to actin filaments via Neurabin 
protein. This interaction is highly dependent on the phosphorylation of Neurabin at S100 and 
decreases the binding of PP1 to actin filaments leading to its diffusion away from the nerve 
terminal (McAvoy et al., 1999).     
Another mechanism for the coordination of the kinases and phosphatases activity is the 
overlap between their regulators. The best-known example of this mechanism in neurons is 
DARPP-32. Depending on phosphorylation status, DARPP-32 can be a potent inhibitor of 
either PP1 or PKA. As it was discussed before DARPP-32 is phosphorylated by PKA at T34 to 
inhibit PP1 inhibitor, whereas when it is phosphorylated at T75 by CdK5 it becomes the 
inhibitor of PKA. Many other kinases and phosphatases (CK1, CK2, PP2A, and Calcineurin) 
modulate the phosphorylation status of DARPP-32 towards ones that mentioned and 
coordinate its inhibitory function with the external signal arriving at the neuron (Greengard, 
2001). The other example of this mechanism, is the phosphorylation of both PKA and PKC at 
threonine in their activation loop by PDK-1, resulting in the co-regulation of PKA and PKC 
activity. 
Overall, based on our observations regarding the autoregulation of kinases/phosphatases 
activity (see section 3.3) as well as the regulation of protein phosphorylation upon 
stimulation (see section 3.2), I propose a model in which Ca2+ is the primary second 
messenger upon stimulation that modulates the activity of tightly interconnected 
kinases/phosphatases (Figure 4-2). 
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Figure 4-2: Activity of kinases and phosphatases is tightly coordinated in the nerve terminal upon stimulation. 
Upon arrival of action potential to the nerve terminal, CaMKII, Calcineurin and conventional PKCs are activated by Ca2+ elevation (1, 2, and 3). Calcineurin 
dephosphorylates active zone and clathrin-mediated endocytosis (dephosphins) phosphosites (Figures 3-13, 3-14 A, 3-19 B) (4, 5), inhibits the activity of 
GSK-3 (Figures 3-20 A and B) (6), increases the activity of CK2 (Figures 3-21) (7) and ERK1/2 (phosphorylation of T183 and Y185) (8). CaMKII inhibits the 
activity of GSK-3 (Song et al., 2010) (9), increases the activity of CK2 (Figures 3-24, A and B) (10) and ERK1/2 (phosphorylation of T183 and Y185) (11). The 
activated CaMKII and Calcineurin phosphorylate synapsin (at S566 andS603) and dephosphorylate (at S436, S508, S549, and S551), resulting in disassociation 
of SVs from actin filaments (Figure 3-15) (12, 13). CaMKII also increases the activity of PKA (phosphorylation of T198) and PKC (phosphorylation of T497), 
probably via activation of PDK-1 (see section 4-3) (14, 15, and 16). PKA increases the activity of PP2A via phosphorylation of B56δ regulatory subunit at S567 
(see section 3.2.4) (17). Moreover, CaMKII decreases the activity of PP1 in the nerve terminal by phosphorylation of its regulatory subunit (Neurabin-2) at 
S100 (see section 3.2.4) (18). The activated CK2 increases the phosphorylation of DARPP-32 at S102 and consequently phosphorylation of DARPP-32 at T34, 
converting it into the inhibitor of PP1 (see section 3.3.2) (19, 20, and 21). Upon Ca2+ elevation, the substrates of proline-directed kinases (GSK-3 and CdK5) 
are dephosphorylated probably via activation of CaMKII and Calcineurin (see number 6 and 9) (22, 23). In the resting condition, CdK5 is more active and 
phosphorylates DARPP-32 at T75, converting it into the inhibitor of PKA (Greengard, 2001) (24, 25). In the resting condition, CdK5 and GSK-3 re-
phosphorylate the clathrin-mediated endocytosis (dephosphins) (26, 27). Adapted and modified from (Chua et al., 2010).
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 Experimental approach  
 Stimulation of synaptosomes 
KCl stimulation 
In this study, a high concentration of KCl (50 mM) was used to stimulate synaptosomes and 
to release neurotransmitters. KCl stimulation has advantages and disadvantages that I will 
discuss in this section. The main limitation of KCl stimulation is that it leads to a stable 
depolarization of the membrane and is not able to mimic the repetitive transient 
depolarization similar to what nerve terminals are subjected to in vivo (Tibbs et al., 1989). 
The membrane depolarization by KCl results in influx of Ca2+ to the nerve-terminal through 
voltage-dependent calcium channels and also through the reversal of Na+/Ca2+ exchanger 
(Carvalho et al., 1988). It is known that KCl stimulation produces a spike in Ca2+ concentration 
1-5 seconds after the stimulation, which recovers to a plateau that lasts for minutes 
(McMahon and Nicholls, 1991). Therefore, the influx of Ca2+ ions in the nerve terminal is 
higher as compared to a physiological condition and remains at the high level for a much 
longer time. 
One the other hand, KCl stimulation is reported to be very robust to initiate the glutamate 
release and decreases the membrane potential noise (Tibbs et al., 1989). Also, most of the 
principal knowledge regarding the activity-dependent phosphorylation of synaptosomal 
proteins have been based on KCl stimulation that enabled us to prove the functionality of our 
approach by comparing our result to them. More importantly, substantial elevation of Ca2+ 
concentration in the nerve terminal by KCl stimulation made the Ca2+-dependent 
phosphorylation/dephosphorylation events more pronounced, resulting in the increase of 
signal to noise ratio and in turn easier detection of phosphorylation changes. 
 
Electrical stimulation 
Electrical stimulation has been used previously to investigate the long-term metabolic 
changes of synaptosome upon stimulation (Rodina et al., 1980) and, in contrast to KCl 
stimulation, very little knowledge are available regarding the neurotransmitter release upon 
electrical stimulation.  We have set up this method to overcome the drawbacks of KCl 
stimulation. Using electrical stimulation, it is possible to control the membrane 
depolarization through the frequency and the number of action potentials (APs). As it is 
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shown in Figure 4-3, the release correlates with the number of APs.  Also, it is responsive to 
the absence of external Ca2+ ions (using EGTA) and application of Na+ channel blocker 
(Tetrodotoxin) (data are not shown). Altogether, this shows that the structure of 
synaptosomes remains intact during the electrical stimulation. The main advantage of the 
electrical stimulation is that it is possible to target distinct SV pools. It is known that RRP and 
recycling pools can be released by 40 AP at 20 Hz (Schikorski and Stevens, 2001, Murthy and 
Stevens, 1999) and 600 AP at 20 Hz (Opazo et al., 2010, Fernandez-Alfonso and Ryan, 2008), 
respectively. I have tried these stimulation protocols on synaptosomes and observed that the 
release of glutamate by KCl stimulation after 2 min (the time point that we have collected 
synaptosomes for the protein phosphorylation analysis) is similar to the release of RRP by 
40 AP at 20 Hz. However, the kinetics of the release with KCl stimulation is much slower than 
electrical stimulation (see Figure 4-3). One reasonable explanation is the inevitable mixing 
artifact caused by the large sample volume (2 ml cuvette). In fact, to avoid this problem a 
rapid mixing device with perfusion system has been developed in order to measure the 
biochemical parameters of release in the initial phase (Leenders et al., 1999) in 
synaptosomes.  
Figure 4-3: KCl stimulation versus electrical stimulation. 
The release of glutamate from synaptosomes was investigated upon KCl stimulation and electrical stimulation 
(7 V) with different number of action potentials (AP) in the first 2 min. KCl (50 mM) stimulation could release 
the glutamate at almost the same levels as 40 AP, 20 Hz which is known to be enough for the release of readily 
releasable pool (RRP) of synaptic vesicles. The release was much lower comparing to 600 AP, 20 Hz stimulation 
that is typically required for the release of recycling pool. The kinetics of the release by KCl stimulation was 
much slower than electrical stimulation. Two minute stimulation by KCl releases glutamate as much as 2 
seconds electrical stimulation (40 AP, 20 Hz).  
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 Time-course of stimulation-dependent phosphorylation changes 
As it was mentioned before, in this study we have collected samples for the analysis of protein 
phosphorylation changes, 2 min after stimulation by KCl. This raised several questions. How 
does the kinetics of the phosphorylation changes relate to neurotransmitter release? Is there 
any order in the activation of kinases or phosphatases? Is there any pattern in the regulation 
of effector proteins in SV recycling? 
Answers to all the questions mentioned above would enhance our knowledge of the 
regulatory machine of neurotransmission. Unfortunately, the experimental approach that 
was used in this study is not efficient to answer them. The primary reason for that is the 
clamped depolarization by KCl. KCl stimulation elevates Ca2+ concentration in the nerve 
terminal for a long period of time (McMahon and Nicholls, 1991). In the physiological 
condition, Ca2+ concentration is buffered very fast (Scott, 2007). This is important when we 
keep in mind that Ca2+ ions are the key second messenger that is elevated by the arrival of 
action potential and directly modulates the activity of Ca2+-dependent kinases/phosphatases. 
Moreover, based on our observations and previous reports Ca2+-dependent 
kinases/phosphatases are involved in the regulation of other kinases and phosphatases (see 
section 4.2 and 4.3). For instance, CaMKII is known to be activated upon the elevation of Ca2+ 
and, only if it is exposed for a longer time to the elevated Ca2+ ion condition phosphorylates 
itself that makes it insensitive to Ca2+ concentration (Lisman et al., 2002). Therefore, it is 
conceivable that CaMKII is highly activated over the time course of clamped depolarization 
induced by KCl. To test this, the phosphorylation status of synapsin pS603 (known as a 
substrate of CaMKII) was assessed by immunoblotting when synaptosomes were stimulated 
by KCl and electrical stimulation (Figure 4-4 B). Two conclusions can be drawn from this 
result, first, the kinetics of synapsin1 phosphorylation is different in KCl stimulation 
compared to the electrical stimulation. In KCl stimulation, the upregulation of 
phosphorylation increased 2 sec after and remained at a high level even after 10 min, 
whereas in case of electrical stimulation the phosphorylation increased after 10 sec and 
clearly decreased 30 sec after stimulation. Second, the extent of phosphorylation is high in 
the KCl stimulation compared to the electrical stimulation. This can be explained by the 
known fact that KCl stimulation overloads synaptosomes with Ca2+ ions through both 
voltage-dependent calcium channels and reverse Na+/Ca2+ exchanger (Carvalho et al., 1988). 
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Similarly, dynamin1 pS774 (the known substrate of Calcineurin) is dephosphorylated faster 
and more extensively by KCl stimulation rather than electrical stimulation. Another reason 
that makes the KCl stimulation not suitable for the time-course study of phosphorylation 
changes is the mixing effect (see previous section). The glutamate release by KCl stimulation 
is clearly slower than during the electrical stimulation. The amount of glutamate that is 
released by KCl stimulation in 10 min is almost the same as released by electrical stimulation 
in 30 sec with 600 AP (20 Hz) (required to release the recycling pool) (Figure 4-4 A). Overall, 
KCl stimulation is not suitable for the time-course investigation of phosphorylation changes 
and does not resemble the fast and repetitive stimulation that neurons encounter under 
physiological condition. 
 
 Mass-spectrometry approach  
Mass spectrometry-based phosphoproteomics is a powerful approach for analysis of large-
scale protein phosphorylation without having any prior knowledge about them. In this study, 
we took advantage of this method to map the phosphorylation changes of presynaptic 
proteins. Despite the fact that we were not able to detect all presynaptic phosphosites in our 
experiments, our dataset provides a comprehensive outlook at phosphorylation events 
taking place in the presynapse upon stimulation. Inability to detect higher amount of 
phosphosites is dictated by several technical limitations. First, we were limited to use 1 mg 
of synaptosomal proteins as a starting material in stimulation reaction cuvette, whereas 
similar studies that were able to identify more phosphosites typically used much more 
starting material (15-30 mg) (Trinidad et al., 2012). Second, nerve terminals are enriched in 
the membrane proteins and solubilization of them in buffers suitable for mass spectrometry 
remained challenging. Several methods has been suggested to improve the recovery of 
digested peptides of membrane proteins. For instance the filter-aided sample preparation 
(FASP) protocol (Wisniewski et al., 2009), which takes the advantage of SDS to solubilize 
proteins and then high concentration of urea is used to wash out the SDS. However this 
method in our hand did not yield in more identification of phosphopeptides. Nevertheless, 
more optimization in digestion protocol of large amounts of membrane protein enriched 
samples would increase the recovery of the peptides and consequently identification of 
phosphopeptides. Third, insufficiency of one phosphopeptide enrichment method to capture  
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Figure 4-4: Dynamics of glutamate release and protein phosphorylation by KCl versus electrical 
stimulation. 
(A) The release of glutamate from synaptosomes was investigated upon KCl stimulation and electrical 
stimulation (600 AP, Hz) for 10 min. Electrical stimulation resulted in the fast and strong release of glutamate 
up to 4.5 folds of baseline in 30 sec. The release was stopped after 30 sec and slowly decreased over time, 
possibly due to the reverse reaction of glutamate dehydrogenase.  KCl stimulation resulted in the slow release 
of glutamate over 10 min, possibly due to the mixing effect. At the beginning the release was faster and after 
almost 3 minutes it reached a plateau and was not decreasing later, due to KCl clamp depolarization of the 
membrane. (B) Immunoblot analysis of synaptosome upon KCl and electrical stimulation for synapsin pS603 
and dynamin pS774 over 10 mins. Both phosphosites were affected by KCl stimulation faster and to a higher 
extent. Synapsin pS603 was upregulated strongly by KCl stimulation after 2 sec and remained highly 
phosphorylated over 10 min. With electrical stimulation, slight upregulation happened 10 sec after stimulation 
and decreased to the basal level after 30 sec. Dynamin pS774 was downregulated strongly with KCl stimulation 
after 2 sec. With electrical stimulation phosphorylation of dynamin S774 was decreased slightly and after 30 
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all the phosphopeptides. It has been shown that different enrichment methods are partially 
biased towards a distinct population of phosphosites. For example, it has been reported that 
IMAC enrichment is more efficient for the enrichment of multiply phosphorylated peptides 
comparing to TiO2 method (Yue et al., 2015). Ideally, a combination of several enrichment 
methods can provide a more comprehensive map of phosphosites. Moreover, as it was 
discussed in the Results part, use of dimethyl-labeling led to the decreased number of 
quantified phosphosites (see section 3.1.4). This is due to the known fact that the labeling 
increases complexity of samples at the MS1 level. Therefore, the decision to use labeling or 
label-free approach is a compromise between number of identified phosphosites and 
reliability of phosphopeptide quantification. However, recent development of quantification 
algorithms and software has increased the reliability of label-free approaches (Cox et al., 
2014) and made it more popular in the field.  
Another important point that needs to be discussed is the method that has been used to 
determine significantly regulated phosphosites. Two common practices are used in the field 
for this purpose. In the first approach, an arbitrary cut-off for the fold changes is applied (for 
instance, H/L ratio >2 or <0.5) and phosphosites that have a fold change higher than the cut-
off are considered as the regulated sites. It is common to use this method when researches 
have some information regarding the extent of changes for number of phosphosites or have 
a similar phosphoproteomics dataset to compare and make an educated guess regarding the 
cut-off. The second practice is to use a statistical approach for determination of phosphosites 
with the outlier H/L ratio. The latter method was used mostly in this study to avoid bias 
towards the dataset.  
 
 Conclusions and perspectives 
Phosphoproteomics analysis of presynaptic proteins has a tremendous potential to 
disentangle the regulation of synaptic transmission. In this thesis, utilizing the combination 
of MS-based phosphoproteomics method and different nerve terminal stimulation 
conditions, we have shown the role of calcium influx to the nerve terminal in modulation of 
the phosphorylation changes. Moreover, we have uncovered the extensive activity-
dependent phosphorylation changes of active zone proteins. Using the pharmacological 
inhibitor of Calcineurin, I was able to determine its role in the dephosphorylation of active 
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zone proteins upon stimulation. Also, in this study, I have proposed a model in which kinases 
and phosphatases coordinate tightly to facilitate the SV release and recycling upon 
stimulation. The dataset generated in this study can be used as the basis for functional 
analysis of single phosphosites or phosphoproteins.    
The similar workflow in a combination with other kinases/phosphatases inhibitors can be 
used to investigate the role of these enzymes in synaptic transmission. In addition, using the 
electrical stimulation protocol established in this study, it is possible to determine the 
phosphorylation events that have a role in the regulation of readily releasable and recycling 
pools of SVs. It is predictable that in future through the improvement of the phosphopeptides 
enrichment methods, development of faster and more sensitive mass spectrometer 
instruments, as well as more advanced and sophisticated modeling tools, more phosphosites 
will be identified and synaptic transmission regulation via phosphorylation will be 
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6 Appendices 
 List of abbreviations 
µg Microgram 
µM  Micromolar 
ACN Acetonitiril  
ADBE Activity-Dependent Bulk Endocytosis  
ADP Adenosine diphosphate 
AP Action potential 
ATP Adenosine triphosphate 
CAA 2-Chloroacetamide 
CaM Calmodulin 
CaMKII Ca2+/calmodulindependent kinase II 
CdK5 Cyclin-dependent Kinase 5 
CID Collision-Induced Dissociation  
CK2 Casein Kinase 2  
CME Clathrin-Mediated Endocytosis  
CycloA Cyclosporine A 
Da Dalton 
DARPP-32 Dopamine- and cAMP-Regulated Phospho Protein 32 
DDA Data-Dependent Acquisition 
DHB 2,5-dihydroxybenzoic acid  
DTT Dithiothreitol 
ERK 1/2 Extracellular-signal Regulated Kinase 1/2  
ESI Electrospray ionization  
ETD Electron Transfer Dissociation  
FA Formid acid 
FDR False Discovery Rate  
g (RCF) Relative centrifugal force (RCF) 
GluDH Glutamate dehydrogenase  
GSK-3 Glycogen Synthase Kinase 3  
h Hour 
HCD High-energy Collisional Dissociation  
HPLC High-Performance Liquid Chromatography  
Hz Hertz 
ID  Inner diametere  
IMAC Immobilized Metal Affinity Chromatography 
LC Liquid chromatography 
M Molar 
m/z Mass to charge ratio 
MALDI Matrix-Assisted Laser Desorption Ionization  
 





MS Mass spectrometry 
MS/MS Tandem Mass spectremtry 
MS1 Peptide precursor spectrum 
MS2 Product ion spectrum 
msec/ms Millisecond 
nL Nanoliter  
nM Nanomolar 
PDK-1 Phosphoinositide-dependent kinase-1  
PKA Protein Kinase A  
PKC Protein Kinase C  
PP Protein phosphatases  
pS Phosphorylated Serine  
pT Phosphorylated Threonine  
PTM Post translational modification  
pY Phosphorylated Tyrosine  
RP Reverse Phase 
rpm Round per minute  
RRP Readily releasable pool  
RT Room tempreture 
S/Ser Serine  
SCX Strong Cation Exchange  
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
sec Second 
SILAC Stable Isotope Labeling with Amino acids  
SV  Synaptic vesicle 
T/Thr  Threonine  
TEAB Triethylammonium bicarbonate buffer 
TFA Trifluoroacetic acid 




WB Western Blot 
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 Supplementary Tables 
In this section all the regulated phosphosites in different experiments are listed. The list of 
all quantified phosphosites (regulated or not regulated) are stored on CD that can be found 
attached at the back of the hard copy of this thesis. 
 
 
Table 6-1: List of regulated phosphosites in comparison K+, EGTA vs K+, Ca2+ 
Regulation Protein names Gene names Aminoacid/ 
position 
Downregulated AP2-associated protein kinase 1 Aak1 S639 
Downregulated AP2-associated protein kinase 1 Aak1 S672 
Downregulated AP2-associated protein kinase 1 Aak1 S670 
Upregulated ATP citrate lyase  Acly  S455 
Upregulated Calcium/calmodulin-dependent protein kinase II Camk2b  T401 
Upregulated Calcium/calmodulin-dependent protein kinase type II subunit 
gamma  
Camk2g S299 
Upregulated Calcium/calmodulin-dependent protein kinase type II subunit 
gamma  
Camk2g S300 
Downregulated Calcium-dependent secretion activator 1 Cadps S89 
Downregulated Calcium-dependent secretion activator 1 Cadps S88 
Upregulated Catenin delta-2  Ctnnd2 S459 
Downregulated Clathrin coat assembly protein AP180 Snap91 S600 
Downregulated Clathrin coat assembly protein AP180  Snap91 S627 
Downregulated Clathrin coat assembly protein AP180  Snap91 S621 
Upregulated Complexin-1  Cplx1 S93 
Upregulated Dihydropyrimidinase-related protein 1 Crmp1 1 S542 
Upregulated Dihydropyrimidinase-related protein 2  Dpysl2 S542 
Upregulated Dihydropyrimidinase-related protein 2  Dpysl2 S540 
Upregulated Dihydropyrimidinase-related protein 2 Dpysl5 S445 
Upregulated Disks large-associated protein 2 Dlgap2 S977 
Downregulated DnaJ (Hsp40) homolog, subfamily C, member 6 Dnajc6  S652 
Downregulated DnaJ (Hsp40) homolog, subfamily C, member 6 Dnajc6  T658 
Downregulated DnaJ (Hsp40) homolog, subfamily C, member 6  Dnajc6  T655 
Upregulated Drebrin  Dbn1 S241 
Experiment Regulates phosphosites All the quantified  
phosphosites on the CD 
Comparison K+, EGTA vs K+, Ca2+ Table 6-1 Table S1 
Comparison EGTA vs K+, Ca2+ Table 6-2 Table S2 
Comparison K+, EGTA vs EGTA Table 6-3 Table S3 
Inhibition of Calcineurin Table 6-4,  Table 6-5 Table S4 
Inhibition of CaMKII Table 6-6 Table S5 
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Upregulated Drebrin-like protein Dbnl Sh3p7 S277 
Upregulated Dynamin-1 Dnm1 Dnm S778 
Downregulated Dynamin-1 Dnm1 Dnm S774 
Downregulated Dynamin-1 Dnm1 Dnm T776 
Downregulated Dynamin-1 Dnm1 Dnm S853 
Downregulated Dynamin-1 Dnm1 Dnm S857 
Downregulated Dynamin-1 Dnm1 Dnm S817 
Downregulated Dynamin-1 Dnm1 Dnm S822 
Downregulated ELKS/Rab6-interacting/CAST family member 1 Erc1 S21 
Downregulated Endophilin-A2  Sh3gl1 Sh3p8 S288 
Upregulated Epsin-1  Epn1 S450 
Downregulated ERC protein 2 Erc2 S16 
Downregulated ERC protein 2 Erc2 S18 
Downregulated Erythrocyte protein band 4.1-like 3, isoform CRA_b  Epb41l3  S578 
Downregulated FXYD domain-containing ion transport regulator 7 Fxyd7 S60 
Downregulated FXYD domain-containing ion transport regulator 7 Fxyd7 S56 
Downregulated FXYD domain-containing ion transport regulator 7 Fxyd7 S58 
Upregulated Glutamate decarboxylase 1  Gad1 Gad67 T53 
Upregulated Glutamate decarboxylase 1  Gad1 Gad67 S55 
Upregulated Glycine--tRNA ligase  Gars T316 
Upregulated Liprin-alpha-3 Ppfia3 S75 
Downregulated Liprin-alpha-3 Ppfia3 S682 
Upregulated MARCKS-related protein Marcksl1  S104 
Upregulated MARCKS-related protein Marcksl1  T85 
Upregulated Microtubule-associated protein Mapt S347 
Upregulated Microtubule-associated protein Mapt S287 
Upregulated Microtubule-associated protein Mapt S344 
Upregulated Microtubule-associated protein Mapt S176 
Upregulated Microtubule-associated protein Mapt T317 
Downregulated Microtubule-associated protein 1A  Map1a Mtap1a S2207 
Downregulated Microtubule-associated protein 1A  Map1a Mtap1a S2206 
Upregulated Microtubule-associated protein 1B Map1b S541 
Upregulated Microtubule-associated protein 1B Map1b S561 
Downregulated Microtubule-associated protein 1B Map1b T1626 
Upregulated Mitogen-activated protein kinase 1 Mapk1 Erk2  Y185 
Upregulated Mitogen-activated protein kinase 1  Mapk1 Erk2  T183 
Upregulated Mitogen-activated protein kinase 1  Mapk1 Erk2  T179 
Upregulated Mitogen-activated protein kinase 3 Mapk3 Erk1  Y205 
Upregulated Mitogen-activated protein kinase 3 Mapk3 Erk1  T203 
Downregulated Myc box-dependent-interacting protein 1 (Amphiphysin II) Bin1 Amph2  S332 
Downregulated Myc box-dependent-interacting protein 1 (Amphiphysin II)  Bin1 Amph2  T328 
Upregulated Myosin-10 Myh10  S1952 
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Upregulated Myosin-10 Myh10  S1956 
Upregulated Myristoylated alanine-rich C-kinase substrate Marcks S163 
Upregulated Myristoylated alanine-rich C-kinase substrate Marcks T143 
Upregulated Myristoylated alanine-rich C-kinase substrate Marcks S138 
Upregulated Neurabin-2 Ppp1r9b S100 
Upregulated Neurabin-2  Ppp1r9b S99 
Upregulated Neuromodulin Gap43 S192 
Upregulated Numb-like protein Numbl Nbl S411 
Upregulated Plasma membrane calcium-transporting ATPase 4  Atp2b4 S1103 
Downregulated Platelet glycoprotein Ib beta chain (Septin 5, isoform CRA_d) Sept5  S17 
Upregulated Poliovirus receptor-related 1 Pvrl1  S421 
Downregulated Protein Ank2 Ank2 S1722 
Downregulated Protein bassoon  Bsn  S241 
Downregulated Protein bassoon  Bsn  S245 
Downregulated Protein bassoon  Bsn  S263 
Downregulated Protein bassoon  Bsn  S265 
Downregulated Protein bassoon  Bsn  S821 
Upregulated Protein bassoon  Bsn  S1220 
Downregulated Protein bassoon  Bsn  S1353 
Downregulated Protein bassoon  Bsn  S1357 
Downregulated Protein bassoon  Bsn  S1475 
Downregulated Protein bassoon  Bsn  T1476 
Downregulated Protein bassoon  Bsn  S1480 
Downregulated Protein bassoon  Bsn  S2016 
Downregulated Protein bassoon  Bsn  S2527 
Downregulated Protein bassoon  Bsn  S2789 
Downregulated Protein bassoon  Bsn  S2792 
Upregulated Protein bassoon  Bsn  S2795 
Downregulated Protein bassoon  Bsn  S2806 
Upregulated Protein bassoon  Bsn  S2842 
Upregulated Protein bassoon  Bsn  S2844 
Downregulated Protein bassoon  Bsn  S3006 
Upregulated Protein bassoon  Bsn  S3497 
Upregulated Protein Dmxl2  Dmxl2 T587 
Upregulated Protein Dmxl2  Dmxl2 S1586 
Upregulated Protein Dmxl2  Dmxl2 S589 
Upregulated Protein Dmxl2  Dmxl2 S593 
Upregulated Protein Dmxl2  Dmxl2 S1584 
Downregulated Protein Dmxl2  Dmxl2 S150 
Downregulated Protein Hecw2  Hecw2  S1048 
Upregulated Protein Iqsec1 Iqsec1  S74 




Appendices | 144 
 
Upregulated Protein LOC100909464 LOC100909464 S567 
Upregulated Protein Map2k4  Map2k4 S42 
Upregulated Protein Map2k4  Map2k4 T40 
Downregulated Protein Pcp2  Pcp2  S92 
Downregulated Protein Pcp2  Pcp2  S98 
Downregulated Protein Pcp2  Pcp2  S111 
Upregulated Protein piccolo Pclo S3632 
Upregulated Protein piccolo Pclo S3626 
Downregulated Protein piccolo Pclo T111 
Downregulated Protein piccolo Pclo S3561 
Downregulated Protein piccolo Pclo S3565 
Downregulated Protein piccolo Pclo S591 
Upregulated Protein Psd3 Psd3 S98 
Upregulated Protein RGD1559864 RGD1559864 T47 
Upregulated Protein Sorcs2 Sorcs2 T298 
Upregulated Protein Sorcs2 Sorcs2 Y299 
Upregulated Rabphilin-3A Rph3a S274 
Upregulated Regulating synaptic membrane exocytosis protein 1 Rims1 S346 
Upregulated Regulating synaptic membrane exocytosis protein 1 Rims1 S1141 
Upregulated Regulating synaptic membrane exocytosis protein 1 Rims1 S991 
Upregulated Regulating synaptic membrane exocytosis protein 1 Rims1 S413 
Downregulated Regulating synaptic membrane exocytosis protein 1 Rims1 S1045 
Downregulated Regulating synaptic membrane exocytosis protein 1 Rims1 S745 
Downregulated Regulating synaptic membrane exocytosis protein 1 Rims1 S742 
Downregulated Reticulon-3 Rtn3 S31 
Upregulated Serine/threonine-protein kinase BRSK1  Brsk1  S508 
Upregulated Serine/threonine-protein kinase MARK1  Mark1 S649 
Upregulated Serine/threonine-protein phosphatase 2B catalytic subunit 
alpha isoform  
Ppp3ca  T458 
Upregulated Serine/threonine-protein phosphatase 2B catalytic subunit 
alpha isoform  
Ppp3ca  S459 
Upregulated Sodium/potassium/calcium exchanger 2 Slc24a2 S41 
Upregulated Sodium/potassium/calcium exchanger 2 Slc24a2 S44 
Upregulated Sodium/potassium/calcium exchanger 2 Slc24a2 S42 
Downregulated Sodium-dependent neutral amino acid transporter SLC6A17  Slc6a17  S682 
Downregulated Sodium-dependent neutral amino acid transporter SLC6A17  Slc6a17  S686 
Upregulated SRC kinase signaling inhibitor 1  Snip S941 
Upregulated SRC kinase signaling inhibitor 1  Snip S1077 
Upregulated SRC kinase signaling inhibitor 1  Snip S1094 
Upregulated SRC kinase signaling inhibitor 1  Snip S547 
Downregulated SRC kinase signaling inhibitor 1  Snip S527 
Upregulated Stathmin Stmn1 S16 
Upregulated Synapsin-1 Syn1 S603 
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Upregulated Synapsin-1 Syn1 S566 
Upregulated Synapsin-1 Syn1 S447 
Downregulated Synapsin-1 Syn1 S436 
Downregulated Synapsin-1 Syn1 S662 
Downregulated Synapsin-1 Syn1 T434 
Downregulated Synapsin-1 Syn1 S432 
Downregulated Synapsin-1 Syn1 S62 
Downregulated Synapsin-1 Syn1 S579 
Downregulated Synapsin-1 Syn1 S39 
Downregulated Synapsin-1 Syn1 S508 
Upregulated Synapsin-2 Syn2 S524 
Upregulated Synapsin-2 Syn2 S530 
Upregulated Synapsin-3 Syn3 S265 
Upregulated Syntaxin-6 Stx6 S2 
Upregulated Syntaxin-binding protein 5 Stxbp5 Llgl3 S1023 
Upregulated Transgelin-3  Tagln3 Np25 S163 
Upregulated Tyrosine 3-monooxygenase  Th S19 
Upregulated Uncharacterized protein LOC690035 S355 
Upregulated Vesicle-fusing ATPase  Nsf S206 
Downregulated Voltage-dependent P/Q-type calcium channel subunit alpha-1A Cacna1a S1589 
 
Table 6-2: List of regulated phosphosites in comparison EGTA vs K+, Ca2+ 
Regulation  Protein names Gene names Aminoacid/ 
position 
Upregulated 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase 
beta-1  
Plcb1 S1199 
Downregulated ADP-ribosylation factor GTPase-activating protein 1 (ARF GAP 
1)  
Arfgap1  S305 
Downregulated A-kinase anchor protein 12 (AKAP-12) Akap12 S1466 
Downregulated AP2-associated protein kinase 1 Aak1 S672 
Downregulated AP2-associated protein kinase 1 Aak1 S670 
Downregulated AP2-associated protein kinase 1 Aak1 T675 
Downregulated Arf-GAP with SH3 domain, ANK repeat and PH domain-
containing protein 1  
Asap1 Ddef1 S973 
Upregulated ATP citrate lyase, isoform CRA_b (ATP-citrate synthase) Acly  S455 
Upregulated ATP citrate lyase, isoform CRA_b (ATP-citrate synthase) Acly  T453 
Downregulated Band 4.1-like protein 1 Epb41l1 S1349 
Downregulated Calcium/calmodulin-dependent protein kinase type II subunit 
delta  
Camk2d T337 
Downregulated Calcium-dependent secretion activator 1 Cadps S89 
Downregulated cAMP-dependent protein kinase catalytic subunit beta  Prkacb Pkacb T198 
Downregulated cAMP-dependent protein kinase catalytic subunit beta  Prkacb Pkacb T196 
Upregulated Caskin-1 Caskin1 T815 
Downregulated Caskin-1 Caskin1 S1362 
 
Appendices | 146 
 
Upregulated cGMP-dependent 3',5'-cyclic phosphodiesterase  Pde2a S900 
Downregulated Clathrin coat assembly protein AP180  Snap91 S600 
Upregulated Dihydropyrimidinase-related protein 1 (DRP-1)  Crmp1 Dpysl1 S542 
Upregulated Dihydropyrimidinase-related protein 2 (DRP-2)  Dpysl2 S542 
Upregulated Dihydropyrimidinase-related protein 2 (DRP-2)  Dpysl2 S540 
Upregulated Dihydropyrimidinase-related protein 2 (DRP-2)  Dpysl2 S517 
Upregulated Dihydropyrimidinase-related protein 2 (DRP-2)  Dpysl2 T514 
Upregulated Dihydropyrimidinase-related protein 2 (DRP-2)  Dpysl2 S518 
Upregulated Discs, large (Drosophila) homolog-associated protein 3, isoform 
CRA_b  
Dlgap3  S712 
Upregulated Discs, large (Drosophila) homolog-associated protein 3, isoform 
CRA_b  
Dlgap3  S185 
Downregulated Disks large homolog 2 (Channel-associated protein of synapse-
110)  
Dlg2 Dlgh2 S360 
Upregulated Disks large-associated protein 2 Dlgap2 S977 
Downregulated DnaJ (Hsp40) homolog, subfamily C, member 6  Dnajc6  S652 
Upregulated Drebrin-like protein (Actin-binding protein 1)  Dbnl Sh3p7 S277 
Downregulated Dual specificity mitogen-activated protein kinase kinase 2 Map2k2  S222 
Upregulated Dynamin-1 (EC 3.6.5.5) (B-dynamin) (D100)  Dnm1 S778 
Downregulated Dynamin-1 (EC 3.6.5.5) (B-dynamin) (D100)  Dnm1  S774 
Downregulated Dynamin-1  Dnm1  T776 
Downregulated Dynamin-1  Dnm1  S857 
Downregulated Dynamin-1  Dnm1  S822 
Downregulated Dynamin-1  Dnm1  S817 
Downregulated Dynamin-1  Dnm1  S853 
Upregulated Dynamin-3  Dnm3 Dyn3 S759 
Downregulated Endophilin-A2  Sh3gl1 Sh3p8 S288 
Downregulated ERC protein 2 Erc2 S18 
Upregulated Eukaryotic translation initiation factor 4B  Eif4b  S497 
Upregulated Eukaryotic translation initiation factor 4B  Eif4b  S498 
Upregulated Eukaryotic translation initiation factor 4B  Eif4b  S504 
Downregulated FXYD domain-containing ion transport regulator 7 Fxyd7 S60 
Downregulated FXYD domain-containing ion transport regulator 7 Fxyd7 S56 
Downregulated FXYD domain-containing ion transport regulator 7 Fxyd7 S58 
Upregulated Glutamate decarboxylase 1  Gad1 Gad67 T53 
Upregulated Glutamate decarboxylase 1  Gad1 Gad67 S55 
Upregulated Glycine--tRNA ligase  Gars T316 
Upregulated GTPase activating RANGAP domain-like 4  Rap1gap2  S324 
Upregulated Intersectin-1 Itsn1 S975 
Upregulated Intersectin-1 Itsn1 S623 
Upregulated Kinesin light chain 2  Klc2  S581 
Upregulated Kinesin light chain 2  Klc2  S582 
Downregulated Liprin-alpha-3 Ppfia3 S682 
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Downregulated MAGUK p55 subfamily member 3 Mpp3 Dlg3 
Dusp3 
S354 
Upregulated MARCKS-related protein  Marcksl1 Mlp S104 
Upregulated Microtubule-associated protein Mapt S347 
Upregulated Microtubule-associated protein Mapt S287 
Upregulated Microtubule-associated protein Mapt S176 
Upregulated Microtubule-associated protein Mapt T179 
Upregulated Microtubule-associated protein Mapt S327 
Upregulated Microtubule-associated protein 1B Map1b S541 
Downregulated Microtubule-associated protein 1B Map1b T1626 
Upregulated Microtubule-associated protein 4 (MAP-4) Map4 S904 
Upregulated Mitochondrial import receptor subunit TOM20 homolog  Tomm20 S138 
Upregulated Mitogen-activated protein kinase 1 Mapk1 Erk2  Y185 
Upregulated Mitogen-activated protein kinase 1  Mapk1 Erk2  T183 
Upregulated Mitogen-activated protein kinase 1  Mapk1 Erk2  T188 
Upregulated Mitogen-activated protein kinase 1  Mapk1 Erk2  T179 
Upregulated Mitogen-activated protein kinase 3 Mapk3 Erk1  Y205 
Upregulated Mitogen-activated protein kinase 3  Mapk3 Erk1  T203 
Downregulated Myc box-dependent-interacting protein 1 (Amphiphysin II)  Bin1 Amph2  S332 
Downregulated Myc box-dependent-interacting protein 1 (Amphiphysin II)  Bin1 Amph2  T328 
Downregulated Myosin, heavy polypeptide 10, non-muscle, isoform CRA_b 
(Myosin-10) 
Myh10  S1956 
Upregulated Myristoylated alanine-rich C-kinase substrate Marcks S163 
Upregulated Neurabin-2 (Neurabin-II)  Ppp1r9b S99 
Upregulated Oxidation resistance protein 1 (Fragment) Oxr1 T178 
Downregulated Peripheral plasma membrane protein CASK Cask S24 
Downregulated Phosphatase and actin regulator Phactr1 S67 
Downregulated Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma Pip5k1c S475 
Downregulated Platelet glycoprotein Ib beta chain Gp1bb Sept5 S234 
Downregulated Platelet glycoprotein Ib beta chain (Septin 5, isoform CRA_d) Sept5 Gp1bb  S17 
Downregulated Protein Ank2 Ank2 S1722 
Upregulated Protein Arhgap1 Arhgap1 S27 
Upregulated Protein bassoon  Bsn  S3497 
Upregulated Protein bassoon  Bsn  S2795 
Upregulated Protein bassoon  Bsn  S1220 
Upregulated Protein bassoon  Bsn  S2632 
Downregulated Protein bassoon  Bsn  S2004 
Downregulated Protein bassoon  Bsn  S3501 
Downregulated Protein bassoon  Bsn  S1357 
Downregulated Protein bassoon  Bsn  S3006 
Downregulated Protein bassoon  Bsn  T1476 
Downregulated Protein bassoon  Bsn  S235 
Downregulated Protein bassoon  Bsn  S2806 
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Downregulated Protein bassoon  Bsn  S265 
Downregulated Protein bassoon  Bsn  S263 
Downregulated Protein Cpne6  Cpne6  S68 
Upregulated Protein Dmxl2  Dmxl2 S589 
Upregulated Protein Dmxl2  Dmxl2 S1584 
Upregulated Protein FAM131B Fam131b S102 
Downregulated Protein Fam57b (Putative uncharacterized protein  Fam57b S269 
Upregulated Protein Iqsec1 Iqsec1  S74 
Upregulated Protein Iqsec1 Iqsec1  S165 
Downregulated Protein kinase C  Prkca T514 
Downregulated Protein kinase C  Prkcd S504 
Downregulated Protein kinase C  Prkcd T505 
Upregulated Protein kinase C and casein kinase substrate in neurons 
protein1  
Pacsin1 S343 
Upregulated Protein LOC100910792  Amph  S239 
Upregulated Protein LOC100911610  LOC100911610 T427 
Upregulated Protein Map2k4  Map2k4 S42 
Upregulated Protein Mon2  Mon2 S1167 
Upregulated Protein NDRG2  Ndrg2 S318 
Upregulated Protein NDRG2  Ndrg2 S324 
Upregulated Protein NDRG2 Ndrg2 T316 
Downregulated Protein Pcp2 (Purkinje cell protein 2 (L7), isoform CRA_c) Pcp2  S111 
Downregulated Protein Pcp2 (Purkinje cell protein 2 (L7), isoform CRA_c) Pcp2  S92 
Downregulated Protein Pcp2 (Purkinje cell protein 2 (L7), isoform CRA_c) Pcp2  T90 
Upregulated Protein phosphatase 1H (EC 3.1.3.16) Ppm1h S220 
Downregulated Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.-) Ppme1 S243 
Downregulated Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.-) Ppme1 T242 
Downregulated Protein piccolo (Aczonin)  Pclo S1353 
Downregulated Protein piccolo (Aczonin)  Pclo S591 
Downregulated Protein Rabl6 (Putative uncharacterized protein  Rabl6  S489 
Upregulated Protein RGD1559864 RGD1559864 S43 
Upregulated Protein RGD1559864 RGD1559864 T47 
Downregulated Protein RGD1559864 RGD1559864 S309 
Downregulated Protein Rras2 (RCG40097)  Rras2  S186 
Downregulated Protein Smap2 (Smap2 protein) Smap2 S219 
Upregulated Protein Sorcs2 Sorcs2 T298 
Upregulated Protein Sorcs2 Sorcs2 Y299 
Upregulated Rab GDP dissociation inhibitor alpha (Rab GDI alpha)  Gdi1 T157 
Upregulated Rabphilin-3A Rph3a S274 
Upregulated Regulating synaptic membrane exocytosis protein 1 Rims1 S346 
Upregulated Regulating synaptic membrane exocytosis protein 1 Rims1 S95 
Upregulated Regulating synaptic membrane exocytosis protein 1 Rims1 S991 
Upregulated Regulating synaptic membrane exocytosis protein 1 Rims1 S413 
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Upregulated Regulating synaptic membrane exocytosis protein 2 Rims2 S369 
Downregulated Serine/threonine-protein kinase BRSK2 (Fragment) Brsk2 S91 
Upregulated Serine/threonine-protein kinase MARK1 (Fragment) Mark1 S649 
Downregulated Serine/threonine-protein kinase MARK1 (Fragment) Mark1 T198 
Upregulated Serine/threonine-protein phosphatase 2B catalytic subunit 
alpha isoform  
Ppp3ca  T458 
Downregulated SH3-containing GRB2-like protein 3-interacting protein 1 
(Endophilin-3-interacting protein) 
Sgip1 T263 
Downregulated Sn1-specific diacylglycerol lipase alpha Dagla  S808 
Upregulated Sodium/potassium/calcium exchanger 2 Slc24a2 S44 
Upregulated Sodium/potassium/calcium exchanger 2 Slc24a2 S41 
Downregulated Sodium-dependent neutral amino acid transporter SLC6A17  Slc6a17  S665 
Downregulated Sodium-dependent neutral amino acid transporter SLC6A17  Slc6a17  S686 
Downregulated Sodium-driven chloride bicarbonate exchanger  Slc4a10  S296 
Upregulated SRC kinase signaling inhibitor 1  (SNIP)  Srcin1  S941 
Upregulated SRC kinase signaling inhibitor 1 (SNIP)  Srcin1  S1077 
Upregulated stathmin 1 STMN1 S16 
Upregulated STE20/SPS1-related proline-alanine-rich protein kinase  Stk39  T363 
Upregulated Synapsin-1 (Synapsin I) Syn1 S603 
Upregulated Synapsin-1 (Synapsin I) Syn1 S566 
Upregulated Synapsin-1 (Synapsin I) Syn1 S447 
Downregulated Synapsin-1 (Synapsin I) Syn1 S436 
Downregulated Synapsin-1 (Synapsin I) Syn1 T434 
Downregulated Synapsin-1 (Synapsin I) Syn1 S432 
Downregulated Synapsin-1 (Synapsin I) Syn1 S579 
Downregulated Synapsin-1 (Synapsin I) Syn1 S62 
Downregulated Synapsin-1 (Synapsin I) Syn1 S508 
Downregulated Synapsin-1 (Synapsin I) Syn1 S39 
Upregulated Synapsin-3 Syn3 S265 
Downregulated Synaptojanin-1 Synj1 S1053 
Downregulated Synaptojanin-1  Synj1 T1048 
Upregulated Synaptotagmin-12  Syt12  S99 
Upregulated Syntaxin-6 Stx6 S2 
Upregulated Syntaxin-binding protein 5  (Tomosyn-1) Stxbp5 Llgl3 S1023 
Upregulated Thymosin beta-4  Tmsb4x  T21 
Upregulated Transcriptional activator protein Pur-alpha Pura T164 
Upregulated Transcriptional activator protein Pur-alpha Pura S163 
Upregulated Transgelin-3 (Neuronal protein 22) (NP22)  Tagln3 Np25 S163 
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Table 6-3: List of regulated phosphosites in comparison EGTA vs K+, EGTA 
Regulation Protein names Gene names Aminoacid/ 
Position 
Downregulated Protein Sept4 Sep4 S306 
Upregulated AP2-associated protein kinase 1 Aak1 S678 
Downregulated A-kinase anchor protein 12 (AKAP-12) Akap12 S509 
Downregulated A-kinase anchor protein 12 (AKAP-12) Akap12 S511 
Upregulated Protein Ank2 Ank2 S1816 
Upregulated AP-3 complex subunit delta Ap3d1  S754 
Upregulated Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel)  Aqp4 S221 
Downregulated Protein Arhgap1 Arhgap1 S50 
Downregulated Protein Arhgap1 Arhgap1 S51 
Downregulated Protein Armc4 Armc4 S304 
Downregulated Protein Armc4 Armc4 S308 
Downregulated Sodium/potassium-transporting ATPase subunit alpha-2  Atp1a2 S439 
Upregulated Protein bassoon  Bsn  S3006 
Upregulated Protein bassoon  Bsn  S2527 
Upregulated Protein bassoon  Bsn  S2054 
Upregulated Voltage-dependent R-type calcium channel subunit alpha-1E Cacna1e S15 
Upregulated Calcium channel, voltage-dependent, beta 1 subunit, isoform 
CRA_a  
Cacnb1  S417 
Downregulated Calcium/calmodulin-dependent protein kinase type II subunit 
alpha  
Camk2a T286 
Upregulated Calcium/calmodulin-dependent protein kinase II, beta, isoform 
CRA_a  
Camk2b  T401 
Upregulated Claudin Cldn11  S194 
Downregulated DnaJ (Hsp40) homolog, subfamily C, member 6  Dnajc6  S568 
Upregulated Dynamin-1  Dnm1 Dnm S822 
Downregulated FXYD domain-containing ion transport regulator 7 Fxyd7 S58 
Downregulated Glycine--tRNA ligase  Gars T316 
Upregulated Guanine nucleotide-binding protein G(o) subunit alpha Gnao1 Gna0  S207 
Downregulated Platelet glycoprotein Ib beta chain Gp1bb Sept5 T13 
Upregulated Probable G-protein-coupled receptor 158 Gpr158 S946 
Downregulated Glutamate receptor ionotropic, delta-2  Grid2 S816 
Downregulated Glutamate receptor ionotropic, delta-2  Grid2 S809 
Downregulated Heat shock protein HSP 90-beta  Hsp90ab1  S255 
Downregulated Heat shock protein HSP 90-beta  Hsp90ab1  S261 
Upregulated Potassium voltage-gated channel subfamily C member 1  Kcnc1 S160 
Upregulated Calcium-activated potassium channel subunit alpha-1  Kcnma1 Kcnma T1001 
Downregulated Kinesin light chain 2  Klc2  S581 
Downregulated Kinesin light chain 2  Klc2 S151 
Upregulated Protein LOC100365676  LOC100365676  S114 
Downregulated Protein LOC100911356  LOC100911356  S35 
Downregulated Protein LOC100911356  LOC100911356  S39 
Downregulated Leucine-rich repeat-containing protein 4B  Lrrc4b Lrig4 S700 
Downregulated Microtubule-associated protein 1B Map1b S614 
Downregulated Microtubule-associated protein 1B Map1b S561 
Downregulated Microtubule-associated protein Map2 S1051 
Downregulated Myristoylated alanine-rich C-kinase substrate Marcks S163 
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Downregulated MARCKS-related protein  Marcksl1 Mlp T85 
Downregulated MARCKS-related protein  Marcksl1 Mlp S22 
Upregulated Unconventional myosin-Va  Myo5a S1625 
Upregulated NCK interacting protein with SH3 domain  Nckipsd  S122 
Downregulated Uncharacterized protein Nefm S641 
Downregulated NSFL1 cofactor p47  Nsfl1c S114 
Upregulated Proliferation-associated protein 2G4 Pa2g4 S2 
Downregulated Protein piccolo (Aczonin)  Pclo S3565 
Downregulated Protein piccolo (Aczonin)  Pclo S617 
Upregulated Protein piccolo (Aczonin)  Pclo S4340 
Downregulated ATP-dependent 6-phosphofructokinase, platelet type Pfkp S2 
Downregulated 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase 
beta-1  
Plcb1 S1199 
Downregulated 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase 
beta-1  
Plcb1 S1197 
Upregulated Neurabin-2 (Neurabin-II)  Ppp1r9b S100 
Downregulated Protein kinase C (EC 2.7.11.13) Prkcd S504 
Downregulated Protein kinase C (EC 2.7.11.13) Prkce S349 
Upregulated Protein Prrt3 Prrt3 S807 
Downregulated Protein Psd3 Psd3 S76 
Upregulated Protein Psd3 Psd3 S337 
Downregulated Rab3 GTPase-activating protein non-catalytic subunit  Rab3gap2 S877 
Upregulated Protein Rabl6   Rabl6  S472 
Upregulated Protein Rabl6  Rabl6  S474 
Upregulated Protein Rabl6   Rabl6  S475 
Downregulated Protein RGD1559864 RGD1559864 T47 
Upregulated Regulating synaptic membrane exocytosis protein 1 Rims1 S991 
Upregulated Reticulon Rtn4 S16 
Downregulated Secretogranin 2, isoform CRA_a  Scg2  S531 
Downregulated Secretogranin 2, isoform CRA_a  Scg2  T274 
Upregulated Signal-induced proliferation-associated 1-like protein 1  Sipa1l1 S1129 
Downregulated Monocarboxylate transporter 1 (MCT 1)  Slc16a1 Mct1 S210 
Downregulated Monocarboxylate transporter 1 (MCT 1)  Slc16a1 Mct1 S213 










Upregulated Sodium/calcium exchanger 2 Slc8a2 S713 
Downregulated Protein Sorcs2 Sorcs2 T298 
Downregulated Protein Sorcs2 Sorcs2 Y299 
Downregulated Stathmin Stmn3 S81 
Upregulated RCG61894, isoform CRA_a (Striatin) Strn  S245 
Upregulated Synapsin-1 (Synapsin I) Syn1 S603 
Upregulated Synapsin-1 (Synapsin I) Syn1 S39 
Upregulated Synapsin-3 Syn3 S700 
Upregulated Synapsin-3 Syn3 S697 
Upregulated Ras/Rap GTPase-activating protein SynGAP Syngap1 T70 
Upregulated Protein Tanc2 Tanc2 S400 
Upregulated Protein Tanc2 Tanc2 S404 
Downregulated Protein Tppp  Tppp  T15 
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Downregulated Transient receptor potential cation channel subfamily V 
member 2   
Trpv2  S15 
Downregulated Tubulin alpha-1B chain (Alpha-tubulin 2) (Tubulin alpha-2 
chain) 
Tuba1b Tuba2 S158 
Upregulated Ubiquitin carboxyl-terminal hydrolase  Usp27x  T149 
Upregulated Vesicle-associated membrane protein 1  Vamp1 S62 
Downregulated Vesicle-associated membrane protein 2  Vamp2 S74 
Upregulated Vesicle-associated membrane protein 2  Vamp2 S60 
 
Table 6-4: List of upregulated phosphosites upon Calcineurin inhibition (putative Calcineurin 
substrates). 
Protein name Gene name Aminoacid/ 
Position 
Beta-adducin Add2 S618 
Ankyrin-2 Ank2 S1725 
Ankyrin-3 Ank2 S1702 
Rho GTPase-activating protein 1 Arhgap1 S51 
Autophagy-related protein 2 homolog B Atg2b S255 
Protein bassoon Bsn S3367 
Protein bassoon Bsn S821 
Protein bassoon Bsn S1357 
Protein bassoon Bsn S2806 
Protein bassoon Bsn S245 
Protein bassoon Bsn S2792 
Protein bassoon Bsn S2795 
Protein bassoon Bsn S3501 
Protein bassoon Bsn S3504 
Protein bassoon Bsn S263 
Protein bassoon Bsn S1473 
Protein bassoon Bsn S241 
Protein bassoon Bsn S245 
Protein bassoon Bsn S2792 
Protein bassoon Bsn S2795 
Protein bassoon Bsn T1086 
Voltage-dependent P/Q-type calcium channel subunit alpha-1A Cacna1a S1981 
Voltage-dependent N-type calcium channel subunit alpha-1B Cacna1b S745 
Voltage-dependent N-type calcium channel subunit alpha-1E Cacna1e S15 
Calcium/calmodulin-dependent protein kinase type II subunit alpha Camk2a S279 
Calcium/calmodulin-dependent protein kinase type II subunit beta Camk2b S397 
Calcium/calmodulin-dependent protein kinase type II subunit beta Camk2b T400 
Calcium/calmodulin-dependent protein kinase type II subunit beta Camk2b T401 
Catenin delta-2 Ctnnd2 S224 
Src substrate cortactin Cttn T327 
Disks large homolog 2 Dlg2 S365 
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DmX-like protein 2 Dmxl2 S119 
Putative tyrosine-protein phosphatase auxilin Dnajc6 S568 
Dynamin-1 Dnm1 S774 
Dynamin-1 Dnm1 S778 
Elongation factor 1-delta Eef1d S133 
Band 4.1-like protein 3 Epb41l3 S724 
Band 4.1-like protein 3 Epb41l3 S978 
Protein Etl4 Etl4 S341 
Mitochondrial inner membrane protein Immt S340 
Kalirin Kalrn S401 
MAP kinase-activating death domain protein Madd S1225 
MAP kinase-activating death domain protein Madd S1038 
Microtubule-associated protein 1A;MAP1A heavy chain;MAP1 light chain LC2 Map1a T504 
Microtubule-associated protein 1B;MAP1B heavy chain;MAP1 light chain LC1 Map1b S1252 
Microtubule-associated protein 1B;MAP1B heavy chain;MAP1 light chain LC1 Map1b S1257 
Microtubule-associated protein 1B;MAP1B heavy chain;MAP1 light chain LC1 Map1b S1778 
MAP7 domain-containing protein 1 Map7d1 S118 
Microtubule-associated protein;Microtubule-associated protein tau Mapt S461 
Microtubule-associated protein;Microtubule-associated protein tau Mapt T460 
Neural cell adhesion molecule 1 Ncam1 T787 
Neurofilament heavy polypeptide Nefh S592 
Protein piccolo Pclo S3565 
Protein piccolo Pclo S1353 
Protein piccolo Pclo S1451 
Protein piccolo Pclo S4615 
Protein piccolo Pclo S3260 
Protein piccolo Pclo S1841 
Protein piccolo Pclo S3632 
Protein piccolo Pclo S591 
Protein piccolo Pclo S1778 
Protein piccolo Pclo S1784 
Protein piccolo Pclo T1772 
Myelin proteolipid protein Plp1 S114 
Liprin-alpha-3 Ppfia3 S682 
Phosphatidylserine decarboxylase proenzyme 3 Psd3 S76 
Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 Ptplad1 S114 
Rap1 GTPase-activating protein 1 Rap1gap S127 
Regulating synaptic membrane exocytosis protein 1 Rims1 S745 
Voltage-dependent anion-selective channel protein 2 Vdac2 S116 
Regulating synaptic membrane exocytosis protein 1 Rims1 S895 
Synapsin-1 Syn1 S508 
VPS10 domain-containing receptor SorCS2 Sorcs2 T298 
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VPS10 domain-containing receptor SorCS2 Sorcs2 Y299 
Clathrin coat assembly protein AP180 Snap91 S300 
Protein RGD1306271 RGD1306271 S1610 
Syntaxin-binding protein 1 Stxbp1 S516 
SH3 and multiple ankyrin repeat domains protein 1 Shank1 S1442 
Synapsin-1 Syn1 S549 
Synapsin-1 Syn1 S551 
Sorbin and SH3 domain-containing protein 1 Sorbs1 S62 
Regulating synaptic membrane exocytosis protein 1 Rims1 S742 
Saccharopine dehydrogenase-like oxidoreductase Sccpdh S217 
Spectrin beta chain, non-erythrocytic 1 Sptbn1 S2158 
Proton myo-inositol cotransporter Slc2a13 S629 
Protein unc-13 homolog A Unc13a S255 
Endophilin-A2 Sh3gl1 S288 
Synapsin-1 Syn1 S436 
NAD-dependent protein deacetylase sirtuin-2 Sirt2 S334 
SRC kinase signaling inhibitor 1 Srcin1 S900 
Spectrin beta chain, non-erythrocytic 1 Sptbn1 S2162 
 
Table 6-5: List of downregulated phosphosites upon Calcineurin inhibition. 
Protein name Gene name Aminoacid/ 
Position 
Rho GTPase-activating protein 39 Arhgap39 S599 
Sodium/potassium-transporting ATPase subunit alpha-2 Atp1a2 S439 
Plasma membrane calcium-transporting ATPase 4 Atp2b4 S1103 
Protein bassoon Bsn T2580 
C2 domain-containing protein 2-like C2cd2l S662 
Calcium/calmodulin-dependent protein kinase type II subunit gamma Camk2g S311 
Calcium/calmodulin-dependent protein kinase type II subunit gamma Camk2g S321 
Calcium/calmodulin-dependent protein kinase type II subunit gamma Camk2g S325 
Calnexin Canx S553 
Calnexin Canx S563 
Cofilin-1 Cfl1 S3 
Choline O-acetyltransferase Chat S365 
Complexin-1 Cplx1 S93 
Dihydropyrimidinase-related protein 1 Crmp1 S542 
Putative tyrosine-protein phosphatase auxilin Dnajc6 S564 
Putative tyrosine-protein phosphatase auxilin Dnajc6 S568 
Dynamin-1 Dnm1 S817 
Dihydropyrimidinase-related protein 2 Dpysl2 S542 
Dihydropyrimidinase-related protein 2 Dpysl2 S518 
Dihydropyrimidinase-related protein 2 Dpysl2 T514 
 
Appendices | 155  
 
Dihydropyrimidinase-related protein 3 Dpysl3 T509 
Epsin-1 Epn1 S453 
F-box only protein 6 Fbxo6 S278 
Neuromodulin Gap43 S142 
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 Hcn2 S812 
Histone H1.4 Hist1h1e S2 
Heat shock protein HSP 90-alpha Hsp90aa1 S263 
Protein Klhl34 Klhl34 T209 
Protein Klhl34 Klhl34 T210 
Ubiquitin carboxyl-terminal hydrolase LOC100911959 S783 
Ubiquitin carboxyl-terminal hydrolase LOC100911959 T623 
Microtubule-associated protein 1B Map1b S930 
Mitogen-activated protein kinase 1 Mapk1 T183 
Mitogen-activated protein kinase 1 Mapk1 T183 
Mitogen-activated protein kinase 1 Mapk1 Y185 
Mitogen-activated protein kinase 10 Mapk10;Mapk8 T183 
Mitogen-activated protein kinase 10 Mapk10;Mapk8 Y185 
Microtubule-associated protein Mapt S473 
Microtubule-associated protein Mapt S413 
Microtubule-associated protein Mapt S453 
Microtubule-associated protein Mapt S255 
Microtubule-associated protein Mapt S453 
Microtubule-associated protein Mapt S457 
Microtubule-associated protein Mapt T460 
Myristoylated alanine-rich C-kinase substrate Marcks S138 
Myotubularin-related protein 9 Mtmr9 S498 
Myotubularin-related protein 9 Mtmr9 T491 
Protein NDRG2 Ndrg2 S318 
Protein NDRG2 Ndrg2 S324 
Oxidation resistance protein 1 Oxr1 S177 
Oxidation resistance protein 1 Oxr1 S179 
Proliferation-associated protein 2G4 Pa2g4 S2 
Protein kinase C and casein kinase substrate in neurons protein 1 Pacsin1 S343 
Protein kinase C and casein kinase substrate in neurons protein 1 Pacsin1 S345 
Protein kinase C and casein kinase substrate in neurons protein 1 Pacsin1 S346 
Pyruvate dehydrogenase E1 component subunit alpha, somatic form Pdha1l1;Pdha1 S232 
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 Plch2 S654 
Phosphomannomutase 1 Pmm1 S242 
Protein phosphatase 1 regulatory subunit 7 Ppp1r7 S24 
Protein phosphatase 1 regulatory subunit 7 Ppp1r7 S27 
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform Ppp3ca S469 
Proline-rich transmembrane protein 2 Prrt2 T74 
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Receptor-type tyrosine-protein phosphatase N2 Ptprn2 S424 
Calcipressin-1 Rcan1;Rcan3 S108 
Calcipressin-1 Rcan1;Rcan3 S112 
Protein Phf24 RGD1559864 T47 
SH3-containing GRB2-like protein 3-interacting protein 1 Sgip1 S265 
SH3-containing GRB2-like protein 3-interacting protein 1 Sgip1 T263 
Sodium/hydrogen exchanger 1 Slc9a1 S707 
STE20-like serine/threonine-protein kinase Slk S645 
STE20-like serine/threonine-protein kinase Slk S649 
Serine/threonine-protein kinase 24 Stk24 S4 
Stathmin Stmn1 S16 
Stathmin Stmn1 S16 
Stathmin Stmn1 S25 
Syntaxin-binding protein 1 Stxbp1 S507 
Syntaxin-binding protein 1 Stxbp1 S509 
Synapsin-1 Syn1 S67 
Synapsin-1 Syn1 S664 
Synapsin-2 Syn2 S524 
Nesprin-1 Syne1 S2320 
Transgelin-3 Tagln3 S163 
Serotransferrin Tf T212 
Thymosin beta-4 Tmsb4x T23 
Tubulin polymerization-promoting protein Tppp S159 
Tubulin polymerization-promoting protein Tppp S34 
E3 ubiquitin-protein ligase TRIM32 Trim32 S330 
Ubiquitin-like modifier-activating enzyme 1 Uba1 S810 
WD repeat-containing protein 44 Wdr44 S24 
 
Table 6-6: List of downregulated phosphosites upon CaMKII inhibition. 
Protein names Gene names Aminoacid/ 
Position 
Alpha-adducin Add1 S355 
Alpha-adducin Add1 S600 
Alpha-adducin Add1 T610 
A-kinase anchor protein 12 Akap12 S364 
A-kinase anchor protein 12 Akap12 S509 
AMP deaminase 2 Ampd2 S21 
 Ankyrin-2 Ank2 T2238 
Ankyrin repeat domain-containing protein 34A Ankrd34a S472 
Adaptor-related protein complex 3, delta 1 subunit Ap3d1 S825 
AP-3 complex subunit delta-1 Ap3d1 S755 
AP-3 complex subunit delta-1 Ap3d1 S760 
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AP-3 complex subunit delta-1 Ap3d1 T758 
 Rho GTPase-activating protein 1 Arhgap1 S27 
Rho GTPase-activating protein 44 Arhgap44 S799 
Armadillo repeat-containing protein 10 Armc10 S43 
Sodium/potassium-transporting ATPase subunit alpha-1 Atp1a1 S228 
Sodium/potassium-transporting ATPase subunit alpha-3 Atp1a3 S442 
Brain acid soluble protein 1 Basp1 S54 
Serine/threonine-protein kinase BRSK2 Brsk2 S387 
Protein bassoon Bsn S3497 
Protein bassoon Bsn S1220 
Protein bassoon Bsn S2844 
Protein bassoon Bsn S2850 
C2 domain-containing protein 2-like C2cd2l S59 
C2 domain-containing protein 2-like C2cd2l T417 
Voltage-dependent N-type calcium channel subunit alpha-1B Cacna1b S2023 
Calcium/calmodulin-dependent protein kinase type II subunit alpha Camk2a S279 
Calcium/calmodulin-dependent protein kinase type II subunit beta Camk2b S395 
Calcium/calmodulin-dependent protein kinase type II subunit beta Camk2b T287 
Calcium/calmodulin-dependent protein kinase type II subunit beta; Camk2b S276 
Calcium/calmodulin-dependent protein kinase type II subunit beta Camk2b S280 
Caskin-1 Caskin1 S1258 
Caskin-1 Caskin1 S936 
Coiled-coil domain-containing protein 85A Ccdc85a S342 
Protein Ccdc92 Ccdc92 S194 
Cell cycle exit and neuronal differentiation protein 1 Cend1 S90 
Cofilin-1 Cfl1 S3 
 Cofilin-2 Cfl2 S3 
Claudin-11 Cldn11 S194 
Claudin-11 Cldn11 S198 
Claudin-11 Cldn11 S194 
Claudin-11 Cldn11 S197 
Claudin-11 Cldn11 S198 
C-type lectin domain family 2 member L Clec2l S47 
C-type lectin domain family 2 member L Clec2l S52 
Cannabinoid receptor 1 Cnr1 S317 
Complexin-1 Cplx1 S93 
Complexin-2 Cplx2 S93 
Dihydropyrimidinase-related protein 1 Crmp1 S542 
Cytoplasmic FMR1-interacting protein 1 Cyfip1 T1234 
Sn1-specific diacylglycerol lipase alpha Dagla S808 
 D-aspartate oxidase Ddo S197 
Disks large homolog 2 Dlg2 S365 
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DmX-like protein 2 Dmxl2 S477 
Dihydropyrimidinase-related protein 2 Dpysl2 S542 
Dihydropyrimidinase-related protein 2 Dpysl2 T509 
Dihydropyrimidinase-related protein 3 Dpysl3 T509 
Cytoplasmic dynein 1 light intermediate chain 1 Dync1li1 S207 
Band 4.1-like protein 3 Epb41l3 S446 
Band 4.1-like protein 3 Epb41l3 T472 
Dematin Epb49 S226 
Protein Eps15l1 Eps15l1 S229 
Protein Fam171b Fam171b S790 
Gamma-aminobutyric acid type B receptor subunit 2 Gabbr2 S883 
Gamma-aminobutyric acid type B receptor subunit 2 Gabbr2 T818 
Neuromodulin Gap43 S142 
Glutamate dehydrogenase 1, mitochondrial Glud1 S79 
Glutamate dehydrogenase 1, mitochondrial Glud1 S450 
Gephyrin;Molybdopterin adenylyltransferase Gphn S192 
Neuronal membrane glycoprotein M6-a Gpm6a S256 
Neuronal membrane glycoprotein M6-a Gpm6a S270 
Probable G-protein coupled receptor 158 Gpr158 S902 
Probable G-protein coupled receptor 158 Gpr158 S904 
Glutamate receptor ionotropic, delta-2 Grid2 S816 
Glutamate receptor ionotropic, delta-2 Grid2 S809 
Glutamate receptor ionotropic, delta-2 Grid2 S816 
Glutamate receptor ionotropic, NMDA 2B Grin2b S1303 
Heat shock 70 kDa protein 4L Hspa4l S74 
Protein IMPACT Impact S295 
Inositol polyphosphate 5-phosphatase OCRL-1 Inpp5f S123 
Intersectin-1 Itsn1 S975 
Potassium voltage-gated channel subfamily A member 2 Kcna2 S434 
 Kinesin-like protein KIF21A Kif21a S1227 
Kinesin light chain 3 Klc2 S151 
Plastin-2 Lcp1 S5 
Ubiquitin carboxyl-terminal hydrolase LOC100911959 S783 
Ephexin-1 LOC100912512 S512 
Protein LOC501194 LOC501194 S38 
Protein LOC681198 LOC681198 Y52 
PRotein LOC688905 LOC688905 S249 
Leucine-rich repeat-containing protein 7 Lrrc7 S949 
Microtubule-actin cross-linking factor 1 Macf1 S2454 
MAP kinase-activating death domain protein Madd S1038 
MAP kinase-activating death domain protein Madd T1045 
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Microtubule-associated protein 1A Map1a S907 
Microtubule-associated protein 1B Map1b S1305 
Microtubule-associated protein 1B Map1b S609 
Microtubule-associated protein 1B Map1b S614 
Microtubule-associated protein 1B Map1b S1382 
Microtubule-associated protein 4 Map4 S522 
Microtubule-associated protein 6 Map6 S681 
Microtubule-associated protein tau;Microtubule-associated protein Mapt S253 
Microtubule-associated protein tau;Microtubule-associated protein Mapt T208 
Microtubule-associated protein tau;Microtubule-associated protein Mapt S391 
Serine/threonine-protein kinase MARK1 Mark1 T198 
Myelin basic protein Mbp S139 
Myelin basic protein Mbp T122 
Malate dehydrogenase, cytoplasmic Mdh1 S241 
Protein-methionine sulfoxide oxidase MICAL3 Mical3 S976 
Misshapen-like kinase 1 Mink1 S777 
Neurobeachin Nbea S372 
Neural cell adhesion molecule 1 Ncam1 S760 
Neural cell adhesion molecule 1 Ncam1 S764 
NCK-interacting protein with SH3 domain Nckipsd S122 
Nuclear distribution protein nudE-like 1 Ndel1 S198 
Neurofilament heavy polypeptide Nefh S872 
Neurofilament heavy polypeptide Nefh S838 
Neurofilament heavy polypeptide Nefh S774 
Neurofilament heavy polypeptide Nefh S538 
Neurofilament heavy polypeptide Nefh S670 
Neurofilament heavy polypeptide Nefh S580 
Neurofilament heavy polypeptide Nefh S658 
Neurofilament heavy polypeptide Nefh S646 
Neurofilament heavy polypeptide Nefh S61 
Neurofilament medium polypeptide Nefm S713 
Neurofilament medium polypeptide Nefm S721 
Neurofilament medium polypeptide Nefm S713 
Neurofilament medium polypeptide Nefm S721 
Neurofibromin Nf1 S2512 
Oxidation resistance protein 1 Oxr1 S470 
Oxidation resistance protein 1 Oxr1 S179 
Paralemmin-1 Palm T145 
Paralemmin-1 Palm S124 
Protein piccolo Pclo S3565 
Protein piccolo Pclo S1575 
Protein piccolo Pclo S3626 
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Protein piccolo Pclo S3632 
cAMP-specific 3',5'-cyclic phosphodiesterase 4A Pde4a S15 
Pyruvate dehydrogenase E1 component subunit alpha, somatic form Pdha1 S232 
Pyruvate dehydrogenase E1 component subunit alpha, somatic form Pdha1 S300 
Pyruvate dehydrogenase E1 component subunit alpha, somatic form Pdha1 S295 
PEX5-related protein Pex5l S232 
Phosphatidylinositol 4-kinase type 2-alpha Pi4k2a S46 
Plectin Plec S580 
Plexin domain-containing protein 2 Plxdc2 S507 
Liprin-alpha-3 Ppfia3 S1162 
Protein phosphatase 1H Ppm1h S220 
Protein phosphatase 1 regulatory subunit 1B Ppp1r1b S102 
Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform Ppp3cb S481 
cAMP-dependent protein kinase catalytic subunit alpha Prkaca; T190 
cAMP-dependent protein kinase type II-alpha regulatory subunit Prkar2a S97 
Protein kinase C;Protein kinase C alpha type Prkca T500 
Protein kinase C beta type Prkcb T642 
Protein kinase C epsilon type Prkce S349 
Protein kinase C epsilon type Prkce S345 
Protein kinase C epsilon type Prkce S349 
Protein Prrt3 Prrt3 S807 
Protein-tyrosine kinase 2-beta Ptk2b S375 
Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 Ptplad1 S114 
Poliovirus receptor-related 1 Pvrl1 S421 
Protein RGD1306271 RGD1306271 S30 
Protein RGD1306271 RGD1306271 T28 
Protein RGD1307235 RGD1307235 S244 
Protein RGD1310819 RGD1310819 S479 
Protein RGD1559864 RGD1559864 T47 
Regulating synaptic membrane exocytosis protein 1 Rims1 S1538 
Regulating synaptic membrane exocytosis protein 1 Rims1 S1277 
Regulating synaptic membrane exocytosis protein 1 Rims1 S413 
Regulating synaptic membrane exocytosis protein 1 Rims1 S991 
Regulating synaptic membrane exocytosis protein 2 Rims2 S177 
Rabphilin-3A Rph3a S683 
Ras-related protein R-Ras2 Rras2 S186 
Septin-5 Sep5 S234 
Septin-5 Sep5 T13 
Serine incorporator 1 Serinc1 S364 
SH3-containing GRB2-like protein 3-interacting protein 1 Sgip1 S293 
SH3-containing GRB2-like protein 3-interacting protein 1 Sgip1 S169 
SH3-containing GRB2-like protein 3-interacting protein 1 Sgip1 S170 
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SH3-containing GRB2-like protein 3-interacting protein 1 Sgip1 S319 
SH3 and multiple ankyrin repeat domains protein 1 Shank1 S1138 
SH3 and multiple ankyrin repeat domains protein 2 Shank2 S1031 
Monocarboxylate transporter 1 Slc16a1 S210 
Monocarboxylate transporter 1 Slc16a1 S213 
Excitatory amino acid transporter 1 Slc1a3 S466 
ADP/ATP translocase 1 Slc25a4 Y195 
Vesicular inhibitory amino acid transporter Slc32a1 S97 
Anion exchange protein 3 Slc4a3 S296 
Sodium/hydrogen exchanger 1 Slc9a1 S697 
 Protein Sntb2 Sntb2 S77 
SRC kinase signaling inhibitor 1 Srcin1 S941 
SRC kinase signaling inhibitor 1 Srcin1 S556 
SRC kinase signaling inhibitor 1 Srcin1 S1077 
Stathmin Stmn1 S16 
Stathmin Stmn1 S16 
Stathmin Stmn1 S25 
Stathmin;Stathmin-2 Stmn1;Stmn2 S46 
Syntaxin-binding protein 5-like Stxbp5l S574 
Syntaxin-binding protein 5-like Stxbp5l S797 
Syntaxin-binding protein 5-like Stxbp5l S798 
Synapsin-1 Syn1 S566 
Synapsin-2 Syn2 S524 
Synapsin-2;Synapsin-1 Syn2;Syn1 S697 
Synapsin-3 Syn3 S572 
Synapsin-3 Syn3 S540 
Synaptophysin Syp Y75 
Synaptotagmin-17 Syt17 S110 
Synaptotagmin-2 Syt2 T128 
 Synaptotagmin-7 Syt7 T58 
Transgelin-3 Tagln3 S163 
Serotransferrin Tf T492 
Tumor protein D53 Tpd52l1 S137 
Tumor protein D54 Tpd52l2 S168 
Tubulin polymerization-promoting protein Tppp T15 
Tubulin polymerization-promoting protein Tppp S31 
Tubulin polymerization-promoting protein Tppp S34 
Trafficking protein particle complex subunit 9 Trappc9 S766 
Tripartite motif-containing protein 2 Trim2 S424 
Tripartite motif-containing protein 2 Trim2 S428 
(E3-independent) E2 ubiquitin-conjugating enzyme Ube2o S892 
(E3-independent) E2 ubiquitin-conjugating enzyme Ube2o S81 
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(E3-independent) E2 ubiquitin-conjugating enzyme Ube2o S83 
Ubiquitin fusion degradation protein 1 homolog Ufd1l S299 
Protein Wdfy3 Wdfy3 S1942 





























Appendices | 163  
 
 Acknowledgements 
I would like to thank Prof. Dr. Reinhard Jahn for his constant support during this project. 
Reinhard, thank you for sharing with us your enthusiasm for science and brilliant ideas, every 
time after meeting with you I was reminded that the world of science is so wonderful and 
interesting and I am grateful for this. It was an honor for me to work in your group. 
I thank Prof. Henning Urlaub for his support and scientific input in the Mass Spectrometry part of 
this project. Henning, thank you for letting me integrate to your group and using your precious, 
expensive instruments.  
I also would like to thank Prof. Jürgen Wienands for being part of my thesis committee and for the 
discussions and inputs during the thesis committee meetings.  
I thank my collaborators in the Neurobiology Department: Dr. Dominika Czernik, Dr. Ángel Pérez-
Lara and Dr. John Chua for their scientific inputs and technical assistance. In addition, I would like 
to thank all the former and present member of the department especially Seichii, Shruttee, 
Dragomir, Hale, Agata, Marcello, Vedran, Claudia, and Vindya. Special thanks go to Tahere for 
proofreading my thesis, my student, Deniz Kaya, working with whom was a pleasure, Dr. Janina 
Boyken for teaching me the synaptosome preparation and Łukasz Jabłoński for helping me to set 
up the electrical stimulation method.  
I would like to thank Dr. Gotfried Meiskes, Dr. Hans Dieter Schmitt and Elisa Reckmann-Heinrich 
for their help with lab-related issues. I would also express an additional thank to Dieter for 
sharing his office with me during the writing phase. I thank Brigitte Barg-Kues, Sigrid Schmidt, 
and Dagmar Diezmann for their technical assistance. 
I would like to thank all the members of Bioanalytical Mass Spectrometry Group especially, Uwe 
Pleßmann, Monika Raabe, and Annika Kühn for their excellent technical support in maintaining of 
the Mass Spectrometry Instruments. I also thank, Dr. Kuan-Ting Pan for very helpful discussions 
and critical review of my paper and thesis. Thank you Kuan-Ting, I learned a lot from you. I also 
thank Dr. Jasmin Corso and Dr. Sunit Mandad for their helpful discussions and technical assistance. 
I thank members of animal facility of MPI-bpc especially Sascha Krause and Thomas Gundlach for 
their help with animal delivery and taking care of rats. 
I want to thank my PhD program, International Max Planck Research School for Molecular Biology, 
for financial support during my thesis and also for providing great opportunities to grow and 
develop through the courses, organization of events and interesting excursions. Particularly, I 
 
Appendices | 164 
 
would like to express my gratitude to Dr. Steffen Burkhardt and Kerstin Grüniger for their 
excellent help, and council from the first day of my arrival in Germany.  
I would like to thank specially Dr. Zohreh Farsi not only for being an excellent colleague but also 
a very supportive friend. زهره گرم دمت    
My great thank goes to Sasha, who was always there for me with a smile to calm me down from 
all my frustrations and worries, reminding me everything is and will be great. Sashko, life with 
you is much more beautiful.  
Finally, I would like to thank my family, who is my strength in life. I am a lucky person to have a 
great family that persuaded me to follow my dreams, support me in any way they can and love 
me unconditionally.  عزیز کاوه و مریم بابا، مامان، مرسی  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
